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ABSTRACT
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder causing many
physical limitations. Rhythmic auditory stimulation (RAS) influences motor complications not
alleviated by medicine and has been used to modify straight line walking in this population.
However, motor complications are exacerbated during more complex movements including
those involving direction changes. Thus immediate RAS effects on direction switch duration
(DSD) and other kinematic measures during a multi-directional step task were investigated in PD
patients. Long term RAS application was also explored by evaluating functional gait and balance
and kinematic step measures before and after 6 weeks of multi-directional stepping either with
(Cue, C group) or without (No cue, NC group) RAS use. Evaluations were also administered 1, 4
and 8 weeks after training termination. Kinematic measures were collected during stepping
without, then with RAS for the C group and without RAS for the NC group. Step testing/training
was performed at slow, normal and fast speeds in forward, back and side directions.
Participants with PD switched step direction during the stepping task faster with RAS use
before training. Like straight line walking RAS application influenced the more complex task of
direction switching and counteracted the well-known bradykinesia in PD.
After training both groups improved their functional gait and balance measures and
maintained balance improvements for at least 8 weeks. Only the C group retained gait
improvements for at least 8 weeks after training termination. Adding RAS resulted in functional
benefits not observed in training without it.
Kinematic measures compared before and after step training clarified the underlying
contributors to functional performances. Both groups reduced the variability of DSD. The C
group participants maintained this alteration longer. DSD reduction also occurred after training

ix

and was retained for at least 8 weeks for this group. These outcomes further support the
advantages of adding RAS to training regiments for those with PD.
The current results indicate that RAS effects are not limited to simple activities like
straight line walking. Moreover, RAS can be used for improving and maintaining improvements
longer in activities involving various forms of transition which present most difficulties for those
with PD.

x

CHAPTER 1: INTRODUCTION
Parkinson’s disease (PD) is a neurodegenerative disorder first introduced by James
Parkinson in Essay on the Shaking Palsy in 1817 as ―Paralysis agitans‖ [1]. PD is the most
common neurodegenerative disease after Alzheimer’s disease with an annual incidence of 13.4
in 10,000 Americans [2]. The main problem in PD is the dopaminergic deficiency of the basal
ganglia (BG) [3]. Under normal conditions dopamine release allows the basal ganglia to serve as
an internal trigger, enabling movements to occur in a sequential manner. Disruption of dopamine
due to PD disrupts the normal functioning of the basal ganglia, thus voluntary movements.
Consequently, motor deficits remain a primary complaint of patients from this population.
Despite the arduous efforts of scientists that have increased our knowledge of the disease,
there is neither a cure for PD nor a definitive treatment for its symptoms. Current rehabilitation
techniques provide a means for reducing some of the motor complications associated with PD [4]
that are not relieved with medication or surgical interventions. Use of external stimuli to help
trigger movement has received special attention, as PD patients show the ability to improve some
of their symptoms under externally triggered conditions that do not occur with other treatments
(i.e. movement variability and efficiency).
External Stimulation
―Kinesia paradoxical‖ refers to the ability of PD patients to produce normal movements
under certain conditions. The use of external stimulation is one condition that can enable patients
to perform a motor task more like their healthy peers. Such ability has been associated with
gaining direct access to other areas of the motor cortex through bypassing the basal gangliasupplementary motor area (BG-SMA) pathway under external stimulation [4-7]. This was
observed directly in a study on regional cerebral flow measures, where authors reported less
activity in SMA and putamen cortical areas in PD patients during an internally driven task but
1

similar activity of the cortical areas of PD patients to that of controls during an externally
(auditory) driven task [7].
Visual stimuli [8-10], cutaneous triggers such as vibration [11] and electrical stimulation
[12] and auditory stimulation [13, 14] are types of external stimulation used successfully in
assisting PD patients alter movement. Although auditory and visual cues are the most common
modalities used as external stimuli for treatment of PD symptoms, there is evidence that
rhythmic auditory stimulation (RAS) may have benefits over visual cues. The termination of
activation of the auditory specific brain areas upon removal of RAS is unlike the continuous
activity of visual specific brain areas after removal of visual stimulation. This phenomenon is
interpreted as direct transfer of auditory information to a stable motor output [15] and/or
inadequacy of the CNS to direct generation of a motor response in response to visual stimuli
[16]. Encoding temporal characteristics of rhythmic visual stimulation to the auditory cortex
accounts for the prolonged brain activity of the visual modality [17]. Increase in excitability of
spinal motor neurons via the reticulo-spinal pathway in response to an unexpected noise [18] and
facilitation of the H-reflex in response to a low threshold single auditory sound [19] are evidence
for sub-cortical processing of auditory stimuli [20, 21] and add to the potential benefits of its use.
Superiority of RAS to visual stimulation is evident with better performance of normal
participants in synchronizing and syncopating a movement to the former modality when
compared to the latter. Because syncopation is considered more complex due to additional
cognitive demands this finding suggests that RAS is easier to follow regardless of the task
complexity [15]. Individuals have a higher tendency to match the pattern of their finger tapping
to auditory distracters during a visual synchronization task when compared to the opposite
condition [22]. In presence of both RAS and visual stimuli the temporal pattern of the inter
response interval (IRI) of finger tapping [23] and the benefits of improving gait velocity and
2

stride length [24] are similar to that of auditory alone. Moreover, reaction time is longest for
vision, followed by that of touch, then by audition [25], allowing for faster initiation of motor
responses to auditory cues than the other senses.
The advantages of auditory stimulation use for motor responses are numerous. Auditory
stimulation offers superior temporal organization of movement and perception, and thus appears
to be the most appropriate external stimulation modality for motor control. Moreover, RAS
seems to activate neural areas that remain functional in PD patients, thus may offer benefits in
rehab for this population that are not offered through other methods.
Methodological Considerations for Intervention
The current literature involving use of different therapeutic techniques incorporate
several characteristics of a good intervention in a guideline suggested for use with PD patients
after a comprehensive Physical Therapy (PT) literature review. This guideline suggests avoiding
simultaneous tasks especially at initial stages of therapy for PD patients and advises breaking a
sequential task into its components at initial stages of the disease for PD patients [4]. This
guideline results in training regimes that follow several motor learning strategies designed to
promote better learning and retention of certain skills, including the practice of single simple
tasks prior to increasing task difficulty. The following text reveals additional factors that should
be considered when designing training regiments for those with PD.
Measures of Evaluation
Tests of balance and mobility and kinematic/kinetic measures of movement performance
offer insight to movement dysfunction in different populations, including PD. In general PD
patients who experience falls perform poorly on the functional reach test [26, 27], as well as
various balance and gait measures such as tandem gait, tandem stance and turning around, the
dynamic gait index (DGI) and the Tinetti gait and balance tests [28]. PD patients with higher
3

rates of falls also show a significant amount of increase in the number of steps when required to
turn [29] and during the Timed-Up-and-Go (TUG) test [27]. Functional outcomes are important
for evaluation of the effectiveness of a program because they offer insight to the potential for
individual success in more ―natural‖ settings and have been linked fall risk. In contrast
kinematic/kinetic measures offer insight to specific functional performances that can help
explain functional outcomes. Slower movement velocity common in PD patients [8], which does
not allow for quick recovery could be from decreases in movement distance, movement
frequency or both. Kinematic analyses of performances help determine the movement
characteristics and the potential causal factors of functional deficits and training results. Testing
of functional outcomes without movement kinematics/kinetics or vice versa may limit the
generalization of the findings, hence by testing different measures one can offer greater insight
needed to better understand the nature of functional performances, including practice outcomes.
Duration of Practice and Retention
Duration of training or practice of a skill can often influence performance outcomes.
Most auditory cued training studies for PD involve single session practices [13, 14, 30, 31]. The
number of studies identifying long term outcomes for this population after intervention with only
RAS use is limited. Many of the collected measures were recorded immediately after practice
termination [32-34].Studies including a retention analysis are few and reveal conflicting results
from methodological differences [35, 36]. Hence, it is very difficult to determine and/or predict
the benefits of auditory stimulation as a rehabilitation regimen. Improvements using RAS
occurring in a short practice period are impressive, however there is still need to determine the
neural plasticity retention sought after practice termination.

4

Direction of Movement
Direction of movement can influence task difficulty thus movement performance and
enhancement with practice. The cause of falls can be specific in PD patients and appears linked
to more complex tasks such as changes in movement direction. Unlike healthy older adults, PD
patients experience indoor falls more than outdoor falls [28]. PD patients report problems (i.e.
freezing, akinesia) while changing directions and crossing over obstacles [37-39]. Freezing due
to a direction change is not a major concern for most older adults without neurological disease.
The literature on RAS use with PD patients primarily focuses on forward movements such as
that used for walking forward in a straight line path (straight line walking). Although these
studies offer good insight to gait function, they exclude movements made in different directions
used commonly for daily movement such as stepping backwards or to the side after hand
washing. Studies for improving more complex movements in PD patients are still needed.
Speed
Changing performance speed often affects performance outcomes. Daily activities are not
always performed at the same speeds. Rushing to answer a ringing phone may be performed
faster than a movement to go check the mail. PD patients perform movements slower than their
aged matched controls [40] and have difficulty controlling relatively fast and slow movements
[41]. Incorporating different speeds in training protocol allows the PD patients opportunity to
prepare for different tasks, while changing the level of movement difficulty.
Multimodal Training
Several recent studies have used auditory cues within their therapeutic design for PD
patients after completion of 3-8 weeks of training. Some report long term retention in functional
improvements after training with external cues compared to those PD participants using the same
techniques with no external cues [36, 42]. These studies incorporate various training strategies.
5

For example, in one study auditory cues of a metronome were combined with other forms of
external stimuli (visual/tactile) [36]. In another study a combination of mobility and stretch
exercises were utilized with various visual cues and ―sounds‖ [42]. Thus while these studies
offer some insight regarding the existence of continuation effects after long term practice with
external stimulation they make it difficult to determine which strategy/strategies led to the
successful outcomes.
Additional Considerations
Motor learning strategies used by scientists are proven effective for normal healthy
people and PD patients alike. Adjusting the amount of feedback [43, 44] and the order of practice
(blocked/random) [45] can affect and enhance motor learning results in those with PD. These
strategies appear to vary according to the task studied, resulting in ambiguities for choosing the
correct technique. Thus while more research is required, it is important to carefully design the
training protocol and utilize the most appropriate learning techniques.
In summary the outcomes of several studies showed that including external stimuli in
rehabilitation are effective in improving various aspects of movement in PD patients. Although
studies involving training with RAS showed improved movement, the effectiveness of RAS
when used as the only external cue for long term intervention and after practice termination are
rare in this population. It appears that the need for an intervention involving training PD patients
with RAS is necessary to understand its effects on motor symptoms and functional performance
in this population. To enhance the chances for success, the training should be for a relatively
long time period (4-6 weeks), should gradually increase task difficulty, use different movement
speeds and utilize movements involving different directions and/or obstacle avoidance.
Successful results in this type of study would offer behavioral evidence that support previous
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work for use of altered neural pathways underlying movements with RAS. A more detailed
literature review is included in Appendix A.
Dissertation Outline
Chapter 1 provided the background information to motivate the experiments to follow.
Background information regarding PD and related motor complications offered insight to the
population studied. Review of the existing literature allowed us to justify the use of RAS and to
identify techniques useful for helping those with PD to improve their existing motor
complications. This was especially important for activities that increase risks of falls such as
those that involve more complex movements such as direction changes. We chose to determine
whether modifications observed for straight line walking in those with PD with the use of RAS
would occur for tasks involving the more difficult task of direction transitions during
performance of a multi-directional step task, while simultaneously improving functional abilities
linked to fall risk. As a result Chapter 2 was designed to explore the immediate effects of RAS
on the multi-directional step task by having individuals with PD perform the task without and
with RAS. The primary goal was to determine the immediate effects of RAS on duration of step
direction switching abilities or direction switching duration (DSD). Several other kinematic
measures were collected and calculated for additional insight to short term effects of RAS on
stepping performance. The results allowed us to determine the immediate effects of RAS on
multi-directional stepping and to pose assumptions regarding the potential long term application
of multi-directional step training with the use RAS.
A training program can be considered effective if participants can generalize what they
learn to similar activities in different contexts of everyday life. Individuals with PD are no
exception and should be able to benefit from a training program beyond the borders of a
laboratory or clinic. In Chapter 3 results of the effects of 6 weeks of multi-directional step
7

training with and without the use of RAS on functional gait and balance activities were
determined. We explored the effects of training on various functional activities immediately after
and up to 8 weeks after training termination. These results provided us with key information
regarding the abilities of those with PD to generalize and maintain step training effects on gait
and balance measures depending on whether they practiced stepping with or without RAS.
In Chapter 4 we compared the kinematic results from performance of the multidirectional step task with and without RAS use before and after training to better understand the
training alterations to functional performances identified in chapter 3. The primary goal was to
determine whether DSD and other kinematics, calculated during performance of the multidirectional step task without RAS use, were influenced by training with and without the use of
RAS differently. The results of this chapter allowed us to better understand the underlying
factors of the observed functional improvements and to pose speculations regarding the involved
central mechanisms.
Figure 1.1 provides an outline of how chapters 2, 3 and 4 were developed as
subcomponents of one large study. All participants completed functional tests of gait and balance
which were always collected without RAS. Step training and testing differed slightly for the two
defined groups so that those who trained with RAS (Cue, C group) were tested without and with
cues in the No RAS and RAS conditions, respectively, while those who trained without RAS (No
Cue, NC group) were only tested in the No RAS condition. In chapter 2 analyses concentrated on
pre-test measures and immediate effects of RAS use. In chapter 3 analyses from training effects
on functional measures were presented. Analyses from training effects on kinematic measure
were offered in chapter 4 to give insight to functional alterations.
The outcomes of chapters 2, 3 and 4, add to previous literature and provide insight
regarding the effects of RAS on activities that have not been explored previously. Chapter 5
8

brings this manuscript to a close by reviewing the key findings, discussing how certain key
findings of each chapter relate, indicating limitations of the current work and offering future
investigations for better assisting individuals with Parkinson’s disease.
Outline
Screening
Pre-test (PRE)*

Chapter 2

Training for 6 weeks, 3 days/week (<1 hour)
Step training with RAS — Cue group
Step training without RAS — No cue group

Chapter 3: Functional testing
Chapter 4: Kinematic testing

Post-test (POST)*
Retention test week 1 (RTW1)*
Retention test week 4 (RTW4)*
Retention test week 8 (RTW8)*

* Testing:
Functional testing — Cue and No cue groups
Kinematic step testing without and with RAS — Cue group
Kinematic step testing without RAS — No cue group

Figure 1.1 The general outline of the overall dissertation study. The outline indicates screening,
testing and training visits and associated training and testing for each group. Results were
separated and presented in three chapters (2, 3 and 4) as shown.
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CHAPTER 2: DURATION TO SWITCH STEP DIRECTION DURING A MULTIDIRECTIONAL STEP TASK IN PARKINSON’S PATIENTS IMPROVES WITH
RHYTHMIC AUDITORY STIMULATION
Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with
many motor complications. Although deficits in performing voluntary movements are evident
in individuals with PD, research suggests that the ability to generate normal movement is not
lost [1]. The main problem in this population involves the inability of the basal ganglia (BG) to
―switch‖ an existing motor pattern with a more suitable response according to the environment
or task demands [2, 3]. The ―switching‖ problem is evident during unilateral [4] or bilateral [5]
multi-limb movements, dual task performance [6, 7], multi-task performance [8] and when
required to change movement direction [9, 10].
Bradykinesia accompanies the difficulties in changing movement direction in PD.
Individuals with PD experience longer transition in muscle activation during a rise-to-toe task
when gastrocnemius activity replaces that of the tibialis anterior [11]. They also experience a
longer gap when switching from hip flexion to hip extension during forward and back direction
stepping [9] and the sit-to-stand task [10]. Delays in switching movement direction accounts for
overall slowness [10] and the augmentation of temporal (longer step durations) and spatial
(smaller step lengths) step deficits in turning compared to straight line walking [12].
In PD the deficient BG are incapable of triggering inhibition and releasing relevant
motor responses [13, 14]. Replacement of this failing internal trigger is suggested in order to
counteract the associated movement deficiencies [15]. Candidates for trigger replacement
include visual [16, 17], auditory [16, 18] and tactile [19, 20] external cues. More extensive
application of rhythmic auditory stimulation (RAS) compared to other external cues for
sequential movements likely occurs because of robust connections between temporal aspects of
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RAS and movement generation [21, 22]. Moreover, RAS can result in temporal gait alterations
for people with PD that do not occur with visual [23] or tactile [24] stimuli.
Gait difficulties are one of the most noticeable motor deficits in individuals with PD [25],
involving spatial [26, 27] and temporal [28-30] aspects of movement. Interestingly, different
frequencies of RAS can influence temporal and spatial measures of walking. Observed changes
in velocity [18, 22, 31-33], step amplitude [22], step duration variability [22], step length [22,
23, 31-33] and cadence [18, 31, 33] contribute to our understanding of RAS applications for
straight line walking. However turning difficulties commonly contribute to gait complications
in this population [34], causing higher incidence of falls [35-37] and regular freezing episodes
[38, 39]. Research on the effects of RAS use involving direction transitions are still needed.
Beneficial effects of RAS use for gait turns performed by individuals with PD exist [38, 40]. In
the present work we continue the study of RAS application for its immediate use in step
direction transitions performed by those with PD as a precursor to training applications.
The primary goal of the current study was to investigate the effects of RAS on step
kinematics obtained when PD patients performed a multi-directional step task. The time
required to switch step direction (direction switch duration, DSD) served as the primary
measure, due to slowing difficulties in shifting direction in this population. We hypothesized
that DSD would decrease with application of RAS compared to without it. As an added value
we explored the relationships between DSD, disease severity and functional performance
measures in this population. Because of the progressive nature of the disease [41] and
associated worsening of motor symptoms [42], we expected longer and/or more variability in
DSD with increased disease severity and decreased function.
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Methods
Participants
Twenty-seven people with idiopathic PD volunteered for the study. Six people were
excluded, thus 21 individuals served as participates in the experiment.
Participants consented to partake in the study approved by the university’s Internal
Review Board. The Hoehn and Yahr (H&Y) scale [43] and Unified Parkinson’s Disease Rating
Scale (UPDRS) [44] were used for determining severity of the disease and PD motor symptoms,
respectively. The participating volunteers were diagnosed with idiopathic PD with disease
severity of 2 to 4 according to H&Y. Inclusion criteria were also contingent on stable drug use,
the ability to stand and walk with or without an assistive device, the ability to hear and
differentiate auditory tones (described below) and a Mini Mental State Examination (MMSE)
score > 24 [45]. Participants were also excluded if they had other disorders that could affect their
performance, if they experienced unexpected off periods (the time when medication effects wear
off and many off medication symptoms return) indicated by items 37 and 39 of UPDRS (scores
= 1 and > 2, respectively), and if they reported a change in medication.
Study Design
During an initial screening visit PD participants were evaluated and informed about the
study. Preliminary data from 5 volunteers provided insight to the effectiveness of the initial
experimental design, thus were placed in a pilot group (group P). Design changes led to limited
data from this group (see characteristic list from all participants in Table 2.1). These
characteristics and various step kinematics during performance of the multi-directional step task
were collected on the remaining 16 volunteers. Eight of these participants performed stepping
with no external cues (No cue group or NC), while the remaining 8 performed the task with and
without external cues (Cue group or C). The grouping for NC and C participants resulted from
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commitments to a step training program with and without RAS use. Overall, we analyzed initial
functional measures from 21/21 qualified participants, kinematic measures for stepping with No
RAS from 16/21 participants and kinematic measures with and without use of RAS from 8/21
participants.
Comfortable/normal walking and/or stepping cadences were determined for each
participant on the screening visit. Participants were asked to walk approximately 6 m at a
comfortable walking speed 5 times. Cadence for 4 m was averaged over the 5 trials and used to
determine each participant’s normal walking cadence. Calculating cadence for the shorter
distance allowed avoidance of large changes expected at the beginning and end of the walkway.
Because participants in group P reported difficulties in using the walking cadence as their step
cadence, C and NC participants were asked to perform forward stepping (see below) for 10 s 5
times to determine an average comfortable stepping cadence. This cadence was used for RAS
frequency determination for individuals in group C. Average step cadence for this group is
presented in Table 2.2.
Multi-directional Step Task
Sixteen participants performed the stepping task approximately 1 hour after medication
intake. Participants from group C performed the task with and without RAS, while group NC
only performed the latter, which is described next.
During the No RAS condition, participants started with legs in anatomical position at a
self-selected distance apart. Instructions and/or a demonstration of the stepping protocol
preceded testing and were repeated after every break. Participants were instructed to step away
and back in three directions (forward—F, side—S and back—B) at a predetermined speed:
―normal‖ or ―relatively faster‖ or ―relatively slower‖ than normal. Stepping started after the
verbal trigger of ―Ready? Start.‖ Stepping in one direction was performed for approximately
16

Table 2.1 Characteristics and test measures from 21 participants
Subject details

Mean ± 1 SEM

Age (years)

72.0 ± 1.26

Gender

F = 8; M = 13

Height (cm)

170.1 ± 2.4

Weight (kg)

76.9 ± 3.8

Disease duration (years)

8.9 ± 1.8

Modified H&Y = number of
participants for each stage

2=3
2.5 = 13
3=3
4=2

Normal walking cadence (steps/min)

110.8 ± 4.1

MMSE

28.1 ± 0.4

DGI

16.3 ± 0.6

UPDRS-Motor

27.6 ± 2.3

UPDRS-ADL

14.3 ± 0.9

UPDRS-Composite

7.6 ± 0.7

Tinetti-total

17.5 ± 1.1

Tinetti-gait

7.0 ± 0.5

Tinetti-blance

10.6 ± 0.7

TUG (s)

14.7 ± 1.3

FOGQ

11.4 ± 1.4

Mean ± 1 standard error of the mean for various characteristics and functional measures of the 21
participants. H&Y—Hoehn and Yahr scale; F—female; M—male; Mini Mental State Examination—
MMSE; Dynamic Gait Index—DGI; Unified Parkinson’s Disease Rating Scale—UPDRS;
Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing of Gait Questionnaire—
FOGQ.
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Table 2.2 Characteristics and test measures from C group participants
Subject details

Mean ± 1 SEM

Age (years)

73.3 ± 2.22

Gender

F= 3, M = 5

Height (cm)

168.8 ± 3.3

Weight (kg)

79.5 ± 0.18

Disease duration (years)

8.9 ± 1.8

Modified H &Y = number of
participants for each stage

2=1
2.5 = 5
3=1
4=1

Normal walking cadence (steps/min)

110.5 ± 4.8

Normal stepping cadence (steps/min)

56.8 ± 6.0

MMSE

28.3 ± 0.50

DGI

16.3 ± 1.0

UPDRS-Motor

27.1 ± 3.6

UPDRS-ADL

13.9 ± 1.31

Composite-Score

8.1 ± 1.0

Tinetti-Total

17.0 ± 1.8

Tinetti-gait

6.4 ± 0.7

Tinetti-balance

10.6 ± 1.2

TUG (s)

15.0 ± 2.0

FOGQ

12.5 ± 1.9

Mean ± 1 standard error of the mean for various characteristics and functional measures of the
Cue group participants (N=8). Normal walking cadence represents the average step frequency of
a 4 meter walk. Normal stepping cadence was calculated from 10 seconds of the forward step
task. H&Y—Hoehn and Yahr scale; F—female; M—male; Mini Mental State Examination—
MMSE; Dynamic Gait Index—DGI; Unified Parkinson’s Disease Rating Scale—UPDRS;
Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing of Gait Questionnaire—
FOGQ.
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11.25 s before switching to the next direction, resulting in the total trial duration of 33.75 s to
complete steps in each direction. Note the relatively short time period (~ 30 s) to avoid fatigue
[46]. For each step participants were told that the foot should be lifted completely from the
ground then come to complete contact with the underlying surface. Instructions to keep speed
constant within each trial and within a speed range were also given. In order to avoid mental
overload that could occur with step counting participants were given a ―Last step‖ cue
approximately 1 second prior to a direction switch and a ―stop‖ cue at the end of the trial.
Participants in the group C were also asked to perform the multi-directional step task with
RAS. Auditory tones, one for each direction, were presented at three stepping speeds: normal
step cadence and 10% faster and slower than normal step cadence, +/-10%, respectively.
Participants were instructed to step in time with the auditory cues. A verbal preparatory
command of ―Ready? Here it comes.‖ was provided prior to the first cue used to signal stepping
onset. A tone change signaled a direction change after the 11.25 s and 22.5 s of the preceding
directions and participants stopped when the beats stopped.
Three different auditory cues: cluck, ding and soft cork, were recorded at a 22.5 kHz. The
cluck, ding and soft cork sounds had frequencies of 1003.3 Hz, 784.93 Hz and 529.38 Hz,
durations of 88 ms, 915 ms and 127 ms and corresponded to the forward, side and back step
directions, respectively. Cue presentations for RAS were generated by a specially designed
LabView program and presented through two speakers at approximately 75 dB, well above the
average hearing loss range (25-40 dB) suggested for older population [47]. Prior to testing P and
C participants were presented with cues in a random order and were able to raise their hands and
describe them when heard.
Several factors were taken into consideration to design the trials for the multi-directional
stepping. The original goal was to test participants on their abilities to switch directions to and
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from all possible directions and speeds. Six direction combinations (FSB, FBS,
BSF, BFS, SFB and SB) at each speed were performed with and without
RAS to total 36 trials during pilot tests. Despite taking sufficient breaks P group participants
were exhausted after functional evaluations and equipment prep time. To offset fatigue effects
during a single session we limited direction combinations to FSB, SFB, and BSF
to yield 18 trials (9 with RAS, 9 without RAS) for the C group and 9 trials for the NC group (No
RAS only). These direction combinations allowed participants to initiate stepping to each of the
three directions and included step changes to each direction. Trials were randomized and
repeated if participants did not adhere to primary instructions. Two participants from group C
and one participant from group NC repeated 1 to 3 trials for not adhering to instructions in the
No RAS condition. Two participants repeated 3 and 4 trials for not adhering to instructions in the
RAS condition.
Evaluation
Participants were evaluated for experimental inclusion and functional measures on
screening and test visits. Comfortable walking/step cadence determined on the screening visit
was used for the stepping task performed on the test day. Visits were at the same time of the day
and in the same location. Medication intake was confirmed prior to each session. Collecting
functional measures during both visits allowed us to determine the stability of these
measurements in participants. RAS frequencies used for step cueing on the test day were
determined from comfortable/normal walking cadence (P group) or step cadence (C group)
determined at the screening visit. Functional tests were conducted before performance of the
multi-directional step task. Order of functional measurements was randomized. The multidirectional stepping with RAS always followed the No RAS condition (for P and C groups) to
avoid carry over effects from the auditory stimulation (e.g. [48, 49]). As mentioned previously,
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speed and direction combinations were randomized within each condition. Reducing direction
combinations along with scheduled and optional breaks for C and NC participants allowed these
participants to complete setup and testing within 1.5 hours and without the fatigue concerns
observed in the P group.
PD symptom severity scores and tests of physical and mental function were evaluated in
all participants. The H&Y and MMSE scores, described previously, offered insight to disease
severity and mental function, respectively. The Dynamic Gait Index (DGI) determined the
likelihood of falling in older adults by testing eight facets of simple and complex gait. The
Timed-Up-and-Go (TUG) offered another measure of fall risk [50]. The Motor and Activities of
Daily Living (ADL) sections of the UPDRS determined the level of overall motor and ADL
functional disability in participants. Similar to previous work [51], the UPDRS-composite score
involving UPDRS gait and balance items (13-15, and 29-30), was also included. The Tinetti gait
and balance test was also used as a measure of fall risk. Lastly, the Freezing of Gait
Questionnaire (FOGQ) determined perceived gait in daily living skills and the quality and
frequency of freezing of gait [52]. See Appendix B for the functional tests’ instructions and score
sheets.
Step kinematics were also determined. Three-dimensional motions of passive reflective
markers placed on the lateral malleoli of the ankles were monitored during the multi-directional
step task using a four camera digital video system (Qualisys Mediacla AB). The first auditory
cue in a trial triggered signal capture at 60 Hz. For the No RAS condition this program was
muted during collection. The visual display corresponded to temporal occurrences in a trial and
allowed the examiner to signal the participant for step initiation, direction switching and
termination in the No RAS condition.
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Position data of ankle markers were filtered using a zero-phase lag 10 point averaging
process. Tangential velocity profiles were calculated using five-point differentiation of the
filtered position data. Position and velocity profiles were plotted across time, visually inspected
and marked to determine kinematic measures. Movement end (END) corresponded to the frame
just after the movement ended and was determined as the last discernable change in the given
movement direction from position profiles. Onset of movement (ON) was determined as the
frame prior to the first discernable movement determined in a given direction.
Several movement kinematics were determined to offer insight to the temporal and
spatial characteristics of stepping in those with PD. We used the average duration to switch step
direction, direction switch duration (DSD), as the primary measure because it offered insight into
temporal transitions in movement direction which are disrupted in PD [9, 10]. DSD was defined
as the interval in seconds between the time one foot returned to the platform and stopped moving
in one direction and the time the opposite foot moved to leave the platform in another direction.
For example, the absolute difference between the frame for END of right ankle back and the
frame for ON of left ankle side was divided by the 60 Hz sampling frequency. Illustration of
vertical bars used to identify frames for END DSD and ON DSD of one trial for one participant
are shown in Fig. 2.1A. Average DSD values were calculated for each direction to which the
switch was made within a given speed for each participant. Peak tangential velocity, known to
decrease in individuals with PD when performing voluntary movements [53], offered insight to
the spatiotemporal kinematics of stepping. This was determined by identifying the maximal step
velocity (VEL) between ON and END of each step from the tangential velocity profiles of the
ankle markers (see ON MOV and END MOV, Fig 2.1B). Step length (SL), step height (SH) and
step number (SN) were also calculated due to reductions in step length [32], increased shuffling
[54] and changes in cadence [55] commonly observed in this population. SL was calculated as
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the displacement of the ankle marker in the lateral (y-) direction for side steps or
anterior/posterior (x-) direction for forward or back steps (see SL, Fig. 2.1B). In a back step for
example, SL was the difference between the x-values at ON and END of a given step. SH was
determined as the z-value difference between the step END and the initial trial z-value during
stance and prior to step initiation (see SH, Fig. 2.1B). Velocity profiles were also used to
determine SN in whole or half steps for each direction of a trial during the 11.25 s. A half trial
was counted if more than half, but less than the whole velocity profile was included in the time
frame. Peak of the velocity profile was used as the half way mark. One can count 7.5 steps in the
back direction using velocity profiles in Fig. 2.1B (the interval between frame 0 and the line
marking 11.25 identify the duration s for this direction). For each participant average SL, VEL,
SH and SN values were determined for each direction within a given speed for each leg (R, L).
Standard deviations were used for variability of these measures, excluding SN, and are presented
with a ―var‖ subscript in the text.
Statistical Analyses
Pair wise t tests were used to determine whether values of patient characteristics and
functional measures did not differ for screening and test visits. In order to evaluate participants’
abilities to follow the presented RAS beats t tests were performed to determine if the number of
steps taken within each speed and direction were similar to the number of RAS beats presented.
A randomized blocked on subject design with a 2 x 3 x 3 treatment analysis and Kenward Rogers
adjusted degrees of freedom was used to determine if differences in each kinematic measure
existed for group C when performing with and without RAS. Within subject factors included:
Condition (RAS, No RAS), Speed (fast, normal, slow) and Direction (forward, side, back).
Subject was the only random factor. Tukey’s post-hoc tests were used when significant main
effects or interactions were identified. A Pearson Correlation Matrix was performed to assess the
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Figure 2.1 Example of position and velocity marking. Examples of position (A and B) and
velocity (B) profiles used for identifying different kinematic variables are presented. Data are
from two different trials for plots in A and B. Example markings used for direction switch
duration (DSD) are plotted in A and those for peak step velocity (VEL), step length (SL), step
height (SH), step number (SN) and reaction time (RT) are plotted in B. Position and velocity
profiles are separated in B for better clarity. Plots in A show the end of the movement of the right
ankle marker in the back direction (x) is indicated by the END DSD solid line and the onset of
the movement of the left ankle marker in the side direction (y) is indicated by the ON DSD solid
line. Plots in B show corresponding lines determined for a single step and indicate ON MOV and
END MOV of the first back step (x) of the right ankle marker. The vertical dashed line
represents 11.25 s associated with the timing for a direction change.
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relationship between kinematic measures (N = 16; C and NC), functional measures (N = 21) and
disease severity (N = 21). Data were analyzed using SAS (V.9.1) with significance level set at 
= 0.05.
Results
Several measurements from the 21 participants and 8 participants in group C are included
in Tables 2.1 and 2.2, respectively, to offer insights to the populations used. The majority of
participants were males and at a moderate stage of the disease (H&Y = 2.5) with 3 participants at
stages 2 and 3, and 2 participants at stage 4 (Table 2.1). Fall risk of participants was high as
indicated by scores on the DGI (≤ 22 [56]), TUG (> 8.50 s [50]) and Tinetti gait and balance test
(total < 19 [57]). Average normal step cadence for the 16 participants used in kinematic analyses
(56.9 ± 4.8 steps/min) was much lower than that for normal walking cadence for all participants
listed in Table 2.1. Step cadence included each foot placement during the forward step task (i.e.
stepping forward and back) with alternating legs, thus required opposing direction adjustments
that account for the slower cadence. According to the t tests walking cadence was similar (p >
0.05) across the 3 groups (C = 110.5 ± 4.8 steps/min NC = 111.3 ± 5.3 steps/min P =110.6 ± 2.4
steps/min) and step cadence was similar for groups C (56.8 ± 6.0 steps/min) and NC (57.0 ± 7.1
steps/min).
Correlations
Significant correlations among disease severity, functional measures and certain
kinematic measures during multi-directional stepping with No RAS were identified. Correlations
between H&Y scores and functional measures from all participants are presented in Table 2.3
and show several significant associations. Higher H&Y scores significantly correlated with lower
DGI and Tinetti scores and higher TUG scores indicating greater fall risk for those with greater
disease severity. Higher H&Y scores also correlated with higher UPDRS-Motor, UPDRS-ADL,
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and UPDRS-Composite scores indicating greater functional motor impairment with greater
disease severity. Moreover, higher scores on the FOGQ correlated with higher H&Y scores
indicating greater perceived gait deficits with greater disease severity. A significant positive
correlation between DSD and H&Y scores was also determined (Table 2.4) so that higher DSD
values were associated with greater disease severity. Thus, it was not surprising to find
significant correlations of functional measures with DSD in the same direction as those with
disease severity (compare signs in Table 2.5 for DSD and Table 2.3 for H&Y), regardless of the
lower number of participants used for kinematic comparisons (N = 16 compared to N = 21).
Moreover, significant correlations of DSDvar with the UPDRS-Motor and FOGQ suggested that
the more variable the DSD, the greater overall motor impairment and the greater perceived gait
dysfunction, respectively. Slowness during step direction switching, and possibly greater
variability in these durations, are associated with greater actual or perceived functional
impairments in those with PD.
RAS vs No RAS
Kinematic measures were determined with and without RAS for the 8 participants in the
C group. Analyses demonstrated no significant difference between the numbers of steps taken
with RAS for each speed (S = 6.0 ± 1.1 steps, N = 9.5 ± 1.1 steps, F = 12.3 ± 1.1 steps) and the
number of RAS beats for compatible speeds (S= 8.6 beats, N= 10.6 beats, F= 12.6 beats). See
Appendix C for average number of steps and RAS beats for each subject. These results provide
evidence that participants were able to step to the different auditory cue frequencies. Similar to
previous work [20], we identified no significant differences between the right and the left sides
for all collected kinematics using pair wise t test comparisons. Therefore data from the two sides
were combined and associated analyses performed. Results presented next are from the
combined data.
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Table 2.3 Correlation analysis of disease severity and functional measures.

H&Y

DGI

TUG

Tinetti
balance

Tinetti
gait

UPDRS
ADL

UPDRS
Motor

UPDRS
Composite

FOGQ

-0.63

0.79

-0.73

-0.58

0.72

0.65

0.54

0.65

The r-values from the Pearson correlation between disease severity (Hoehn and Yahr scale—
H&Y) and functional measures of the 21 participants. Bold numbers represents significant rvalues. Dynamic Gait Index—DGI; Timed-Up-and-Go—TUG; Unified Parkinson’s Disease
Rating Scale—UPDRS; Activities of Daily Living = ADL; Freezing of Gait Questionnaire—
FOGQ.
Table 2.4 Correlation analysis of disease severity and kinematic measures

H&Y

DSD

DSDvar

VEL

VELvar

SL

SLvar

SH

SHvar

SN

0.60

0.00

-0.22

0.02

0.06

0.02

-0.35

0.39

-0.28

The r-values from the Pearson correlation between disease severity (Hoehn and Yahr scale,
H&Y) and various kinematic measures obtained from the 16 participants from C and No cue NC
groups performing the multi-directional step task in the No RAS condition. Bold numbers
represent significant r-values. Direction switch duration—DSD; velocity—VEL; step length—
SL; step height—SH; step number—SN. Variability of presented measures is shown with a ―var‖
subscript.
Significant main effects of Direction and Speed were identified for various kinematic
variables, however a Condition x Speed interaction was also revealed. Results of the Condition x
Speed interactions for DSD (F2, 26 = 6.10, p = 0.01), VEL (F2,25.8 = 9.59, p = 0.04) and SN (F2,20.9
= 23.66, p < 0.01) are shown in Fig. 2.2A, B and C, respectively. Plots reveal the main effects of
speed (square brackets with asterisks) with or without RAS for DSD (F2,23.91 = 5.81, p = 0.045),
VEL (F2,26.21 = 8.32, p = 0.04) and SN (F2,24 = 3.62, p = 0.04), showing that for the faster cadence
VEL (0.51 ± 0.03 m/s) and SN (11.3 ± 0.8 steps) increased and DSD (1.04 ± 0.14 s) decreased
compared to the normal cadence (VEL = 0.44 ± 0.03 m/s, SN = 8.8 ± 0.8 steps, DSD = 1.23
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Table 2.5 Correlation analysis of kinematic and functional measures
DGI

TUG

Tinetti
balance

Tinetti
Gait

UPDRS
ADL

UPDRS
Motor

UPDRS
Composite

FOGQ

DSD

-0.89

0.93

-0.64

-0.67

0.72

0.52

0.70

0.76

DSDvar

-0.22

-0.40

-0.38

-0.41

0.39

0.56

0.40

0.58

VEL

0.08

0.25

0.01

-0.28

-0.11

0.28

0.19

0.30

VELvar

-0.12

0.23

0.05

-0.09

0.12

0.08

0.11

0.07

SL

0.20

0.31

-0.05

-0.21

0.14

0.18

0.09

0.17

SLvar

-0.23

0.35

-0.05

-0.19

0.19

0.19

0.21

0.20

SH

0.44

-0.46

-0.33

0.34

0.49

0.33

0.37

0.59

SHvar

-0.42

0.32

-0.31

-0.46

0.49

0.30

0.26

0.38

SN

0.32

0.24

-0.29

-0.38

0.29

0.37

0.41

0.28

The r-values from the Pearson correlation analysis of kinematic and functional measures of the
16 participants from the C and NC groups. Bold numbers represent significant r-values. Dynamic
Gait Index—DGI; Timed-Up-and-Go—TUG; Unified Parkinson’s Disease Rating Scale—
UPDRS; Activities of Daily Living—ADL; Freezing of Gait Questionnaire—FOGQ; Direction
switch duration—DSD; velocity—VEL; step length—SL; step height—SH; step number—SN.
Variability of presented measures is shown with a ―var‖ subscript.
±0.13 s). In addition VEL (0.31 ± 0.02 m/s) and SN (5.8 ± 0.8 steps) decreased while DSD (1.47
± 0.14 s) increased at slower cadences compared to normal cadence values. Voluntary speed
changes and those induced by RAS had a similar relative influence on VEL, SN and DSD. Plots
also reveal shorter DSD (Fig. 2.2A) and faster VEL (Fig. 2.2B) values for the RAS condition
compared to the No RAS condition (see asterisks for curly bracket comparisons). SN also
increased for some subjects with the use of RAS, however the larger mean SN values with RAS
use (Fig. 2.2C) did not achieve significance for slow (p = 0.07), normal (p = 0.07) and fast (p =
0.06) speeds. Overall, stepping with RAS resulted in shorter durations in switching step direction
and increased peak step velocity.
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Analyses also revealed a significant main effect of Direction for SLvar (F2,29.6 = 3.89 , p =
0.03) and SHvar (F2,25.4 = 9.56 , p < 0.001) and showed that variability of step length and height
were greater during back steps (SLvar = 0.17 ± 0.02 m, SHvar = 0.035 ± 0.003 m) compared to
forward (SLvar = 0.15 ± 0.02 m, SHvar = 0.028 ± 0.002 m) and side (SLvar = 0.16 ± 0.02 m, SHvar =
0.026 ± 0.003 m) stepping directions. These results demonstrate that the back stepping direction
involved the highest variability of these spatial measures compared to the other directions. In
summary individuals with PD were able to modify their stepping movements under various
speed requests with or without the use of RAS.
RAS use influenced the movement regardless of the movement direction and speed, but
did not affect spatial aspects of the movement, unlike that of movement direction effects on SL
and SH variability. Moreover, DSD was significantly correlated with disease severity, both of
which were significantly correlated with functional measures. Implications of these results are
discussed in the following section.
Discussion

Everyday activities require constant changes in movement patterns that present problems for
those with PD. We expanded on the limited findings for RAS effects and its use in direction
switching in this population for which we also describe associations among disease severity,
functional performance and kinematic measures. Those with less severe PD had shorter durations
for switching step direction during multi-directional stepping with No RAS and greater
functional abilities than those in later stages of the disease. Participants with disease stages 2-4,
were able to move faster during stepping and when switching directions, and some participants
did this with a greater number of steps with the use of RAS during task performance. These
findings add to the evidence on effects of RAS that offset certain deficits in movement
kinematics resulting from the disease.
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Figure 2.2 Kinematic measures across different speeds with and without RAS. Kinematic
measures of (A) direction switch duration (DSD), (B) peak step velocity (VEL) and (C) step
number (SN) for slow (triangles), normal (squares) and fast (circles) speeds are shown. Filled
shapes represent the No RAS condition while the empty shapes represent the RAS condition.
Note, curly brackets are for RAS and No RAS condition comparisons within a given speed,
while square brackets are for slow and fast comparisons relative to the normal speed. The
asterisks indicate significant differences of the corresponding values at each bracket ends.
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Variable Associations
Disease severity was associated with several functional measures. Functional scales such
as the DGI [56], TUG [50] and Tinetti [57] are successful tools for identifying PD fallers.
Frequencies of falls from self-reports also have a robust linear relationship with disease severity
[58, 59]. Together these results explain the significant correlations of DGI, TUG and Tinetti with
disease severity as identified on the H&Y scale. Results from significant associations between
FOGQ and disease severity here and elsewhere [39] indicated that perceptions of gait
deficiencies also increase with severity of the disease in PD. The significant correlations between
UPDRS scores and disease severity were expected, as the H&Y scale was used to determine the
convergent validity of UPDRS scores [60], which are known to worsen (increase) with advanced
stages of the disease [52].
Only one kinematic measure determined during multi-directional stepping with No RAS
(i.e. DSD) was significantly correlated with disease severity (Table 2.4) and functional measures
(Table 2.5). In addition greater variability in DSD (DSDvar) showed a significant correlation with
UPDRS-Motor and FOGQ, thus overall motor and perceived gait dysfunction. In other studies
step duration variability of PD patients was significantly correlated to disease severity [26],
incidence of falls, UPDRS-Motor and UPDRS-ADL [61] during straight line walking, while
mean step duration was not [61]. With evidence that transitions during movement is abnormally
slow in PD [10], we suggest that transition durations and variability of step durations or step
transition durations can be valuable measures that offer insight to motor complications in PD.
Non-significant results of the present work also support previous findings from gait
studies in this population. For instance, although the time from toe off to heel contact when
walking differs from the time to switch step direction as defined in this study, step length during
walking was not significantly associated with disease severity [26]. Moreover, peak step velocity
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during walking was not significantly associated with incident of falls, UPDRS-Motor or
UPDRS-ADL [61]. Clearly, temporal kinematics differ from spatial and spatiotemporal
kinematics by definition. Their relative change may also differ for certain behaviors and
populations, suggesting different mechanistic control [26].
Direction Effects
For people with PD backward directional effects for variability of step length and height
for multi-directional stepping match those for postural instabilities in the backward direction
[62]. Authors identified that smaller stability margins in the backward direction after
perturbation in this direction exist in PD patients. Abnormal muscular function [63] as indicated
by higher muscular noise and higher variability of generated forces [64] explain the greater
instabilities. Such muscular abnormalities could also explain the greater variability in step length
and height in the back stepping direction in the present study and the shorter backward walking
step lengths elsewhere [65]. One may blame less activity after disease diagnosis for the abnormal
muscular behavior, however with no significant correlations between SLvar and SHvar and disease
severity, it appears that neural connections associated with temporal movement control are
responsible. The disruption of BG-SMA connections in PD, which disrupt the temporal
organization of movement [66], support this view. Further testing is required to verify this
hypothesis.
Speed Effects
Speed effects in peak step velocity and duration of step direction switching were
observed when stepping with and without the use of RAS. Participants in the current study
adjusted DSD, VEL and SN from their comfortable self-selected stepping cadence, regardless of
RAS use. Previous research also reports adaptation abilities for voluntary speed change in
activities like a self-selected [67] or cued [68] sit-to-stand task. Furthermore, individuals with PD
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can modify cadence, average gait velocity and step duration at different self-generated walking
speeds [55]. Cadence, average velocity and step duration during walking can also be modified at
lower [22, 31] and higher [18, 22, 31] RAS frequencies. Despite their ability to modify
movement with speed, individuals with PD have a lower peak velocity, a lower amplitude of
muscular activity [53] and an abnormal motor firing pattern during speed changes [69] compared
to healthy age-matched controls. Thus although participants modified the movement speed
relative to their comfortable stepping, it is probable that the underlying muscular pattern was not
comparable to that of healthy adults performing the same task.
Spatial measures in the current manuscript including step length and step height were not
influenced by speed. This is in line with previous work which reports no changes in step length
[55] and step height [70] at different non-cued gait speeds and for step length with RAS set to
7.5% and 15% higher than the comfortable waking speed [18]. Low muscle activation at
different speeds of gait apparently does not allow those with PD to alter step amplitude changes
while walking [55].
PD patients maintain the ability to increase or decrease their stepping cadence for
relatively small changes in RAS frequencies (e.g. ±10% [31] and ±15% [18]). This is not true for
frequencies of ±20%, for which those with PD are unable to modify cadence and average gait
velocity [22, 31]. In addition both PD and age-matched healthy individuals show irregularities in
stride length regulations at these frequencies [18, 22]. Thus, it seems that larger speed alterations
lead to spatial gait irregularities for healthy and individuals with PD, alike. Whether PD
individuals can become accustomed to more extreme cadence alterations with training is yet to
be determined.
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RAS and No RAS Comparisons
Despite an overall ability to modify stepping speed regardless of RAS use, additional
differences were observed when use of RAS was compared to the No RAS condition within each
speed (i.e. fast, normal and slow). Higher peak step velocities were observed with RAS
frequencies compared to the compatible No RAS conditions. Higher values of average gait
velocity were also reported during gait with a 10% faster RAS frequency compared to a selfgenerated maximum gait speed for individuals with PD, on and off medication [32]. Another
investigation revealed increased average gait velocity with use of a comfortable RAS frequency
compared to a self-selected, comfortable walking cadence in PD [22]. Interestingly, a higher
average velocity of gait was observed for PD patients walking with a 10% lower RAS frequency
in comparison to their comfortable self-generated gait speeds [22]. Clearly use of RAS can and
does increase movement velocity. Two possibilities can be used to explain the greater movement
velocity with RAS use. It may be that the underlying central mechanism for movement control
differs in the presence of RAS [22] and/or that certain central neurons entrain to temporal RAS
features [71]. Regardless of the underlying explanation for RAS control, its use in PD patients
also results in significant reduction in DSD during the multi-directional step task, a decrease in
step duration variability and the overall duration during gait with a turn [38, 40]. Therefore, RAS
use is not limited to increases in movement velocity for straight line walking, as it can modify
temporally related variables during various tasks, including those that require direction change.
We expected changes in step number with the use of RAS to accompany the decreases in
DSD and increases in peak step velocity in this same condition. One can reason that if time
between each step decreases and the movement speed during the step increases with no increase
in step length, that step number should also increase. It is possible that the duration between each
step in the same direction increased or stayed the same instead of a reduction similar to that for
34

DSD. It is also possible that the average step velocity increased or remained constant while the
peak step velocity increased. However, it seems more likely that step number changes with RAS
were not deemed significant because the magnitude of the counts (in half steps) was not sensitive
enough to detect such a change given the relatively large variability among subjects. This is
highly possible, especially when one considers the relatively small p-values reported for SN at
each speed (p < 0.10).
Conclusion
The current findings indicate that the effects of RAS on lower limb movements are not
limited to temporal features of straight line walking. RAS can also influence temporal features of
the multi-directional step task where participants must constantly change directions to oppose the
movement (out and back) and intermittently change their radial direction of movement. These
abilities are not limited to one stepping speed or direction. Moreover, the short term alterations
mirror those of other studies, while offering a task that requires little space and a setup which
makes it easy to monitor using a gait belt for safety. Use of the multi-directional step task with
RAS for a potential training regime in the PD population is currently underway.
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CHAPTER3: PARKINSON’S PATIENTS TRANSFER MULTI-DIRECTIONAL STEP
TRAINING EFFECTS TO FUNCTIONAL MEASURES OF GAIT AND BALANCE

Introduction
Neurodegeneration of the basal ganglia (BG) results in Parkinson’s disease (PD) which is
a common disorder disrupting gait and balance. These difficulties are not well treated by
medication [1] or surgery [2] and can lead to falls [3]. Individuals with PD have a 9 times greater
risk than age-matched controls of experiencing falls [4]. Therefore, complications of gait and
balance affect patients’ perceptions of their quality of life [5] and are considered key factors of
PD disability [5].
When people with PD encounter multiple movement options or require movement
changes, the BG do not function properly to release appropriate motor responses, while
inhibiting others [6]. These individuals experience problems, especially when adaptations to the
environment become necessary (i.e. changing directions, clearing obstacles, etc) [7]. They
experience falls while turning [4 ], and freeze during gait initiation [8], turning [9] and dual
tasking [8]. This explains why difficulty in movement transition is a fundamental motor
performance issue for PD [10]. Difficulties in timely inhibition and release of movement further
explain poor functional performance on the Dynamic Gait Index (DGI), Tinetti gait and balance
test [4] and Timed-Up-and-Go (TUG) test [11], tasks which involve several movement
transitions.
Medication and surgery limitations on functional performance, and the debilitating
consequences of falls on physical and emotional welfare of individuals with PD, highlight the
importance of supplementing standard medical treatments with effective rehabilitation. Although
successful conjunctive rehabilitation for PD patients exists [12], use of inconsistent strategies
and inadequate support for many applied methods do not offer clinicians the most effective
training approach for use with this population. One tactic that appears effective for enhancing
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motor aspects in PD is the use of external cues. It is assumed that those with PD maintain the
ability to generate correct movements [6] and that proper movement can be released by replacing
the lost internal trigger with an external cue [13]. Research provides support for its use with PD
[14].
External cues vary by sensory modality, however auditory cueing appears the most
effective in terms of its translation to motor output. Temporal components of auditory cues can
directly transfer into accurate and stable motor output, dismissing the need for continuous
activation of modality-specific brain areas after stimulation removal [15]. Auditory stimulation
can increase excitability of spinal motor neurons using the reticulospinal pathway [16] and
facilitate the H-reflex, thus enhance motor activation [17] without involving the damaged BG.
This becomes significant as limitations in temporal movement organization via connections
between the BG and Supplementary Motor Area lead to inadequate movement execution in
Parkinson’s patients [18].
Rhythmic auditory cues directly alter gait kinematics of individuals with PD [19-21].
Single session application of rhythmic auditory stimulation (RAS) leads to increased gait
velocity [20], step length [20] and cadence [22] and decreased double support time [22]. Practice
with auditory stimulation can also alter movement. Practice with RAS results in reduced
variability of leg muscle activity patterns [23], increased gait velocity [21], stride length [21] and
cadence [24], however RAS shows no change in the number of freezing episodes [19].
Research on the ability of individuals with PD to retain practice effects [25] or transfer
training effects to non-cued functional performance [21, 25] using RAS are limited. RAS effects
for straight, single direction walking are promising, and may or may not transfer to more
complex environments like those in the home, where PD gait complications occur most often due
to the need for constant adjustments [4]. Use of auditory, visual and sensory external stimuli with
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multi-directional gait practice as its primary intervention has produced immediate functional
benefits in PD patients [25]. However further research is needed to clarify training effects with
RAS alone on skills for which people with Parkinson’s have difficulties performing (i.e.
changing direction).
The goal of this study was to test the hypothesis that a RAS based intervention would
improve the abilities of PD patients to transfer multi-directional step training effects to gait as
measured by the DGI and to retain the functional improvements that occur. Specifically, we
wanted to determine: if training with and without RAS for 6 weeks would improve functional
gait of people with PD (immediate training effects); if any improvements beyond pre-training
values would be maintained for 1, 4 and/or 8 weeks after practice terminated (retention effects);
and if differences in functional gait immediately after training and during retention tests existed
between the groups trained with and without RAS. We hypothesized that 6 weeks of multidirectional stepping would significantly improve gait function for individuals with PD and that
improvements in gait function would still be observed after eight weeks of no practice for those
who trained with RAS.
Methods
Participants
Twenty-seven individuals with PD were screened to take part in this study. Six patients
did not meet all the inclusion and exclusion criteria and 5 participants were used for pilot tests.
As such, 16 volunteers participated in this study. Participants signed informed consent approved
by the university’s Internal Review Board. Inclusion criteria was as follows: diagnosed with
idiopathic PD; identified as Hoehn and Yahr (H&Y) stage 2 to 4; maintained stable drug use;
could stand independently and walk with or without an assistive device; and be able to hear and
differentiate auditory cues (described below). Disease severity from the modified H&Y scale
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[26] was administered alongside the Unified Parkinson’s Disease Rating Scale (UPDRS) [27] for
categorizing PD motor symptoms. Participants were excluded if they presented with: cognitive
deficits (Mini Mental State Examination Score (MMSE) < 24); history of disorders other than
PD that could potentially influence balance and walking abilities and interfere with successful
completion of the program; long lasting unexpected off periods indicated by items 37 (score = 1)
and 39 (score > 2) of UPDRS or medication change.
Study Design
PD participants were given study details, consented to participate and were evaluated for
participation during a screening visit. Qualified participants were pseudo-randomly assigned to
one of two training groups: a group that received auditory cues during training (Cue, C) or one
that did not (No cue, NC). Once disease stage was determined, the individual was randomly
assigned to a group. The next participant with the same disease stage was assigned to the
opposite group to maintain the same distribution of disease severity between groups. Pilot data
from 5 people with PD indicated that 6 individuals per group were needed to achieve 80% power
on our primary measure, the DGI. Participant and group information are included in Table 3.1.
Comfortable/normal stepping cadence was also determined during the screening visit. Forward
stepping cadence of 5 trials each lasting 10 seconds was averaged to establish this cadence and
RAS frequencies.
Multi-directional Step Training
Participants trained 3 times per week (45-60 minutes) for 6 weeks. Pre-tests on the
screening visit and day 1 of training (PRE), a post-test on the last day of training (POST), and
retention tests, 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training
terminated, were conducted in the same location. Collections during the screening and PRE visits
allowed us to determine the initial stability of measurements in participants. Participants were
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Table 3.1 Characteristics and pre-test measures from the C and NC groups

Items

C group

NC group

p value

Age (years)

73.3 ± 2.2

70.5 ± 2.2

0.59

Gender

F=3, M=5

F=2, M=6

Height (cm)

168.8 ± 3.3

171.8 ± 4.3

0.52

Weight (kg)

79.5 ± 0.2

78.4 ± 0.2

0.80

Disease duration (years)

8.9 ± 1.8

7.5 ± 1.2

0.28

Modified H&Y = number of
participants for each stage

2=1, 2.5=5
3=1, 4=1

2=1, 2.5=5
3=1, 4=1

MMSE

28.3 ± 0.5

27.8 ± 0.8

0.23

DGI

16.3 ± 1.0

15.4 ± 0.8

0.46

UPDRS-Motor

27.1 ± 3.6

27.0 ± 3.4

0.98

UPDRS-ADL

13.9 ± 1.3

14.9 ± 1.2

0.61

UPDRS-Composite

8.1 ± 1.0

8.1 ± 0.8

0.71

Tinetti-total

17.0 ± 1.8

16.6 ± 1.5

0.67

Tinetti-gait

6.4 ± 0.7

6.5 ± 0.8

0.91

Tinetti-balance

10.6 ± 1.2

10.1 ± 0.8

0.71

TUG (s)

15.0 ± 2.0

15.4 ± 2.2

0.93

FOGQ

12.5 ± 1.9

12.8 ± 2.1

0.67

Mean ± 1 standard error for various characteristics and functional measures of the C (cue) and NC (no
cue) groups recorded on the first day of practice are provided. The p-value results of t tests used to
compare groups on these measures are listed. F—female; M—male; Hoehn and Yahr— H&Y; Mini
Mental State Examination—MMSE; Dynamic Gait Index —DGI; Unified Parkinson’s Disease
Rating Scale —UPDRS; Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing
of Gait Questionnaire—FOGQ.
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encouraged to continue with normal daily activities from screening to RTW8 periods, but
received no step training after POST.
A physical therapist, certified in UPDRS collection, evaluated and trained all participants.
Each participant attended training and testing sessions 1 hour after medication intake at the same
time of day. Medication intake was confirmed before each session. Sessions were postponed and
repeated on the earliest available date within the same week 1 time each for 3 participants due to
off periods or improper medication intake.
When training with RAS, participants started with feet in anatomical position at a selfselected distance apart. They stepped away and back in time with each beat of RAS presented at
one of 3 speeds: normal/comfortable cadence—N and 10% faster (fast) and slower (slow) than
normal cadence. Each tone represented one step direction (forward—F, side—S, back—B). Trial
step time was 33.75 s close to 30 seconds to avoid fatigue in this population [28]. Participants
were instructed to step in time with the beat and that the foot should completely leave the
surface, then completely contact the floor with each step. Speed remained constant within trials.
Demonstrations and/or instructions were repeated every session before practice/testing, after
breaks and when requested. Due to challenges in alternating limbs [29] and changing directions
[30] for this population, training increased in complexity based on the following schedule:
Week 1: each direction separately, legs separately (e.g. right leg, forward steps (and back) for
33.75 s);
Week 2: each direction separately, legs alternated;
Week 3: two directions per trial, legs separately (e.g. left leg, backward steps for 11.25 s,
then sideward steps for 22.5 s);
Week 4: two directions, legs alternated;
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Week 5: three directions per trial, legs separately (e.g. left leg, sideward steps for 11.25 s,
then forward steps for 11.25 s, then backward steps for 11.25 s; and
Week 6: three directions, legs alternated.
Thirty-six trials were performed in each training session. During week 1, participants
performed each speed/direction combination twice (3 speeds x 3 directions x 2 legs x 2 times).
During week 3, 6 direction combinations (BF, BS, FS, FB, SF and SB) were
performed (3 speeds x 6 direction combinations x 2 legs). During week 5, 6 different direction
combinations (FSB, FBS, BSF, BFS, SFB and SBF) were
performed (3 speeds x 6 direction combinations x 2 legs). During even numbered weeks
alternating feet replaced performing each side independently. Combinations were randomized
within each training day and for each leg separately on odd weeks. One to five trials were
repeated for 4 participants for not adhering to instructions.
Auditory cues used for the RAS training included cluck, ding and soft cork sounds
recorded at a 22.5 kHz with durations of 88 ms, 915 ms and 127 ms, respectively. Sound
volumes were approximately 75 dB, well above average hearing loss range (25-40 dB) reported
for older adults [31]. Participants acknowledged cues upon presentation and could describe each.
Step training setup and scheduling for the No RAS condition were the same as that for
the RAS condition with the following exceptions. Participants were to keep speed constant
within a speed category and to perform the task for each direction at ―comfortable‖, ―relatively
faster‖ or ―relatively slower‖ pace than normal. Participants were given a ―last step‖ verbal cue
approximately 1 second before a direction switch and a ―stop‖ cue to end the trial to maintain the
desired protocol and lessen the potential cognitive load. Three participants repeated 3-5 trials for
not adhering to instructions.
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Evaluation
Several functional measures were performed to offer a comprehensive determination of
gait and postural difficulties associated with PD [32] and to gain insight to improvements
participants experienced after training. The DGI, a fall risk indicator that challenges participants
to perform simple to difficult gait patterns, was selected as the primary measure of functional
gait. Secondary measures included the UPDRS-Motor and UPDRS-ADL sections to evaluate
overall motor symptoms of PD and activities of daily living (ADL), respectively. Similar to
previous work [25], the UPDRS-Composite score, involving UPDRS gait and balance items (1315, and 29-30), was also included. The TUG test evaluated fall risk as the time to stand from a
chair, walk 3 meters, turn, walk back and sit down. Evaluations of the Tinetti (gait, balance and
total) identified impaired gait and balance and assessed fall risk [33]. The Freezing of Gait
Questionnaire (FOGQ) assessed perceived changes in gait and the quality and frequency of
freezing of gait [34]. Measurement order was randomized within evaluation sessions.
Statistical Analyses
Pair-wise t tests were performed on functional measurements collected during screening
and PRE visits to determine short term stability of these measures within our participants. Pairwise t tests were also used to compare MMSE scores, disease duration, age, height, weight and
PRE functional measures of groups prior to training to determine group similarities. Repeated
measures ANOVAs with a random factor for subject, a between subject factor of Group (C, NC)
and repeated measures of Test-day (PRE, POST, RTW1, RTW4 and RTW8) were used to
compared measurement differences between groups and among test days. A Kenward Rogers
adjusted degrees of freedom was used because of the relatively small sample size and some
missing test values (Fig. 3.1). Tukey’s post-hoc tests were used when appropriate to answer the
experimental questions via PRE/POST comparisons and PRE/retention comparison for each
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PD participants assessed for eligibility (N=27)

Enrollment (N=16: 11 did not meet inclusion/exclusion criteria; 0 refused to participate)

TEST

C group

NC group

Screening

(N=8)

(N=8)

PRE

(N=8)

(N=8)

POST

(N=8)

(N=8)

RTW1

(N=8)

(N=8)

RTW4

(N=6: 1 med change; 1 conflict)

(N=7: 1 med change)

RTW8

(N=7: 1 med change)

(N=6: 2 med changes)

Figure 3.1 A schematic of the number of participants (N) at various stages of the study. Pre-test
(PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks
(RTW8) after training were performed. C—Cue group; NC—No cue group. Reasons for reduced
numbers are provided: Med change—change in medication and conflict—scheduling conflict
that was not made up.
group and C and NC comparisons for each POST and retention test. Significance level was
preset at p < 0.05 for all analyses (SAS V.9.1).
Results
Similarities in functional measures identified between screening and PRE visits suggest
that participants were functionally stable before training. Values of various group characteristics
and PRE measurements are presented in Table 3.1 and reveal relatively poor scores associated
with increased fall risk (DGI ≤ 22 [32]; TUG > 8.5 s [35] and Tinetti-total < 19 [33]) in
participants before training. Groups did not differ in age, height, weight, disease duration or
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mental status and had similar functional scores at baseline. A moderate disease stage (2.5 H&Y)
was most common. Seven freezers (4 C and 3 NC) were identified as those who experienced
freezing at least once per week [25]. Figure 3.1 depicts the number of participants at each stage
of the study and shows that all participants completed training, yet not all completed follow-up
evaluations due to scheduling conflicts or a medication change.
Figures 3.2 and 3.3 depict the primary training results of the study. It is important to note
that the analyses and plots account for the missing participants for RTW4 and RTW8. The
number of participants were C = 6 and NC = 7 on RTW4 and C = 7 and NC = 6 on RTW8. A
main effect of Test-day (F4,35.2 = 55.62, p < 0.0001) and a Group x Test-day interaction (F4,35.2 =
16.30, p < 0.0001) were observed for the DGI. Figure 3.2 shows that although higher DGI scores
for both groups were identified immediately (POST) and 1 week (RTW1) after training
compared to pre-training (PRE), scores for the C group were greater than those for the NC group
for 1 week and 4 week follow-up evaluations. Only people in the C group retained higher scores
relative to PRE values for 8 weeks. Moreover, 4 participants in the C group recorded scores
greater than 22 at POST, thus were identified as non-fallers [32] immediately after training. A
main effect of Test-day for Tinetti-balance scores (F4,37.9 = 11.67, p < 0.0001) revealed that
scores higher than PRE values for combined groups were achieved immediately after training
and maintained for 8 weeks (Fig. 3.3). These findings indicated that multi-directional step
training results in functional gait and balance improvements in PD patients and that use of RAS
can enhance the retention effects on gait function.
Outcomes from secondary measures show several similar results to those reported for the
DGI. Significant effects of Test-day were identified for all measurements, UPDRS-ADL (F4,32.1 =
14.55, p < 0.0001), UPDRS-Motor (F4,39.8 = 18.08, p < 0.0001), UPDRS-Composite (F4,33.5
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Figure 3.2 Mean scores of the Dynamic Gait Index (DGI) for the C and NC groups. C and NC
groups are presented in blue and red colors respectively. The DGI scores are shown for the pretest (PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks
(RTW8) after training. Colored asterisks represent a significant difference from the PRE values
for the corresponding group. Curly brackets with black asterisks indicate significant differences
between C and NC groups.
=26.84, p < 0.0001), Tinetti-total (F4,36.2 = 30.19, p < 0.0001), Tinetti-balance (F4,37.9 = 11.67, p <
0.0001), Tinetti-gait (F4,40.4 = 22.17, p < 0.0001), TUG (F4,18.18 = 23.30, p < 0.0001) and
FOGQ(F4,37.6 = 32.76, p < 0.0001), indicating improvements over PRE values. UPDRS-Motor
measurements were back to baseline values within 1 week (Table 3.2). Group x Test-day
interactions identified for the UPDRS-ADL (F4,32.1 = 2.8, p = 0.0425), UPDRS-Composite (F4,33.5
= 3.33, p = 0.024), Tinetti-total (F4,36.2 = 3.63, p = 0.014), Tinetti-gait (F4,40.4 = 3.91, p = 0.009),
TUG (F4,18.18 = 8.16, p = 0.0005) and FOGQ (F4,25.8 = 5.34, p = 0.0029) are also shown in
Table.2. People in the C group retained several improvements in the UPDRS-Composite, Tinetti-
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Figure 3.3 Mean Tinetti-balance scores for the two groups combined. These values are shown
for the pre-test (PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4)
and 8 weeks (RTW8) after training. Asterisks represent a significant difference from PRE values.
Error bars represent 1 standard error.
total, Tinetti-gait, TUG and FOGQ scores relative to PRE values for 8 weeks. UPDRS-ADL
improvements were also maintained up to 4 weeks for this group. The NC group only maintained
improvements over PRE values in the UPDRS-Composite, Tinetti-total and Tinetti-gait for 1
week and in the UPDRS-ADL and the TUG on the post-test. Clearly, use of RAS resulted in
retention of better functional scores over training without it. Furthermore, self-identified freezers
in the C group received FOGQ scores of 16-22 before training and 10-14 after training, whereas
scores for freezers in the NC group only dropped from 15-20 before training to 13-19 after
training. FOGQ scores for the NC group did not change significantly, suggesting this group did
not perceive meaningful changes in gait with training like group C. Overall, 6 weeks of multidirectional step training enhanced participant function. Results also revealed important benefits
of RAS application discussed next.
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Table 3.2 Secondary functional measures of C and NC groups for each test day

Test

Group

PRE

POST

RTW1

RTW4

RTW8

UPDRS

C

13.9 ± 1.3

11.0 ± 0.8

11.6 ± 1.0

10.8 ± 0.7

12.7 ± 1.3

ADL

NC

14.9 ± 1.2

13.5 ± 1.1

14.0 ± 1.1

14.9 ± 1.3

13.2 ± 1.3

UPDRS

C

27.1 ± 2.7

25.1 ± 3.3

25.6 ± 3.5

22.8 ± 2.3

26.3 ± 3.8

Motor

NC

27.0 ± 3.4

27.0 ± 3.3

27.0 ± 3.3

24.7 ± 3.2

25.2 ± 3.9

UPDRS

C

8.1 ±1.0

6.3 ± 0.9

6.8 ± 1.0

6.3 ± 1.1

8.3 ± 1.2

8.1 ± 0.8

6.6 ± 0.9

7.5 ± 0.9

8.3 ± 0.9

6.7 ± 0.7

Composite NC

Tinetti

C

17.0 ± 1.8

22.9 ± 1.3

22.8 ± 1.4

23.7 ± 1.1

24.0 ± 1.2

total

NC

16.6 ± 1.5

22.3 ± 1.3

21.0 ± 1.3

18.9 ± 1.4

18.0 ± 1.2

Tinetti

C

6.4 ± 0.7

9.9 ± 0.6

9.8 ± 0.6

10.3 ± 0.4

9.4 ± 0.7

gait

NC

6.5 ± 0.8

9.8 ± 0.8

9.0 ± 0.8

8.1 ± 0.7

7.8 ± 0.8

C

15.0 ± 2.0

9.4 ± 1.1

9.9 ± 1.1

9.1 ± 0.8

11.1 ± 1.3

NC

15.4 ± 2.2

12.7 ± 1.8

15.2 ± 2.1

14.6 ± 3.0

14.1 ± 2.3

C

12.5 ± 1.9

7.5 ± 1.3

8.3 ± 1.2

9.7 ± 1.6

11.4 ± 1.8

NC

12.8 ± 2.1

11.9 ± 1.9

12.3 ± 2.0

11.6 ± 2.0

10.3 ± 2.2

TUG

FOGQ

Mean ± 1 standard error of several secondary functional measures are provided for the C (cue)
and NC (no cue) groups on each test day. Values are for the pre-test (PRE), post-test (POST) and
retention tests, 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training. Bold
values represent a significant difference from the PRE values. Unified Parkinson’s Disease
Rating Scale—UPDRS; Activities of Daily Living—ADL; Timed-Up-and-Go—TUG; Freezing
of Gait Questionnaire—FOGQ.
Discussion
Eighteen sessions of multi-directional step training improved the DGI scores and other
functional measures for individuals with PD and thereby demonstrate that practicing step training
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transfers to a variety of functional gait and balance tasks. Although RAS use did not always
provide immediate post-training improvements over step training with No RAS, it was superior
to help participants extend the maintained improvements in gait function for 8 weeks after
training ended. These findings support other studies that show positive outcomes of PD training
programs, and highlight the importance of supplementing regular treatments with rehabilitation
for this population.
The present results support evidence that motor learning abilities are preserved in people
with PD [36]. Participants generalized multi-directional step training effects to the different
contexts of gait and balance, two well-known deficiencies in this population [37]. The abilities of
the participants to improve functional gait measures after step training, that unlike others [25, 38,
39] did not involve walking, indicate that the training context for PD patients may be generalized
to different tasks. PD patients’ abilities to generalize 8 weeks of pedaling practice to manual
dexterity skills [40] support this view. However PD patients were also unable to reach the
desired arm movement speed in a blocked or random practice paradigm after training in the
opposite paradigm for 2 days [41]. This inability to transfer training outcomes to a different
context may be due to short term practice or practice using the upper limb in this population,
however further tests are needed to test these possibilities.
Balance in Parkinson’s patients improved with multi-directional step training. Inability of
individuals with PD, to properly respond to external (i.e. platform movement [42]), and internal
(i.e voluntary movements such as rising-to-toes [43]) demands account for balance difficulties in
these individuals. Some researchers blame immobility for these problems [44], explaining why
balance improvements occur after 10 weeks of tai chi [45] and 8 weeks of gait training [39] and
are maintained after 10 weeks of balance and strength training exercises [46]. Increased activity
partially explains the improved balance observed in the present study as 9/16 participants
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reported no commitments to regular physical activity before training. We reasoned that switching
between different movement components and standing between trials during training also helped
participants improve Tinetti-balance items for standing balance and turning.
Different abilities of groups to maintain improvements after training adds to the limited
research on effects of external cues on retention abilities in PD patients [21, 25, 38]. Longer
training duration [47], providing augmented [48] and positive feedback [49], higher intensity of
practice [40] and modifying levels of contextual interference [50] can result in longer retention.
Adherence to one or more of these strategies resulted in longer retention of accurate/better
performance of sequential whole body positioning and shirt buttoning [47], balancing (Jessop et
al., 2006; Jobges et al., 2004) and grasping [40] in this population. Longer retention abilities for
the C group compared to the NC group indicates that use of RAS is effective for acquiring longer
retention of certain motor skills. These results comply with reported retention of UPDRS-ADL
scores 6 weeks after 6 weeks of physical therapy with auditory cues compared to those without
them [38]. With reduced improvements in TUG and UPDRS-Composite scores 6 weeks after a
3-week cued gait training protocol [25], it is clear that training duration and external cues can
influence retention abilities, thus should be considered when enhancing retention in PD patients
is desired.
Using RAS during multi-directional step training may alter fall risk in people with PD.
The greater improvement in POST scores on the DGI for the C group and individual differences
exemplify such benefits. Remember that 4 participants in the C group scored greater than 22 on
the DGI, while all NC participants scored less than 22 immediately after training. Thus, half the
C participants at low disease stage (H&Y ≤ 2.5) changed from faller to non-faller status (i.e. DGI
> 22 [32]) after training. Although possible, the idea that longer training with RAS may result in
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better scores for those at higher disease stages requires verification. Regardless, the use of RAS
clearly enhanced performance to a more meaningful extent from a fall risk perspective.
C group participants also identified perceptible differences in their gait and/or number of
freezing episodes. Self-identified freezers in the C group dropped 5-8 points in their FOGQ after
training, revealing an obvious dichotomy and significant change for PRE/POST score
comparisons (Table 3.3). The 1-2 point FOGQ score drop for freezers in the NC group did not
produce significant changes in this measure. With freezing episodes associated with temporal
gait deficits [51] and rhythmic auditory cues targeting temporal aspects of the movement [52],
we associate C group FOGQ improvements with temporal improvements in movement. The
current freezing results also follow those where PD patients revealed less freezing after 3 weeks
of cued gait training [25]. Since freezing episodes remained unchanged after 1 week of home cue
training [19], the observed freezing improvements were attributed to longer cue training
duration, further emphasizing the necessity of relatively long training periods for individuals
with PD.
Group similarities in UPDRS-Motor scores were identified so that improvements
observed immediately after training were not maintained on follow-up evaluations. This seems to
contradict the effectiveness of long term rehabilitation protocols in improving UPDRS-Motor
scores, thus overall motor deficits in Parkinson’s patients [40, 53, 54]. Note this measure was
unsuccessful in presenting an accurate portrayal of mobility in this population based on its low
correlation with functional measures (TUG, Berg Balance scores and Functional Reach tests
[55]), while gait and posture items of the UPDRS showed high correlations with functional
measures of the Tinetti [33]. These associations explain the different outcomes for UPDRSComposite and UPDRS-Motor scores observed in this study. Further investigations are required
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to determine the sensitivity of the UPDRS-Motor in detecting more specific motor changes in PD
patients.
Current results are indicative of central changes as research indicates that practicing
sequential movements with [56] or without RAS [57, 58] results in changes in activity of
various brain areas. Activation of additional cortical and sub-cortical regions despite continuous
activity of the deficient BG in those with PD allows these individuals to achieve motor
improvements after practice without RAS [57, 58]. RAS use also enhances motor performance
by recruiting similar brain regions [56]. However, unlike self-generated movements, activity of
the BG is not required because the movement is externally paced [59]. This pattern of activity is
sustained after withdrawal of auditory tones [56]. Apparently, individuals with PD can benefit
from practice alone however application of RAS holds additional benefits. Although not tested
directly, the current results add to the evidence that rhythmic auditory cues facilitate a
compensatory pathway in people with PD that offers at least a temporary substitute for the
defective internal clock, the BG. How long such improvements are maintained in people with PD
is likely linked to disease severity, but requires further testing for verification.
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CHAPTER 4: PEOPLE WITH PARKINSON’S DISEASE CHANGE STEPPING
DIRECTION FASTER AFTER MULTI-DIRECTIONAL STEP TRAINING WITH
RHYTHMIC AUDITORY STIMULATION
Introduction
Movement difficulties [1], including those with walking [2], are prominent in
individuals with Parkinson’s disease (PD). Walking deficits also contribute greatly to the
perception of quality of life and disability for these individuals [3]. Their gait manifests
decreased stride length and gait speed [4, 5], hypokinesia, increased cadence [6], freezing of
gait and stride-to-stride variability [7]. Longer step duration and reduced step length observed
in people with PD during straight line walking [8] worsen during a turn [9]. Some of these gait
abnormalities are observed in other populations and do not limit daily function. For example,
decreases in stride length and gait speed commonly exist in normal older persons [10], but do
not limit these people’s abilities to grocery shop or perform other daily tasks. However other
difficulties such as those associated with turning can play a significant role in loss of stability
and balance [11]. Additional complications such as freezing of gait are also experienced during
turning [12] and further contribute to increased fall risk in this population [13].
In PD central problems with the basal ganglia (BG) inadequately inhibit and release
movement responses to the task demands [14, 15], thus are most observable during tasks
involving transitions. The transition problem is evident in several activities. For example,
difficulties are experienced during unilateral [16] or bilateral [17] multi-limb movements, dual
task performance [18, 19], multi-task performance [20], when performing a sit-to-stand task
[21] and when required to change movement directions during gait [22]. Orderly inhibition and
excitation of associated muscles are necessary for transitions in each of these tasks.
Scientists suggest that training with rhythmic auditory stimulation (RAS) is an effective
method for improving gait and balance in PD [23, 24]. It is thought that RAS serves as an
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external trigger to replace the deficient internal trigger, the BG [25]. Training of this type
involves the use of repetitive auditory cueing to which individuals attempt to synchronize a
sequential and repetitive task. Finger tapping [10, 26], repetitive reaching [27] and stepping
[28-31] to a rhythmic input are common tasks for investigation, although stepping is more
common when gait is of interest. Music and metronomes offer different sources of rhythmic
input [32]. Use of a metronome seems to offer advantages over music [33]. Other forms of
external modalities such as visual [34] and tactile [35, 36] cues are also used for those with PD.
However the inherent temporal connections between RAS and movement generation appear to
surpass the effects of the other modalities [37, 38].
Immediate effects of RAS on gait have been investigated to a great extent and reveal
changes according to that of RAS frequency. For example, frequencies of RAS higher than the
normal/comfortable walking cadence result in increased velocity [30, 37, 39, 40, 41, 57], step
amplitude [37], step length [28 , 42] and cadence [30, 39, 41]. Frequencies of RAS lower than
normal cadence usually cause the opposite response. Use of RAS commonly decreases step
duration variability [37], regardless of frequency, as long as the frequency is not too extreme
relative to the comfortable cadence (e.g. [43]). Few immediate RAS effects for turning exist for
those with PD. These studies reveal turning alterations in response to RAS similar to those of
walking [44, 45].These findings provide useful information for applications of RAS but do not
offer insights regarding the potential long term use of RAS.
Unlike the short term investigations, effects of RAS on movement after its long term use
are rare for PD. Those that do exist have offered several insights to RAS use for straight line
walking. These studies report changes in the pattern of leg muscle activation [46, 47], velocity
[47, 29], stride length [47] and cadence [29] more similar to those of healthy age-matched
controls after weeks of RAS gait training. Some retention abilities after weeks of training with
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RAS use also exist. Improved activities of daily living were maintained 6 weeks after 6 weeks
of physical therapy with auditory cues imbedded in the training [49]. In contrast gait, balance
and physical function measures were not maintained 6 weeks after a 3 week cued gait training
protocol [50]. Further investigations are warranted to uncover whether the retention effects of
using RAS are limited to the duration of training and to establish RAS effects on more difficult
movement patterns.
The primary goal of the current study was to explore the abilities of individuals with PD
to alter their stepping performance with no cues after 6 weeks of multi-directional step training
with RAS. Since switching from one task to another is a major function of the BG and this
ability is impaired in PD, the duration of switching step direction (direction switch duration,
DSD) served as the primary kinematic measure of step performance. The ability of PD patients
to retain changes over baseline values for a relatively long period of time was also investigated.
We hypothesized that DSD during step performance without RAS would decrease after training
with RAS and that changes would remain at least for several weeks after training. Other
kinematic measures were determined to offer comparisons between the present step task and the
more commonly used task of walking. Step performance with RAS before and after training
offered additional insight to training effects on the trained task (task specificity).
Methods
Participants
Twenty-seven individuals diagnosed with PD volunteered to participate in the study. Of
the 21 who qualified for participation 5 were used for pilot tests (group P), leaving 16 to
participate using the final protocol. All participants provided consent approved by the
university’s Internal Review Board. Disease severity was identified according to the Hoehn and
Yahr (H&Y) scale [51] and the intensity of the motor symptoms was determined according to
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Unified Parkinson’s Disease Rating Scale (UPDRS) [52]. Qualified participants: 1) were
diagnosed with idiopathic PD; 2) presented with disease severity stages 2 to 4 (H&Y); 3) had
stable drug usage; 4) were capable of standing and walking independently with or without an
assistive device; 5) were able to identify auditory cues and 6) had no signs of cognitive deficits
as determined by the Mini Mental State Examination Score (MMSE > 24, [53]). Participants
were also disqualified if they reported a history of other disorders or acute injuries that could
influence their ability to complete the program. Unstable drug use was determined according to
individual reports of medication change and according to items 37 (score = 1) and 39 (score > 2)
of the UPDRS.
Study Design
Participants visited the training site during a screening visit where they became familiar
with the study design, were evaluated for qualification and agreed to participate. Once qualified,
participants were assigned to a Cue (C) or a No cue (NC) training group in a pseudo-random
fashion. This design allowed homogeneity across groups by randomly assigning the first
qualified volunteer to one group and allocating the next participant with the same disease level to
the opposite group, yielding 8 participants per group. Those in the C group participated in a
multi-directional step training protocol with and without RAS while those in the NC group
performed the step training with No RAS only. In addition to several individual characteristics
an average forward stepping cadence from five 10 second trials was calculated to obtain a
comfortable/normal step cadence (Table 4.1). Screening, training and evaluations were
conducted in the same location by a physical therapist, certified in UPDRS collection.
Multi-directional Step Training
Step training took place 3 times per week for 6 weeks in sessions approximately 1 hour in
length. Participants took medication about 1 hour prior to each session, which was confirmed
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upon arrival. Three participants had to postpone 1 session each for not adhering to their
medication schedule.
During RAS step training participants received instructions and demonstrations for the
corresponding step training task at the beginning of each session, after given breaks and upon
request. Participants started with their feet in anatomical position at a self-selected distance apart.
They were asked to step away and back in time with the RAS beats and told that the foot should
completely leave the ground and foot sole completely contact the floor with each step. Trial
duration was kept relatively short (33.75 s) in order to avoid fatigue [54]. This duration resulted
from the specially designed software. The training schedule followed previous suggestions for
PD training regiments, which suggest breaking down complex movements at initial training
sessions [23]. Accordingly, the following weekly schedule was implemented:
Week 1: each direction separately, legs separately (e.g. right leg, forward steps (and
back) for 33.75 s);
Week 2: each direction separately, legs alternated;
Week 3: two directions per trial, legs separately (e.g. left leg, back steps for 11.25 s, then
side steps for 22.5 s);
Week 4: two directions, legs alternated;
Week 5: three directions per trial, legs separately (e.g. left leg, side steps for 11.25 s, then
forward steps for 11.25 s, then back steps for 11.25 s; and
Week 6: three directions, legs alternated.
Thirty-six trials were performed in each training session. During week 1 participants
performed each speed/direction combination twice (3 speeds x 3 directions x 2 legs x 2 times).
Participants performed 6 direction combinations (BF, BS, FS, FB, SF and SB) for
week 3 (3 speeds x 6 direction combinations x 2 legs). They performed 6 different direction
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combinations (FSB, FBS, BSF, BFS, SFB and SBF) for week 5 (3
speeds x 6 direction combinations x 2 legs). During even numbered weeks the number of trials
was equal to that of the two legs combined of the odd weeks, as alternating feet replaced
performing each side independently. Combinations were randomized within each training day
and for each leg separately on odd weeks. One to five trials were repeated for 4 participants for
not adhering to instructions.
Three different auditory cues, cluck, ding and soft cork, were recorded at a 22.5 kHz. The
cluck, ding and soft cork sounds had frequencies of 1003.3 Hz, 784.93 Hz and 529.38 Hz and
durations of 88 ms, 915 ms and 127 ms, respectively. Cue presentation for RAS was generated
by a specially designed LabView program and presented through two speakers at approximately
75 dB, well above the average hearing loss range (25-40 dB) for older adults [55]. Prior to
testing participants in P and C groups were presented with cues in a random order and were
asked and able to raise their hands and describe them when heard.
RAS was absent during the No RAS condition, thus individuals were instructed to step at
a ―comfortable‖ cadence or ―relatively faster‖ or ―relatively slower‖ than their normal step
cadence. In order to avoid mental fatigue and allow accurate performance within a specified
direction, participants were given a ―last step‖ verbal cue approximately 1 second before a
direction switch. Initiation of trials was prompted by ―Ready?‖, pause, ―Start‖ command and a
―Stop‖ command was used for trial termination. Other details of the training protocol were
similar to the RAS condition. Three to 5 trials were repeated for 3 participants for not adhering to
instructions.
Evaluation
Testing sessions involved the multi-directional step task performed on week 6 to gain
insight to kinematic alterations that were expected with training. Three direction combinations,
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FSB, SFB, and BSF, were performed at the 3 speeds to yield 9 trials without RAS
for the NC group and 18 trials (9 RAS and 9 No RAS) for group C. These direction
combinations allowed participants to initiate stepping in each of the three directions and to
change step direction to and from each direction. The reduction from the 6 possible combinations
to 3 resulted from fatigue effects noted with group P. Since group C was tested with and without
RAS, the No RAS condition was always tested first. This allowed comparison of the No RAS
condition after similar warm up to the NC group and eliminated immediate short term effects of
RAS. The order of direction combinations was randomized within each condition on each test
day.
Stepping performance of participants was recorded on the first day of training for a pretest (PRE), on the last day of training for a post-test (POST), and for retention tests, 1 week
(RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training. Three-dimensional motion of
reflective markers placed on the lateral malleoli of the two ankles, were recorded with a four
camera digital video system (Qualisys Mediacla AB). The first auditory cue of RAS triggered
initiation of the camera capture and simultaneous 60 Hz data collection of markers. The RAS
cues in a direction change occurred after the 11.25 s and 22.5 s according to the given cadence
for a given speed. For the No RAS conditions this program was silenced and the visual display of
the programs allowed the examiner to signal the participant for movement initiation, direction
switching and termination as described previously. Participants did not receive step training
between POST and RTW8 and were asked to continue with normal activities during the
program.
Data from the ankle markers were analyzed through customized Matlab and LabView
programs. Position data were filtered through a zero phase lag 10 point averaging design.
Tangential velocity profiles were calculated by five-point differentiation of the filtered position
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data. Position and tangential velocity profiles were plotted across time, visually scanned and
marked to help determine kinematic measures. Figures 4.1A and 4.1B) show plots from these
profiles and example markings used for calculating kinematic measures described below.
Movement onset (ON) and end (END) corresponded to the frame prior to the first discernable
movement in the given direction and the frame after the last discernable change in the given
movement direction, respectively, from position profiles.
Several spatial and temporal kinematic measures affected by PD were calculated to offer
insight regarding movement changes before and after training. Selected measures were based on
reductions in gait velocity [56] and step length [57] in addition to shuffling of the feet during
gait[6] and changes in cadence [58] for those with PD. Direction switch duration (DSD) was
selected as the primary measure because temporal movement transition is a well-known
disruption in PD [21, 22]. DSD was defined as the duration between the time the foot returning
to the platform stopped moving in one direction and the time when the opposite foot moved to
leave the platform to the next direction according to ankle markers. For example, the frame for
ON of the left ankle side was subtracted from the frame for END of the right foot back divided
by the 60 Hz sampling frequency (see ON-DSD and END-DSD, Fig. 4.1A). Peak tangential step
velocity (VEL) was identified as the maximal step velocity between ON and END of each step
from the tangential velocity profile of the ankle marker of interest (see ON-MOV and ENDMOV, Fig. 4.1B). Kinematic variables of step length (SL), step height (SH) and step number
(SN) were also calculated. SL was calculated as the displacement of the ankle marker in the
lateral (y-) direction for side steps or anterior/posterior (x-) direction for forward or back steps.
In a back step, for example, SL was the difference between the x-values at END and ON of a
given step (see END-MOV and ON-MOV, Fig. 4.1B). SH was determined as the maximal zvalue during this same time minus the average of the first five z-value frames during stance at
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Figure 4.1 Example of position and velocity marking. Examples of position (A and B) and
velocity (B) profiles used for identifying different kinematic variables are indicated. Data are
from two different trials for plots in A and B. Example markings used for direction switch
duration (DSD) are plotted in A and those for peak step velocity (VEL), step length (SL), step
height (SH), step number (SN) and reaction time (RT) are plotted in B. Position and velocity
profiles are separated in B for better clarity. Plots in A show the end of the movement of the right
ankle marker in the back direction (x) is indicated by the END DSD solid line and the onset of
the movement of the left ankle marker in the side direction (y) is indicated by the ON DSD solid
line. Plots in B show corresponding lines determined for a single step and indicate ON MOV and
END MOV of the first back step (x) of the right ankle marker. The vertical dashed line
represents 11.25 s associated with the timing for a direction change.
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the beginning of a trial. SN in whole or half steps for each direction of a trial during the 11.25 s
was also determined. A half trial was counted if the peak of the profile was included in the time
frame while the END was not (7.5 steps were identified for Fig. 4.1B). For SL, VEL, SH and SN
average values for each participant were determined for each direction within a given speed. For
DSD trials were separated based on the direction to which switching occurred. For example, a
BSF trial included switching to S and to F directions, thus DSD was determined for these
directions, before average values were calculated for each direction within a given speed for each
participant. Standard deviations were used to determine variability of these measures (see ―var‖
subscripts), except for step number. Including initial reaction time (RT) in the RAS condition for
the C group allowed us to determine effects of RAS use on RT, if any. RTs to the first cue of
each trial were calculated. These measures were determined as the time interval between the first
cue and the ON frame of the ankle marker of interest (see RT between frame 0 and ON-MOV,
Fig. 4.1B). Final RT values were averaged for each direction, speed and participant.
Statistical Analyses
Pair-wise t tests were performed to compare group characteristics obtained before training (see
characteristics under subject details, Table 4.1). Repeated measures ANOVAs with a random
factor for subject,, between subject factor of Group (C, NC), within subject factors of Direction
(F, S, B) and Speed (F, N, S) and repeated measures on Test-day (PRE, POST, RTW1, RTW4,
and RTW8) were used to compared differences between groups and among test days for the No
RAS condition while accounting for direction and speed effects. A similar design with a within
subject factor of Direction and Speed and repeated measures on Test-day was used to compared
the RAS condition across test days. A Kenward Rogers adjusted degrees of freedom was used
because of the relatively small sample size and missing participants on certain test days. Tukey’s
post-hoc tests were used when appropriate to compare selected measures across test days.
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Table 4.1 Characteristics and pre-test measures from C and NC groups.

Subject details

C group

NC group

p-value

Age (years)

73.3 ± 2.2

70.5 ± 2.2

0.59

Gender

F= 3, M = 5

F = 2, M = 6

Height (cm)

168.8 ± 3.3

171.8 ± 4.3

0.52

Weight (kg)

79.5 ± 0.18

78.4 ± 0.2

0.80

Disease duration (years)

8.9 ± 1.8

7.5 ± 1.2

0.28

Modified H&Y = number of
participants for each stage

2=1
2.5 = 5
3=1
4=1

2=1
2.5 = 5
3=1
4=1

Normal step cadence (steps/min)

56.8 ± 6.0

57.0 ± 7.1

0.63

DSD (s)

1.34 ± 0.19

1.36 ± 0.25

0.59

DSDvar (s)

0.41 ± 0.08

0.45 ± 0 .09

0.41

VEL (m/s)

0.37 ± 0.04

0.31 ± 0.05

0.56

VELvar (m/s)

0.47 ± 0.08

0.33 ± 0.08

0.53

SN (steps/11.25 s)

8.0 ± 0.9

8.3 ± 0.8

0.27

SL (m)

0.28 ± 0.02

0.26 ± 0.02

0.40

SLvar (m)

0.15 ± 0.02

0.14 ± 0.02

0.09

0.06 ± 0.04

0.06 ± 0.03

0.027 ± 0.032

0.024 ± 0.037

SH (m)
SHvar (m)

0.23
0.18

Mean ± 1 standard error for subject characteristics and kinematic measures of the C (cue) and NC (no
cue) groups recorded on the first day of practice are provided. The p-value results of t tests used to
compare groups on these measures are listed. F—female; M—male; H&Y—Hoehn and Yahr score;
DSD—direction switch duration; VEL—peak step velocity; SN—step number; SL—step length and
SH—step height. The ―var‖ subscript stands for variability of associated measures.

Significance level was preset at p < 0.05 for all analyses (SAS V.9.1).
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Results
Sixteen participants completed 6 weeks of training and PRE, POST and RTW1 tests. Three
participants were unable to complete RTW4 and RTW8 tests either because of medication
change or a scheduling conflict. Two participants from the C group and 1 participant from the
NC group missed testing on RTW4, while 1 participant from the C group and 2 participants from
the NC group missed testing on RTW8. Analyses and plots in Figs. 4.2 and 4.3 and Table 4.2
account for the change in participant numbers during tests conducted 4 and 8 weeks after training
ended.
Subject characteristics and pre-training kinematic measures for stepping with No RAS
are presented in Table 4.1 to offer insight to the C and NC participants. These data verify the
disease matching between groups and show that most participants were at the moderate stage of
the disease (H&Y = 2.5). Results from t tests show that age, weight, height, disease duration,
MMSE scores, normal stepping cadence and kinematic measures did not differ between groups.
Training Effects for the No RAS Condition
Certain step kinematics were influenced by training type, but only when accounting for
Test-day. Significant Group x Test-day interactions existed for DSD (F4,99.2 = 7.74, p < 0.0001),
DSDvar (F4,66.1 = 7.03, p < 0.0001), SN (F4,58.9 = 21.03, p < 0.0001) and VEL (F4,65.9 = 10.03, p <
0.0001) and reveal the major results of this study. For the C group DSD values decreased (Fig.
4.2A), while those of VEL (Fig. 4.2B) and SN (Fig. 4.2C) increased after training and alterations
compared to pre-training values were maintained for at least 8 weeks (see blue asterisks, Fig.
4.2). DSD, VEL and SN were significantly different for the C group compared to the NC group
on POST, RTW1 and RTW4 (see black asterisks on brackets in corresponding plots identifying
group differences). DSDvar also remained lower than PRE values up to RTW4 for both groups
and was maintained up to RTW8 for the C group (Table 4.2). Differences between groups were
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Figure 4.2 Mean kinematic values during the No RAS condition for C and NC groups. Values of
(A) direction switch duration (DSD), (B) peak step velocity (VEL) and (C) step number (SN) for
C (blue diamonds) and NC (red squares) groups are shown for pre-test (PRE), post-test (POST)
and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training for the
No RAS condition. Blue asterisks represent a significant difference from the PRE values for the
C group. Curly brackets with black asterisks represent a significant difference between groups on
the given test day. Error bars represent 1 standard error.
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Table 4.2 Mean direction switch duration variability for test day
Group

PRE

POST

RTW1

RTW4

RTW8

C

0.413 (8)

0.247 (8)

0.259 (8)

0.189 (6)

0.231 (7)

NC

0.449 (8)

0.264 (8)

0.244 (8)

0.324 (7)

*

*
0.331 (6)

Mean variability of direction switch duration (DSDvar) during the No RAS condition of the C
(cue) and NC (no cue) groups for each test day are shown for the pre-test (PRE), post-test
(POST) and follow-up retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8)
after training. The values in parenthesis represent the number of participants for that test day.
Bold values represent significant differences from the PRE values. Asterisks on curly brackets
represent a significant difference between groups for the given day.
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Figure 4.3 Mean variability values during the RAS condition. Variability measures of (A)
direction switch duration (DSDvar), (B) peak step velocity (VELvar), (C) step length (SLvar) and
(D) step height (SHvar) for the C (cue) group are shown for the pre-test (PRE), post-test (POST)
and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8 weeks (RTW8) after training.
Asterisks indicate significant differences from the PRE test. Error bars represent 1 standard error.
identified for RTW4 and RTW8 (see asterisks on brackets, Table 4.2), showing that training with
RAS helped maintain decreased DSD variability for at least 8 weeks and longer than training
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without it. Overall these findings indicate that certain step kinematics changed more or lasted
longer for those training with RAS compared to those without it for the No RAS condition.
Training Effects for the RAS Condition

Training effects on kinematic variables during step performance with RAS for group C
showed that variability of the different kinematics during multi-directional stepping was
influenced by training with RAS use. A significant effect of Test-day existed for DSDvar (F4,117 =
3.00, p = 0.0214), VELvar (F4,91.9 = 3.40, p = 0.0122), SLvar (F4,74.1 = 6.54, p = 0.0001) and SHvar
(F4,70.5 = 6.56, p = 0.0002). Plots in Figs 4.3A-D, show that these values decreased after training
termination, and remained below PRE values on all retention tests. Other spatial and temporal
measures, including RT, did not change significantly after training. Thus 6 weeks of multidirectional step training with RAS decreased the variability of spatial and temporal measures
during task performance that were maintained at least 8 weeks after training termination.
Speed and Direction Effects
A main effect of Speed was identified for different kinematic variables obtained during
step task regardless of RAS condition. Main effects of Speed were determined for DSD (No
RAS: F2,222 = 18.73, p = 0.002; RAS: F2,115 = 7.35, p = 0.001), VEL (No RAS: F2,110 = 10.51, p =
0.006; RAS: F2,117 = 13.42, p < 0.0001) and SN (No RAS: F2,78.2 = 14.19, p = < 0.0001; RAS:
F2,115 = 9.13, p = 0.002). Figure 4.4 shows that VEL (A) and SN (B) increased for the fast speed
and decreased for the slow speed relative to the normal stepping speed for No RAS (left panels)
and RAS (right panels) conditions. Participants also decreased DSD for the fast speed and
increased it for the slow speed in comparison to the normal stepping speed (Fig 4.4C). These
results suggest that participants were able to adjust peak step velocity, duration of step direction
switching and number of steps to either follow task instructions related to speed change in the No
RAS condition or follow auditory cues in the RAS condition. Direction effects were also
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Figure 4.4 Mean kinematic values across speeds without and with RAS. Mean values of the (A)
peak step velocity (VEL), (B) step number (SN) and (C) direction switch duration (DSD) are
shown for slow, normal and fast speeds for the No RAS (black plots, left panel) and RAS (blue
plots, right panel) conditions. N = 16 (C and NC participants) for the No RAS plots and N = 8 (C
participants) for the RAS plots. Asterisks between slow and normal and normal and fast speeds
indicate a significant difference between the corresponding values. Error bars represent ±1
standard error. Note, some bars are too small to see in plots.
identified for most kinematic variables during the step task whether RAS was used or not.
Significant main effects of Direction were determined for SL (No RAS: F2,88.2 = 13.69, p <
0.0001; RAS: F2,116 = 7.75, p < 0.0001), SLvar (No RAS: F2,109 = 16.57, p < 0.0001; RAS: F2,115 =
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17.02, p < 0.0001), SH (No RAS: F2,229 =17.21, p < 0 .0001; RAS: F2,116 = 5.03, p < 0.0001),
SHvar (No RAS: F2,141 = 21.82, p < 0.0001; RAS: F2,116 = 3.84, p = 0.001), VEL (No RAS: F2,118 =
24.31, p < 0.0001; RAS: F2,118 = 18.01, p < 0.0001) and VELvar(No RAS: F2, 171 = 3.48, p = 0.03;
RAS: F2,115 = 268.65, p < 0.0001). Figure 4.5 shows that SL(A), SH (B) and VEL (C) were always
smallest for the back stepping direction for the No RAS (left panels) and RAS (right panels) conditions.
In contrast the variability of these measures were largest for back steps (No RAS: SLvar = 0.17 ± 0.09 m,
SH var = 0.028 ± 0.002 m, VELvar = 0.44 ± 0.05 m/s; RAS: SLvar = 0.15 ± 0.09 m, SH var = 0.027 ± 0.002 m,
VELvar = 0.41 ± 0.02 m/s) and significantly different from forward (No RAS: SLvar = 0.13 ± 0.09 m, SH var
= 0.025 ± 0.009 m, VELvar = 0.40 ± 0.05 m/s; RAS: SLvar = 0.12 ± 0.09 m, SH var = 0.020 ± 0.002 m,
VELvar = 0.29 ± 0.03 m/s) and side (No RAS: SLvar = 0.13 ± 0.94 m, SH var = 0.023 ± 0.002 m, VELvar =
0.39 ± 0.05 m/s; RAS: SLvar = 0.12 ± 0.89 m, SHvar = 0.021 ± 0.002 m, VELvar = 0.31 ± 0.02 m/s) step
directions. Step length, step height and peak step velocity clearly differed for back steps compared to the
forward and side steps in this task. Overall, 6 weeks of multi-directional step training with and without
RAS resulted in alterations that were maintained at least 4 weeks after training termination. These
alterations are discussed further in the following section.

Discussion
This study was conducted in order to add to the limited research on long term training
effects of RAS use on transitional movements for those with PD. The multi-directional step
protocol was designed to focus on step direction changes in a supervised environment. Such
changes in movement are known to cause difficulties for people with PD [22]. C group
participants decreased their absolute duration of step direction switching, increased their peak
step velocity and the number of steps in a given time period and maintained these improvements
above baseline values at least 8 weeks after practice terminated. Step practice resulted in
decreased variability of the duration of step direction switching during the No RAS task
regardless of RAS use in training. Participants who trained with RAS were able to maintain these
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Figure 4.5 Mean kinematic values across directions without and with RAS. Mean values of the
(A) step length (SL), (B) step height (SH) and (C) peak step velocity (VEL) are shown for
forward, side and back directions for the No RAS (black plots, left panel) and RAS (blue plots,
right panel) conditions. N = 16 (C and NC participants) for the No RAS plots and N = 8 (C
participants) for the RAS plots. Horizontal bars indicate significant differences at the bars’ ends.
Error bars represent ±1 standard error. Note, most bars are too small to see in plots.
improvements longer. Supplementing multi-directional step training with RAS offered several
kinematic alterations when performing the step task without RAS use that were not observed in
those training without it. These alterations appear beneficial as the changes that occurred mimic
those of walking in healthy adults.
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Training Effects
The severe slowness during transitions observed previously for PD patients [22, 69] led
to expected slowing of step direction switch durations in this population prior to training. The
present study did not, nor was it designed to observe this slowing prior to training. Rather, it
revealed a significant reduction in DSD accompanied by increase in peak step velocity and step
number for the No RAS condition after training for the C group participants. No such changes
were detected for those in the NC group. These findings follow those of straight line walking
where reduced durations of Vastus Lateralis activity accompanied increased step cadence and
average gait velocity only for PD participants who received 3 weeks of gait training with RAS
[47]. Minimal, non-significant changes were detected for individuals with PD receiving the same
type and amount of training with no external cues [47]. Together these studies provide evidence
that RAS training results in movement modifications when performing tasks involving
directional adjustments without cues that do not occur without use of RAS in training. Moreover,
results from the current study showed that PD patients were able to retain such improvements in
the stepping task for at least 8 weeks.
Unlike the aforesaid measures DSDvar obtained during stepping in the No RAS condition
decreased similarly for both groups immediately after training termination and was maintained
for at least 1 week. Higher temporal variability without cues reported for finger tapping [59],
repetitive wrist flexion [60] and stepping [4] in this population is observed, thus it is not
surprising that temporal variability can decrease with certain applications. Remember that verbal
commands were given at the end of each direction time period for participants during the No
RAS condition. Results from the No RAS condition mimic those for reduced variability of
movement duration after presentation of a single auditory tone provided shortly before initiation
of a multi-segmented reaching task compared to reaching without a tone [61]. It is possible that
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the attention control offered by a verbal start cue [21] for the direction change in the No RAS
condition for both groups was adequate to result in the immediate decrease in DSDvar. However,
this does not explain why participants in the C group were able to maintain these improvements
longer. Alterations in neural pathways may help explain the greater retention capabilities
observed for this group as reductions in step to step variability during non-cued walking after
RAS gait training are directly linked to changes in central pathways according to Positron
Emission Topography (PET) records [62]. These activated pathways were similar to those
reported during RAS paced finger tapping and different from those of internally generated finger
tapping [63]. Further studies are warranted to verify such direct effects of RAS on attention and
neural pathway alterations in this population.
Retention abilities in No RAS conditions were not exclusive to DSDvar as changes in
DSD, VEL and SN, were also maintained 8 weeks after training termination for the C group
participants. Using RAS during training appears to help people with PD maintain alterations in
step kinematics for a period of time longer than the training period, exceeding that of equal
retention reported previously; 6-week retention of UPDRS-ADL scores were observed after 6
weeks of physical therapy with auditory cues compared to that with no cues [49]. The present
results suggest that longer retention of these scores would be observed if tested, however
maintaining movement alterations for a period of time twice as long as the training period seems
unlikely for walking or stepping, as loss of improvements in average gait velocity and stride
length were observed when walking without RAS, 6 weeks after a 3-week RAS gait training
protocol [50]. Future studies could determine whether longer training regimes such as 6 weeks
can produce longer relative training retention over shorter training regimes such as 3 weeks.
Regardless of such findings, it seems clear that supplementing training with RAS results in
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certain kinematic changes that carry over to the No RAS condition and can be maintained over a
relatively long period of time.
Training effects with RAS use on spatial kinematic measures during the No RAS
condition are not as consistent as the kinematic measures just discussed. No changes in spatial
values of SL, SH and their associated variability measures were detected for the No RAS
condition of the multi-directional step task. Increase in step length with and after application of
RAS was reported in some cases of straight line walking (e.g. [41]), however not in others [30,
40]. It is thought that RAS use may not influence muscular amplitude to an extent to cause
absolute step length changes [40], as its primary influence is on temporal aspects of movement
[30, 40]. Thus although effects of RAS on spatial measures do exist, these different outcomes
may result from indirect rather than direct links to RAS use. Direct effects of RAS use on spatial
variability help explain the different study findings in absolute length changes and offer further
insight on this issue.
Kinematic outcomes from multi-directional step training with RAS for the C group often
differed from those in the No RAS condition. Kinematic alterations after training were limited to
the variability measures for RAS condition. These variability reductions remained at least 8
weeks post training. Thus, although temporal variability reductions were detected for both RAS
and No RAS conditions for DSDvar, changes in spatial variability were limited to the RAS
condition. Different neural mechanisms suggested for temporal and spatial variability measures
are blamed for this disparity. While temporal variability appears under the control of central time
keepers, possibly located in BG and cerebellum [62], spatial variability has been linked to the
noisy muscle output [64]. Specifically, the abnormal activity of sub-cortical structures such as
the reticular formation is linked to the abnormal muscle activity in PD [65]. Thus, it is possible
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that changes in spatial variability represent the influence of RAS on the proposed reticulo-spinal
pathway [66, 67] because it does not carry over to the No RAS condition.
Results on reaction time (RT) support previous findings for people with PD. Step RT to
initial cues did not change for C participants after training. Previous work indicated no changes
in simple and choice RT after hundreds of practice trials for a discrete reaching task for those
with PD [68]. It appears that, whether using the upper or lower limbs or simple or choice RT,
training does not affect RT in certain subgroups of this population. These findings are not
verified for PD patients with more or less disease severities or severe freezers with the disease.
Several alterations in kinematics determined during performance of the multi-directional
step task after practice with RAS use were observed. On the other hand only one measure, the
variability of step direction switch duration, changed after training without RAS use. Training
with RAS resulted in significant reductions in spatial and temporal variability measures. In this
case the temporal variability of step measures reduced in the No RAS condition after training, no
such alterations occurred for spatial variability measures. Thus, not all RAS training effects
transferred to the No RAS condition.
Speed and Direction Effects
Certain kinematic alterations were identified during multi-directional step performances
in RAS and No RAS conditions. Most effects of speed and direction on these variables occurred
regardless of training.
Individuals with PD are capable of adjusting muscular force internally [69] and to
external demands [21]} when movement speed requires adjustments. However, the peak
movement velocity and muscle amplitude remain abnormally low [69] due to deficient muscle
activation [70]. Thus, individuals with PD can also modify cadence, average step velocity and
step duration for different non-cued [58] and cued [39] walking speeds even though the overall
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speed remains slower than healthy controls [39, 58]. In the current study participants showed
similar capabilities by adjusting DSD, VEL and SN to slow and fast stepping speeds regardless
of the RAS condition. They also showed no alterations in step length like other PD individuals
walking at different speeds [58] or with different RAS frequencies [30]. Therefore, PD
participants in the current study were able to adjust certain step kinematics to alter their speed for
the selected stepping task even with expected low muscle activation levels and overall slowness.
It is important to note that although individuals with PD can modulate movement speed,
adding RAS can enforce further alterations for a given speed. For example, gait velocity
increased with use of a comfortable RAS frequency compared to a self-selected walking speed in
PD [37]. Higher values of velocity detected during gait with +10% RAS compared to a selfgenerated maximum gait for individuals with PD, on and off medication also exist [57].
Furthermore previous findings indicated higher VEL and lower DSD values for all RAS speeds
compared to their corresponding No RAS stepping speed prior to training (see chapter 2).
According to these findings it is evident that speed regulation occurs regardless of RAS, but
adding this modality may lead to faster movements in response to a given speed (e.g. peak step
velocity for the normal speed with RAS was higher than peak velocity for the normal speed
without RAS, Chapter 2). Moreover, the speed adaptations occurred, regardless of the movement
direction and despite higher instabilities reported for the back direction [71].
Moving in the back direction clearly differs from side and forward movements for those
with PD. In the current study stepping back resulted in lower VEL and higher VEL variability.
These findings agree with a previous report which indicated that back direction stepping is
significantly slower than forward stepping for those with PD [72]. However no known reports on
greater peak step velocity variability for this direction and population exist until now. The lower
SL, SH and associated variability measures for back stepping in the present work is likely
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indicative of greater imbalance in this direction. This is because higher stride length variability
[73], reduced step height [74] and stride length [72] are associated with gait initiation
instabilities.
Conclusion
Results from the current study indicate that movement kinematics for multi-directional
stepping are modified after RAS training. This was indicated by a faster step direction transition
(DSD), greater step frequency and velocity and lower variability for DSD. These changes were
maintained at least 8 weeks after training terminated and indicate the effectiveness of this
modality for modifying activities that require direction transition, a difficult movement for those
with PD.
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CHAPTER 5: GENERAL DISCUSSION
Key Results
The debilitating effects of PD on motor performances have led to many investigations for
alleviating motor symptoms for this population. Medical and surgical treatments relieve several
motor symptoms but some complications such as temporal movement parameters are resistant to
these treatments. Rehabilitation methods such as RAS application hold many benefits as
noninvasive strategies for improving motor performance for repetitive movements such as
straight line walking in those with PD. In this document studies on the effects of RAS use during
performance of the multi-directional step task extend the knowledge of RAS use to a more
complex activity which presents difficulties for those with PD.
In chapter 2 we explored the effects of RAS on multi-directional stepping kinematics in
PD participants where they performed the stepping task with and without RAS. Results showed
that direction switch duration (DSD) of stepping, peak step velocity (VEL) and step number
(SN) differed across speeds for performances with and without the use of RAS. An increase in
VEL and decrease in DSD was observed for participants stepping with the use of RAS. Various
functional gait and balance measures were also collected to evaluate associations of kinematic
and functional measures with one another and disease severity. Results showed that DSD was the
only kinematic measure with significant links to disease severity and various functional measures
of gait and balance including the primary measure of interest, the dynamic gait index (DGI).
These results offered short term effects of RAS use on the multi-directional step task.
Investigation of the long term effects of RAS use with multi-directional step training
were explored in chapters 3 and 4. Step training and RAS influence on functional gait and
balance measures were presented in chapter 3. The multi-directional step task was performed by
two groups of PD patients, those who received RAS/auditory cues (Cue, C) and those who did
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not (No cue, NC). Both groups underwent 3 days/week of multi-directional step training for 6
weeks with increasing difficulty each week. Performance of PD participants during non-cued
gait and balance functional testing was investigated before training, immediately after training
and up to 8 weeks after training termination. Immediately after practice both C and NC groups
showed improvements in the primary gait measure of interest (DGI), as well as other gait
measures. Although both groups were able to maintain balance improvements for at least 8
weeks, only the participants from the C group maintained gait improvements during this time.
Chapter 4 was used to explore the underlying cause of such functional improvements.
Kinematics obtained from C and NC groups during performance of the multi-directional step
task without RAS use was studied along with functional tests before training, immediately after
training and up to 8 weeks post training. The variability of DSD (DSDvar) during step
performance without RAS use reduced immediately after practice and remained lower than pretest measures at least 4 weeks post training for both groups. The C group maintained this change
for at least 8 weeks. Participants in this group were also able to decrease DSD and increase VEL
and SN after training and maintain these changes relative to pre-test measures on all retention
tests. After training the C group was also able to reduce the variability of SL, SH, VEL and DSD,
retaining these changes on all post training visits in the RAS condition.
The following sections will focus on discussion of the relationship among the major
results from chapters 2-4. Limitations of the current work and suggestions for future research
directions complete this chapter.
Discussion of the Key Results
Linking Immediate and Long Term RAS Effects
Several investigators have evaluated the use of RAS on gait related activities for various
populations to offer insight to either its short term (immediate) or long term (training) effects.
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The following section will focus on RAS effects for such immediate and training comparisons
for the PD population.
Studies to examine RAS effects after its short term [1-7] and long term [8-11] use exist.
While in the short term studies investigators evaluate activities with and without RAS, those for
the long term investigations emphasize assessment of non-cued performances only. This latter
assessment offers excellent insight into generalization of activities to a more common, non-cued
environment but does not clarify the specific cue influence on movement after practicing with
RAS. The current design allowed us to compare some short term and long term training effects
with use of RAS on multi-directional step performance with and without cueing.
Figure 5.1 shows the major outcomes for the RAS/No RAS comparisons of different
kinematic measures for the C group. Immediate RAS effects were identified for DSD and VEL
during the pre-test (Fig. 2.2A, B) and did not change significantly with training (chapter 4). The
values for each of these variables after training for post and retention tests were very similar to
pre-test values and similar to values for the No RAS condition (see Fig. 5.1A, B). The nonsignificant trend identified for immediate RAS effects for SN (Fig. 2.2) also did not change
significantly with training (chapter 4), however post-test and retention test values were similar
for the RAS and No RAS condition regardless of the training improvements observed for the
latter (see Fig. 5.1C). Thus, it is evident that for the specified measures any immediate RAS
effects do not improve with training. Furthermore, training with auditory cues resulted in
alterations in the No RAS condition to achieve similar changes to those immediate effects of
RAS use. These results indicate no additional improvements in these measures with the use of
RAS during step performance after training (i.e. observe similar POST-RTW8 values for RAS
alterations in the No RAS condition to achieve similar changes to those immediate effects of
RAS use. These results indicate no additional improvements in these measures with the use of
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Figure 5.1 Mean kinematic values with and without RAS for the C group across test-days. Mean
values of (A) direction switch duration (DSD), (B) peak step velocity (VEL), (C) step number
(SN), (D) direction switch duration variability (DSDvar), (E) peak step velocity variability
(VELvar ), (F) step length variability (SLvar) and (G) step height variability (SHvar) are shown for
the pre-test (PRE), post-test (POST) and retention tests 1 week (RTW1), 4 weeks (RTW4) and 8
weeks (RTW8) after training. All data are from the C (cue) group participants for No RAS (blue)
and RAS (black) conditions. Blue and black asterisks represent a significant difference from the
PRE values for the No RAS and RAS conditions respectively. Error bars represent 1 standard
error. Note, some bars are too small to see in plots.
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RAS during step performance after training (i.e. observe similar POST-RTW8 values for RAS
and No RAS, Fig. 5.1A-C). In contrast, no immediate changes for DSDvar were found with RAS
application, but DSDvar decreased after training completion and remained that way during all No
RAS (see group C, Table 4.2) and RAS (Fig. 4.3A) post-training tests. Figure 5.1D shows these
results plotted together, emphasizing a greater variability reduction for DSD with the use of RAS
during post training evaluations. The reductions in DSDvar observed after training with RAS
results in DSDvar reductions for stepping with and without cues, however stepping with cues will
offer additional reductions in this variable for those with PD. Like DSDvar, variability of step
length, (SLvar), step height (SHvar) and peak step velocity (VELvar) did not change significantly
with RAS use on pre-tests (chapter 2) but did change significantly after training completion for
the RAS condition (Fig. 4.3B-D and Fig. 5.1E-G). No alterations in these variables were
observed for the No RAS condition across different test days (Fig. 5.1E-G). It appears that for
these variables RAS training effects are context specific. Together, these results provide
evidence for immediate RAS effects on absolute temporal variables and training RAS effects on
spatial and temporal variability measures for the multi-directional step task. Previous work on
RAS effects for either its immediate or long term use support the findings just listed, and were
discussed in chapters 2 (immediate) and 4 (long term).
The Underlying Mechanisms
By including C and NC groups and testing functional and kinematic parameters we are
able to make several speculations regarding the underlying mechanisms involved for the
observed changes. As specified earlier RAS use with training for participants with PD resulted in
several kinematic measurement alterations in the No RAS condition that were maintained on
follow-up evaluations (see DSD, VEL and SN plots, Fig. 4.2). Alteration in one functional
measure was also determined for post- and follow up tests exclusively for the C group (see
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FOGQ values in Table 3.2). In other cases training resulted in kinematic and function
measurement alterations regardless of RAS use, however the measurement changes retained for a
longer period of time in PD participants that trained with RAS (see DSDvar values, Table 4.3;
DGI plots, Fig. 3.2 and UPDRS-ADL, UPDRS-composite, Tinetti-gait and TUG values, Table
3.2). These observations indicate that the underlying factors for the observed alterations differed
between groups. Thus different mechanisms can be suggested for practice with and without
RAS.
Two suggestions have been posed to explain the carry over effects of RAS use to a no
RAS condition for people with PD. One suggestion is that RAS resets the central time keepers
which allow the movement to be entrained to temporal features of RAS [8]. This assumption is
based on the ability of PD participants to regenerate a given movement with high levels of
accuracy and low levels of temporal variability during a no RAS walking condition performed
immediately after a RAS walking condition [8]. This explanation leaves one to wonder how the
central time keepers reset in PD with a deficient component. Thus, a second suggestion to
explain the carry over effects of RAS use in PD is the activation of a compensatory pathway
which bypasses the defective BG. Projections from the cerebellum to the SMA and higher
cortical areas offer a suitable compensatory pathway for explaining kinematic and functional
findings in general [11]. Activation of such a pathway was proposed when associated activities
were observed during a PET scan of finger tapping without RAS immediately after RAS gait
training in the same participants with PD. Not only was there a transfer to an environment with
no external cueing, the movement task changed from the lower to upper limbs. A similar
pathway has also been suggested to take over auditory paced finger tapping compared to
internally generated tapping [12]. Outcomes of the current and other RAS studies offer
behavioral evidence for insights to the neural compensation abilities using external cueing.
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Practice without RAS also results in central changes which can explain some of the
improvements observed for the NC participants. PET scans [13] and functional magnetic
resonance imaging (FMRI) [14] results after practice reflect the patient’s ability to overcome
certain deficiencies by recruiting greater neural areas. After learning sequential aiming tasks, PD
patients revealed additional brain activation in pre-frontal and parietal cortices compared to
healthy individuals [13]. Patients who presented with abnormal activity in the BG recruited
additional areas including parts of the cerebellum, pre-motor, pre-frontal and parietal cortices
after learning a sequential finger movement sequence while counting letters [14]. Similar
increased activation exists following learning of sequential arm movements [15] and aiming
tasks [16]. Evidently, patients recruit multiple cortical and sub-cortical regions to override the
inappropriate output of the BG and to overcome certain motor deficits during motor learning.
While practice without the use of RAS helps individuals with PD activate additional brain areas,
the primary neural pathway involving the deficient BG does not change. Alternatively, externally
paced movements using RAS are better performed because they are controlled through a
pathway that circumvents the BG. Thus while similar compensatory brain areas are involved
with or without RAS practice the abnormal signals from the deficient BG do not interfere when
RAS is applied. This can be a possible advantage for adding RAS to a regular practice regiment
and might be the primary source of the observed differences between C and NC participants.
It is possible that the aforementioned central mechanisms are not the only factors behind
the observed changes. The improvements that occurred only during the RAS testing for the C
group (SLvar and SHvar) which did not transfer to the No RAS condition is an indication of this
issue. In addition lack of correlation between DSDvar and functional tests that improved in the
NC group indicates that other factors might be involved. Reports indicate changes in muscle
activation symmetry in lower extremities during gait after RAS gait training [8] and increases in
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muscle strength after No RAS balance training [17]. It is possible that similar muscular related
changes occurred but we cannot verify this as they were not collected in this study. Furthermore,
it is difficult to make assumptions regarding the underlying muscle changes based on the current
findings because several gait related kinetic and kinematic measures appear to be independent of
one another. For example, the generated power in the lower extremity appears to have no
connections to gait velocity [18]. Elsewhere, the generated forces during walking are
independent of walking speed, gait symmetry and gait swing durations [19]. More research is
required to clarify muscular mechanisms involved with training in PD and RAS use. Such
findings would allow us to better understand the underlying causes of behavioral improvements
post-training and to better identify the effectiveness of various training programs.
Limitations
Limitations that may affect generalization of findings exist in every study. Those linked
to participant characteristics are listed first. This is followed by those linked to study
methodology.
One of the primary limitations is that associated with the participants’ disease
characteristics. Participants in the current study were primarily at the moderate stage of the
disease. While those with more severe disease within this group revealed observed
improvements, the overall lack of distribution in terms of disease severity poses limitations to
generalizing the current results to individuals at more and less severe stages of the disease.
Other participant characteristics present potential limitations in the present study. Since
most of the participants were recruited from a local support group, it is likely that participants
were seeking strategies to deal with their disease and were highly motivated, thus represent a
limited group of individuals with PD. The participating individuals also lacked obvious cognitive
disorders. Lack of cognitive deficits is used as the primary inclusion criterion for many of the
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rehabilitation studies [8, 20-22]. Yet research indicates that the annual MMSE decline for those
with PD is 1 point per year [23]. One in 5 individuals with Parkinson’s disease has dementia [24]
and declines 2 points per year in the MMSE scores [23]. These observations make one wonder
whether the training protocol could be generalized to people with PD with less motivation or
greater cognitive deficits.
Other limitations of the study were not dependent on participant characteristics. Although
numbers of participants needed to achieve 80% power on the main functional measure of the
DGI were only 6 in each group, this number did not ensure appropriate power on all variables of
interest. Having a design with a tester not blind to the study is another limitation. It is clear that
double blind placebo controlled studies can produce more credible results. Lastly, including a
healthy age-matched control group would have provided more insight to the pre-test deficits and
nature of improvements in those with PD.
Regardless of study limitations, several positive outcomes were identified. Overall, use of
auditory cues for multi-directional step training altered certain movement abilities to mimic those
of controls and/or helped with maintenance of abilities in people with Parkinson’s.
Future Directions
Rehabilitation is considered a useful non-pharmacological approach to accompany
regular medication in controlling motor complications in PD (Morris, 2000). Reviews of the
previous rehabilitation literature [25-27] indicate beneficial effects of practice for PD [28].
Training through rehabilitation appears to be a valuable means for improving motor abilities of
PD, including those identified by the UPDRS-Motor and ADL scores and the PD disability scale
[29]. With numerous techniques and no unified rehabilitation approach it is difficult to
specifically determine a single beneficial rehab regime for those with PD [28]. Rehabilitation
effects on motor deficits in PD should continue to add to the evidence-based practices to devise
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such a regime or a series of specific well-accepted guidelines to better assist individuals from
this population. Studies addressing the limitations listed for the current study are suggested in
addition to the following.
Weeks of motor training are reported to cause improvements when certain strategies are
followed. These strategies offer evidence based procedures for future rehab studies and may
contribute to the final ―specific guidelines‖ for therapists to assist individuals with PD. PD
patients learned to correct their own body position errors and retain these abilities for a relatively
long period of time when given more practice time than healthy individuals [30]. Providing these
people with constant augmented feedback (observing their body sway via their center of pressure
measurement on a computer screen) also resulted in improvements and maintenance in balance 1
week post training [31]. Positive reinforcement allowed people with PD to learn and maintain
compensatory stepping strategies up to 1 month after 7 weeks of gait training [32]. Practice
schedules that began with easy skills and progressed to more difficult skills likely contributed to
the improvements observed for stepping [32] and body positioning [30] just reported, as breaking
down a sequential movement at initial training period is also suggested for this population [33].
We observed several successful outcomes in the present study by following several of these
strategies. While C and NC groups followed similar training techniques, RAS use resulted in
longer retention and better improvements for the C group participants. Our knowledge of the
neural mechanisms involved with externally paced movements, the behavioral evidence
regarding RAS use and more importantly the simplicity of RAS application makes this modality
a suitable candidate for further use in other training programs for those with PD. Future research
should incorporate this modality with effective learning strategies in order to enhance the
training outcomes in individuals with PD with mild and severe levels of disability.
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Physical activity is an essential factor for preventing many motor complication associated
with sedentary life and alleviating emotional problems associated with PD [34]. Recent
investigations also indicate neuro-protective benefits of exercise in a PD animal model [35].
However research indicates low rates of participation in physical activity and sports in those with
PD [23]. Similar to these findings over half the participants (9/16) in the current study were not
involved in a regular activity or a rehabilitation program. These participants expressed many
reasons for activity limitations including transportation limitations (11/16), financial issues
(9/16) and insurance restrictions (14/16). These concerns are not limited to the current
participants as the average health care costs for an individual with PD is twice and much as a
healthy age matched individual [36], while the amount of rehabilitation covered by insurance for
these individuals is limited [37]. Therefore it is clear that designing a safe yet effective exercise
protocols that can be performed by individuals with PD at home is essential. In fact, research
indicates that 8 weeks of self-supervised home exercise can be as effective as a physical therapist
supervised design in reducing UPDRS-Motor and TUG scores[21]. However, safety should be a
major concern. Use of the multi-directional step protocol from the current study may be a homebased training possibility for these people. Stepping from a stationary position where one can use
a walker for assistance should be easier and safer for those at later stages of the disease with
severe difficulties in balance and walking. Other techniques, such as mental imagery [38], have
been successful to combat motor complications in this population and may offer greater safety in
the home. However, evidence regarding its effects on retention abilities are not currently
identified. Thus, future investigations are needed to explore and design safe, simple and effective
activities specific for individuals with PD at various disease stage that can be performed in the
convenience of their home. Based on results from the present work, we suggest that the multidirection step task with RAS may be such an activity.
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NOMENCLATURE
AS—Auditory Stimulation,
BG—Basal Ganglia
bmp—beats per minute
BOS—Base Of Support
COG—Center Of Gravity
COM—Center Of Mass
COP—Center Of Pressure
CPG—Central Pattern Generators
DBS—Deep Brain Stimulation
DLPFC—DorsoLateral Prefrontal Cortex
FEF—Frontal Eye Field
FMRI—Functional Magnetic Resonance Imaging
FOG—Freezing Of Gait
GM—Gastrocnemius muscle
GP—Globus Pallidus
GPe—Globus Pallidus pars externa
GPi—Globus Pallidus pars interna
HSV—Herpes Simplex Virus
IRI—Inter-Response Interval
M1—Primary Motor cortex
MLR—Mesencephalic Locomotor Region
MT—Movement Time
NAC—Nucleus Accumbens
PD—Parkinson’s Disease
PET—Positron Emission Tomography
PM—Premotor cortex
PMv—Premotor Area ventral region
PNF—Proprioceptive Neuromuscular Facilitation
PPN—PedunculoPontine Nucleus
PT—Physical Therapy
ROM—Range Of Motion
RT—Reaction Time
SAPDDS—Self Assessment Parkinson’s Disease Disability
SIP—Sickness Impact Profile
SL—Soleus muscle
SMA—Supplementary Motor Area
SNc—Substantia Nigra pars compacta
SNr—Substantia Nigra pars reticulate
STN—Subthalamic Nucleus
STR—Striatum
TA—Tibialis Anterior muscle
TMS—Transcranial Magnetic Stimulation
UPDRS—Unified Parkinson’s Disease Rating Scale
VL—Vastus Lateralis
VP—Ventral Pallidus
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1. INTRODUCTION
1.1. Aims of Review
Ever since James Parkinson described the clinical features of Parkinson’s disease (PD) in
1817, scientists became curious to know more about this disease. Despite the arduous efforts of
scientists that have increased our knowledge of the disease, there is neither a cure for PD nor a
definitive treatment for its symptoms. Consequently, motor deficits remain a primary complaint
of patients from this population.
Current rehabilitation techniques provide a means for reducing some of the motor
complications associated with PD. Use of external stimuli to help trigger movement has received
special attention, as PD patients show the ability to improve some of their symptoms under
externally triggered conditions that do not occur with other treatments. Emphasis will be on
auditory stimulation because of the greater temporal benefits identified with its use.
The first aim of this review is to introduce major motor complications of people with PD.
The second aim of this document is to review the rehabilitation techniques applied to Parkinson’s
patients, incorporating the benefits of using auditory stimulation as the external stimulation for
improved motor outcomes for those with PD.
1.2. Scope of Review
Because PD reflects the dysfunctional basal ganglia, these complicated nuclei and their
cortical and sub-cortical connections are introduced first. These findings will lead to the
description of the disease and its pathophysiology with emphasis on motor complications. The
role of the basal ganglia in motor control is then addressed in theoretical links. A complete
review on the medical and surgical interventions is beyond the scope of this review; therefore a
brief discussion on these interventions is provided and followed by a more detailed review of
different rehabilitation techniques and motor learning outcomes in PD patients. Presentation of
movement alterations in PD patients from rehabilitation using auditory stimulation complete the
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topics reviewed. Finally, a summary of the findings, which lead to questions for future research
and the associated hypotheses, are offered.
2. OVERVIEW OF PARKINSON’S DISEASE
Parkinson’s Disease (PD) is a neurodegenerative disease which was first introduced by
James Parkinson in Essay on the Shaking Palsy in 1817 as ―Paralysis agitans‖ [1]. PD is the most
common neurodegenerative disease after Alzheimer’s disease. The incidence of PD is 13.4 in
10,000 Americans per year [2]. The main problem in PD is mainly the dopaminergic deficiency
of the basal ganglia [3]. Under normal conditions dopamine release allows the basal ganglia to
serve as an internal trigger, enabling movements to occur in a sequential manner. Disruption of
dopamine due to PD disrupts the normal functioning of the basal ganglia, thus voluntary
movements. Clearly, to better understand PD and its associated deficiencies, one should first
understand the normal functioning of associated neural structures and pathways. The focus of
this chapter is to examine the major neural structures and pathways associated with PD,
including the major nuclei of the basal ganglia and its connections, and to review the
pathophysiology of the disease.
2.1. Neural Structure Overview
2.1.1. Major Nuclei and Pathways of the Basal Ganglia
The basal ganglia (BG) are a group of sub-cortical nuclei that have been grouped and
sub-grouped various ways in the literature. For this manuscript BG composition will include: the
striatum (STR), which includes the caudate, putamen and nucleus accumbens (NAC); the
subthalamic nucleus (STN); the two sections of the substantia nigra (substantia nigra pars
reticulata-SNr and substantia nigra pars compacta-SNc), the globus pallidus (GP) divisions of
the internal segment (GPi), external segment (GPe) and the ventral pallidum (VP) [4]. The
internal and external connections of the BG described below are represented schematically in
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Figure 1.

Figure 1. A schematic diagram of the major connections of the Basal Ganglia (BG). Arrow ends connect the
structure(s) releasing neurotransmitters and points connect to the targeted structure(s). Excitatory
connections are represented by filled arrows and inhibitory connections are represented by empty arrows.
Bold arrows represent connections of the BG to external cortical and sub-cortical structures (see key). The
orange, blue and red lines represent direct, hyperdirect and indirect pathways, respectively. D1 and D2 are
the dopamine receptors located on most striatum neurons. (SNc—substantia nigra pars compacta; SNr—
substantia nigra pars reticulata; STN—sub-thalamic nucleus; Gpe—globus pallidus pars externa; Gpi—
globus pallidus pars interna; PPN—pedunculopontine nucleus; BS—brain stem; VP—ventral pallidum)

Many BG nuclei are involved in inhibition or dis-inhibition of their associated targets.
The STR [5] and STN [6] serve as the input nuclei. While GPi and SNr are considered the major
output nuclei of BG [7], VP is also known as an output nucleus [8]. The striatum receives input
from different areas of the cerebral cortex [6], the hippocampus and the amygdala [9]. The
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structures of the striatum contain several receptors for different types of neurotransmitters. Of
our interest are the dopamine receptors, D1 and D2, which receive their dopamine from the SNc.
D1 receptors project to output nuclei, while D2 receptors project to GPe. Upon receiving the
dopamine, D1 receptors facilitate the neural transmission of cortically received information in
striatum while D2 receptors inhibit such transmission. The output nuclei GPi, VP and SNr
receive projections from STN, STR and GPe prior to sending the signals to the ventro-lateral
(VL), ventro-anterior (VA), mediodorsal (MD) and intralaminar (IL) nuclei of thalamus, which
further target different areas of the cortex (for further details, see [10]). Figure 1 shows a
schematic representation of these connections.
Research on BG has led to the proposal of a classic view including two parallel cerebrobasal ganglia loops which start in cerebral cortex, pass through the BG and end back in the
cerebral cortex [11-13]. The loop involves direct and indirect pathways which are responsible for
excitation and inhibition of voluntary movements, respectively. In the direct pathway the STR
inhibit the major output nuclei (yellow arrow, Fig. 1), removing their inhibitory effect on the
thalamus, resulting in excitation of the cortex and facilitation of voluntary movements [13].
However in the indirect pathway the STR first inhibit the GPe, which removes the inhibition
over the STN (red arrows, Fig. 1), thus facilitating the inhibitory effect of the output nuclei on
the thalamus [13].
Although projections of cortex to STN were identified long ago [6] only recently a third
pathway was added to the cerebro-basal ganglia model [14, 15]. The relatively new hyperdirect
pathway (blue arrow, Fig. 1) involves direct activation of STN from frontal lobe projections [14]
leading to movement inhibition similar to the indirect pathway, but faster [15]. It is suggested
that during the voluntary movement the three pathways work together to withhold (hyperdirect),
release (direct pathway) and terminate (indirect) the desired motor commands [15]. In addition to
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these three external pathways several other external and internal circuits exist (Fig. 1), which
contribute a great deal to the normal functioning of the BG [16]. For example besides the
aforementioned indirect influence, GPe receives feedback from the STN and has direct
projections to the output nuclei [17], and the thalamus [18]. The dopaminergic connection of the
SNc to the STR [19] is another example of an internal circuit essential for normal functioning of
the input nuclei.
2.1.2. Other Connections of the Basal Ganglia
Just listing the structures associated with basal ganglia pathways allows one to
appreciate the intricate nature of BG function. However, knowledge of the cortical and subcortical connections will assist in understanding complications following disruption of BG.
Anatomical techniques such as anterograde and retrograde viral injections [20] and electrical
stimulation [21] have made it possible to reveal projections among the BG and cortical or subcortical structures. Activities in some of the cortical areas have been noted through single neuron
recordings to identify the specific functions of different regions [22].
2.1.2.1. Cortical Connections
The input and output nuclei of the BG have well organized topographic areas for several
cortical regions [23]. For example, through retrograde viral transportation a certain location
within GPi directly linked to the distinct arm area of primary motor cortex (M1) [24]. Support
for this finding includes evidence that stimulation of M1 led to the inhibition of GPi [25] and that
trans-neuronal transport of herpes simplex virus (HSV1) revealed that the mid-rostrocaudal level
of the GPi nucleus had direct connections to M1 [20]. Similar results exist for the input nuclei
where anterograde transmissions show the connection of BG to the motor cortex, as injection of
anterograde traces in forelimb and hind limb areas of rats label dorsolateral quarters of the
caudate and putamen [26].
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Similar examples are available for areas other than M1 and non-motor regions. Research
indicates links between supplementary motor area (SMA) neurons and dorsal regions of GPi as
well as pre-motor cortex/ventral section (PMv) and the ventrolateral portion of GPi [20]. Frontal
eye fields (FEF) connect to the lateral region of posterior two third of SNr [20] and dorsomedial
regions of striatum [26]. Gpi and SNr projections also target areas in prefrontal cortex [20],
suggesting that areas in GPi and SNr are not only limited to motor areas.
The evidence regarding cortical area connections with the BG are numerous. These
studies converge on the fact that cortico-basal ganglia connections via input or output nuclei are
related to motor and non-motor areas, are topographically separated and the separation allows for
parallel processing of sensory and motor information [27]. Organization of BG could be thought
of as reentering loops that start from a specific region in cortical area, pass through functionally
related BG region by entering input nuclei and returning to the cortical areas once again.
Therefore basal ganglia cortical circuits could be referred to as cortico-basal ganglia-thalamocortical circuits.
General functions of different cortical areas are fairly well-known. Through connections
with the BG, knowing the major functions of each cortical area will assist with understanding the
function of the BG. For example, knowing that SMA is involved in internal guidance of
sequential movements [20] will allow us to make sense of how the BG could be involved in such
guidance. Moreover, understanding that a patient with damage to dorsal regions of GPi will
likely have difficulty with sequential guided movements will help with their rehabilitation.
2.1.2.2. Sub-cortical Connections
The basal ganglia have direct and indirect connections to sub-cortical structures. Direct
outputs of BG target the brainstem or more specifically the midbrain [28, 29]. Projections of BG
connect to the mesencephalic locomotor region (MLR) [30, 31] and the pedunculopontine
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nucleus (PPN) [32] of the mesopontine tegmentum (the junction of midbrain and pons) [33].
Some connections of midbrain and BG are reciprocal but indirect, as the midbrain is the major
recipient of BG output [34-37]. Other examples include STN connection to PPN [38], and
unidirectional projections from the PPN to SNc [39]. Topographical organization observed in the
cortical region is also reported for BG-tegmental projections [36, 40].
The connections of the BG nuclei to midbrain are of importance because the medial
reticulo-spinal tract, which passes through the ventromedial medulla and therefore spinal cord,
stems from the midbrain region [41]. There is evidence that projection of MLR to the spinal cord
through medial reticulospinal tract activates central pattern generators (CPG) in cats [42],
therefore it is also linked to locomotion control [28]. The involvement of MLR in locomotion is
further supported as stimulation of areas (e.g. PPN and SNr) with major associations to MLR
evoke locomotion in rats [43] and cats [40, 44].
More specifically, descending projections of PPN can reduce inhibition of muscular tone
[21] and increase muscle tone inhibition via reticulo-spinal tract connections [40, 44-46]. If the
MLR through its connection to PPN controls muscular activity and contributes to initiation of
locomotion and its maintenance [21], it is reasonable to assume that projections of BG to MLR
control locomotion by projecting to PPN and controlling muscular activation.
Although neurological structures of cats or rats are not identical to that of human, some
scientists regard the PPN as a BG nucleus (Webster, 1990), while others regard it as a close
family member [47]. In humans it seems that the efferent projections of the brainstem (PPN) to
the BG may be more important to movement compared to afferent stimuli [48], however its exact
role is yet to be discovered.
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2.1.2.3. Functions of the Basal Ganglia Based on Connections
Regardless of whether through the cortical or sub-cortical connections, functions of the
BG involve contributions to movement. Review of the major functions of the corresponding
connections with these nuclei will precede the associated pathophysiology in the following text.
As mentioned previously, the input nuclei of the BG receive numerous projections from
different cortical areas in a topographic manner [49]. However, indications of several
overlapping areas result in common functions of separate regions [50]. For example, because of
prefrontal cortical projections to the caudate and pre-commisural putamen and somatosensory
cortical projections to the putamen with few to the caudate, it should not be surprising that the
caudate appears to be mostly involved in preparation of the movement (prefrontal) and that parts
of caudate and the anterior putamen are involved in preparation (prefrontal), response and
generation (somatosensory) of movement [51]. Due to the nature of connections malfunction of
the caudate cause behavioral disorders [52], cognitive disorders [53], spatial neglect [54],
language difficulty (aphasia) [55] and other major prefrontal syndromes such as dysfunctions in
planning, abstracting rules and working memory function [56]. The putamen on the other hand
has a significant roles in control of movement and is rarely involved in emotional or cognitive
control [57-59].
Because of the nature of these connections the projections of the STR and STN could be
regarded as the sensori-motor, associative or limbic [60]. The function of other nuclei such as
GPi/SNr, GPe and SNr cannot be evaluated in isolation. These nuclei complete the loop
originally started from the cortex and the input nuclei and similar to the input nuclei these areas
are topographically and functionally distinct [48, 61]. Therefore, the function of each specific
region within these nuclei depends on their anatomical connection to the STR and STN. For
example, the area of GPe associated with caudate will regulate emotion and cognition [62]. The
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section of SNr receiving input from head and body of caudate contributes to saccadic eye
movement [63]. Therefore the functions of different areas of GPi/SNr in internal generation of
sequential movements, or control of cognition and executive function depend on the origin
within the BG or the cortex [20, 58]). Specifically, inputs to the BG specify what type of
information these nuclei can process, while outputs from the BG reflect their function [64].
Connectional organization of the BG shown in Fig. 2 should help with understanding these
functions.
The numerous individual roles of the BG nuclei act collectively, so that they function as a whole.
Thus, a BG lesion in one nucleus will affect whole system function [65]. During the review of
the pathophysiology of PD the focus is on the function of BG once again, but only relative to the
associated pathology.
2.2. Pathophysiology
PD results from a dopaminergic deficiency within the nigrostriatal pathway of the BG
[3]. Loss of neurons within the SNc, faster turnover of dopamine and reduction in the enzyme
that converts the amino acid, L-Dopa, to dopamine cause dopamine depletion within the STR [1,
66]. Reduction of dopamine levels, which vary from individual to individual, is more apparent in
the putamen than the caudate, both of which contain major receptors for dopamine [58]
discussed previously (i.e. D1 and D2). In the classic model upon reception of dopamine, D1
receptors facilitate the direct pathway, while D2 receptors inhibit (suppress) the indirect
pathway, thus lack of dopamine reduces the activity of the direct pathway and over activating
that of the indirect [67]. This excessive inhibition of the output nuclei suppress thalamic and
corresponding cortical activity, leading to akinesia or other hypokinetic symptoms observed in
PD. However, findings from more recent experiments oppose the classical model as they show
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that dopamine does not affect the direct and indirect pathway as previously assumed [68]. In a
newer dynamic perspective (discussed in detail in chapter III) researchers suggest

Figure 2. A schematic representation of functional organization of the Basal Ganglia (BG) based on
cortical connections. The input and output BG nuclei are usually segregated based on three major
functions: limbic function (behavior, emotion, attention, memory, learning), associative function
(planning, oculo-motor, perception, speech) and sensori-motor function (planning and execution of motor
actions). Each function is not limited to one pathway (note multiple pathways for each function). From top
to bottom each schema includes: the cortical areas that project to the BG, the input BG nuclei (1st bold
box), the output BG nuclei (2nd bold box), the thalamic nuclei and the cortical efferent target(s). Bold font
represents structures that receive or send more prominent projections than normal font structures. Efferent
cortical areas and thalamic nuclei vary depending on the cotical source. (Association areas—the
dorsolateral and ventrolateral pre-frontal cortices, areas 8, 9, 10, 46, portions of the intraparietal sulcus and
the border of the superior temporal sulcus; Gpi—Globus Pallidus pars interna; Gpe—Globus Pallidus pars
externa; MD—Medio-Dorsal thalamic nucleus; M1—primary motor area; SMA—Supplementary Motor
Area; SNr—Substantia Nigra pars reticulate; VA—Ventro-Anterior thalamic nucleus; VAL—Ventral
Antero-Lateral thalamic nucleus; VApc—Ventro-Anterior parvocellularis thalamic nucleus; VAmc—
Ventro-Anterior pars magnocellularis thalamic nucleus; VL—Ventro-Lateral thalamus nucleus; VLa—
Ventro-Lateral thalamic nucleus anterior part; VLd—Ventro-Lateral thalamic nucleus dorsal part; VLp—
Ventro-Lateral thalamic nucleus principal part; VM—Ventro-Medial thalamic nucleus; VP—Ventral
Pallidus).
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that the depletion of dopamine changes the synchronized activity of the direct, indirect
and hyperdirect pathways [16]. After depletion of dopamine, the weak direct pathway can no
longer oppose the stronger hyperdirect pathway [16] and therefore fails to release the selected
motor command(s) withheld by the hyperdirect pathway [69]. As a result the hyperdirect
pathway expands its target areas in the thalamus and cortex and remains active for a longer
period of time [15]. Even in cases where the selected motor command is released, it is present for
a shorter duration of time [15]. How the indirect pathway is affected is not clear, however it is
assumed that the initiation of a movement is associated with a sharp activity of the adjacent
areas, therefore the striatal region related to the direct pathway [70]. This sudden activity is
conducted to the region of the striatum designated for the indirect pathway to trigger the
termination of the movement [70]. In PD the weak signals of the direct pathway are not
sufficient to trigger the neighboring indirect pathway, thus terminating the motor command [70].
The complete pathophysiology of PD remains unclear. Although a general consensus in
dopamine deficiency and nigrostriatal pathway involvement in PD exists, the role of dopamine
involvement is still under debate. No matter what the role of dopamine, its contribution to the
motor dysfunction cannot be denied. In the next section research on motor dysfunctions
associated with PD are presented.
3. TEMPORAL CONTROL AND HUMAN MOVEMENT
When it comes to temporal control of movement there are discrepancies regarding the
role of BG and cerebellum in timing sequential movements [71-74]. The focus of this section is
to review the literature on temporal control and human movement, differentiating the role of the
BG from other regions, which will help associated its use with Parkinson’s patients.
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3.1. Central Representation of Time
Internal generation of a rhythmic movement requires accurate perception of the temporal
sequence, preparation of the motor plan and production of the rhythm which is sometimes based
on the perceived temporal characteristics [75]. An accurate temporal perception and a temporally
organized motor output necessitate a central representation of time through which a neural
control could occur (Ivry 2001). This representation serves as an internal clock that characterizes
the time point, duration or interval and will therefore determine the temporal characteristics of an
event [76].
The internal representation is viewed as a system of oscillatory pacemakers with flexible
and reproducible frequencies [77] or as a battery of hour glasses [78], each corresponding to a
specific frequency or duration. In humans several oscillatory units might interact and form
various temporal patterns, which then serve as a reference for estimating a specific duration or
performing a rhythmic action [77, 79]. Rhythm is defined here as ―a patterned sequence of
events, which can be completely characterized by the number of events in the sequence and the
time interval between those event‖ [75].
Use of the ―multiple time model,‖ an expansion of the hour glass model, may help
explain the internal representation of time [80]. According to the authors the representation of
time, whether perceptual or motor, is composed of elements with specific connections and
duration. These elements can be considered a group of neurons, which habituate to a specific
temporal range as one starts to learn a specific rhythm, produce a rhythmic movement or
perceive a rhythmic modality. For a rhythmic action to occur distinct temporal representations
are set for each effector system. Several motor commands compete and the first motor plan to
reach the specified temporal threshold will be selected. If a novel rhythm is introduced, the set
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effectors are inhibited to allow for development of a new element, temporal range and associated
motor responses.
Temporal elements can be located in any cortical or sub-cortical area. Cortical regions
which are active during performance of rhythmic motor tasks may involve motor, premotor,
parietal and prefrontal, cortices [75, 81-83]. Certain areas within each region make specific
contributions. For example, SMA and Pre-SMA regulate movement initiation and its internal
guidance, while pre-motor cortex (PM) and M1 contribute to preparation and execution of the
movement [75]. The controversial issue revolves around the role of sub-cortical areas, such as
the roles of the BG and cerebellum in temporal perception and performance.
3.2. Comparison of BG and Cerebellum in their Temporal Role
The BG are associated with different aspects of temporal control including perception,
learning and execution. Unfortunately, some of these functions are also related to the cerebellum
and therefore complicate the exact role of the BG. The focus of this section is to review the
literature on the temporal roles of the BG and cerebellum.
Numerous investigators that recognize the cerebellum as the major sub-cortical structure
for temporal processing, perception [84], learning [85, 86] and execution [84-86]. These
functions are attributed to cerebellum as patients with cerebellar atrophy are incapable of
detecting time interval changes in rhythmic auditory stimulation, show a significant amount of
inter-response interval (IRI) variability when tapping to a rhythmic pattern [84] and severing
different areas of cerebellum interferes with learning and executing a new temporal sequences
[85]. The role of the BG in temporal control is less clear.
The BG play a role in temporal perception [87, 88]. This assumption is based on activity
of the BG during temporal discrimination tasks [88], increase in the minimal threshold of the
temporal discrimination in PD [87] and deficiency of these patients in estimating time intervals
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of presented rhythmic stimuli [89]. Such deficiency in perception of temporal intervals is not
modality specific and is present with tactile, visual and auditory rhythmic sequences [87]. On the
other hand because of the pattern of activation of the STR and cerebellum during temporal
sequence learning, the BG are associated with encoding time intervals, while the cerebellum is
associated with temporal perception [74]. In this case the BG contribute to learning temporal
sequences, while the cerebellum functions to optimize sensory input upon receiving it from the
associated areas.
The role of BG in movement timing is implied from various experiments involving PD
patients. It is suggested that the increase in variability of the IRI during generation of a selfpaced rhythmic movements in PD patients reflects involvement of the BG in temporal control of
internally generated movements [89-91]. Because the ability to synchronize finger tapping to
external stimulation is also impaired, the BG may contribute to externally guided rhythmic
movements as well [92]. EEG recordings of the PD patients during cued and uncued rhythmic
movements reveal reduced BG and SMA activity prior, during and after the uncued rhythmic
movement compared to the cued movement [93]. Such pattern of an activity and its sensitivity to
the temporal component, bring further evidence for the role of BG in internal temporal control of
movement via connections to SMA.
The role of the BG in temporal control of movement has been viewed yet another way. It
is suggested that the BG play a functional role in integration of spatial and temporal components
of a sequence, as PD patients are capable of performing [72] and learning [94] spatial and
temporal sequences in isolation, but they fail to do so when the two are combined. In contrast,
because of the inability of cerebellar patients to perform temporal or sequential tasks in isolation,
the cerebellum is associated with forming temporal or spatial sequences. [72].
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The temporal role of the BG is rejected by other investigators who report activation of
cerebellum only during changes of temporal intervals of a rhythm [95, 96] and those who show
insensitivity of the BG to temporal sequencing of the movement [97]. The latter study makes a
comparison between temporal and ordinal sequencing. Their ordinal sequence involved
performing a rhythm in different tone orders (fixed intervals) with several key pads (one for each
tone), while the temporal sequence involved producing a rhythm with one key pad by changing
the stroke interval. FMRI recordings of the BG and cerebellum under these conditions suggested
that the BG have no role in temporal control of movement, but contribute significantly to ordinal
organization. They further propose that the cerebellum is important for temporal control,
spatiotemporal organization and ordinal control of the movement. However, in a case where
primates were trained to reach to a sequence of fixed number illuminated targets but in various
orders of presentations (ordinal task), the BG became active only if a target was presented in a
specific order and formed a temporal relationship with the other targets [98]. The temporal
control of movement viewed in a different context may help explain these differences.
Rhythmic movements can be categorized into those that need event-based timing
(discrete rhythmic movements) or emergent timing (continuous rhythmic movements) [99].
Comparison of PD patients with those of cerebellar lesion and healthy controls reveals a similar
performance in PD patients and healthy individuals for event-based timing task [99]. It is also
reported that patients with unilateral striatum damage show no evidence of motor timing problem
during finger tapping to auditory rhythmic stimulation in ipsilesional and contralesional hands
[100]. These findings suggest: 1) event-based timing deficits are dissociated from the emergent
timing; 2) tasks that require precise timing are more vulnerable to cerebellar damage; 3) the BG
are involved in emergent-based timing task; and 4) PD is not a good model for studying temporal
movement dysfunction. Unlike the studies mentioned previously [91, 101], these experiments
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reject the role of BG in precise timing of rhythmic sequential movement (event-based timing),
however may help explain discrepancies regarding the role of the BG in temporal control.
Some investigators relate the controversy regarding temporal role of BG and cerebellum
to the complexity of the rhythmic tasks [75, 102]. Both the cerebellum and BG are involved in
temporal organization of sequential movements, however considerable reduction in BG activity
and escalation in cerebellum activity with the increased complexity of the rhythmic motor task
(defined as number of different time intervals implanted within the rhythm) occur [75]. An
opposite pattern of BG activation is suggested for temporal perception [102]. In this case
temporal duration estimation of simple rhythms relate to activation of the cerebellum, however
as the duration estimation task becomes more difficult other brain areas such as the BG,
dorsolateral prefrontal cortex (DLPFC), PM and SMA are recruited, suggesting a context
dependent activity of BG but a constant control of cerebellum in temporal perception.
Some authors suggest that some tasks are inadequate in bringing out the contribution of
the BG [78, 103]. The following roles are reported for the cerebellum (Penhune, Zattore, &
Evans, 1998): 1) Extracting temporal aspects of the perceived sensory information: 2) Extracting
temporal aspects of motor output; and 3) ―leaning novel temporally precise motor responses‖
[103] and temporal characteristics of the sequence in response to the environment (Dreher &
Grafman 2000). These authors further describe the ―non-significant‖ role of the BG as detectors
of the unpredictable temporal errors in a task including ordinal information alone (anterior STR)
or a combination of timing and task order (posterior putamen, head of the caudate). It is possible
that those who deny the role of the BG in temporal control probably did not design a task that
could tap the BG.
In a comprehensive literature review Ivry and Spencer, 2004 propose that the cerebellum
is the major structure for rhythmic perception, learning and execution and the BG are the
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threshold regulators to determine the amount of required sensory input (perception) and to
regulate the threshold for the desired response (motor execution). Therefore, if the BG lower the
threshold for a specific response, it has a better chance to be selected and executed. Considering
that a dysfunctional BG may cause a rise in the threshold [104], may explain why PD patients
recognize two distinct temporal stimuli at a higher interval and threshold [87]. Reflecting back to
the ―multiple time model‖ the function of the BG would select the first movement plan to reach
the minimum threshold set.
One should be aware that the debate over the distinct function of cerebellum and BG
continues to this date. Investigations are successful in clarifying some of the overlap, but not all.
The presented models have their limitations as they fail to explain the behavior of the BG during
ordinal and temporal tasks and across sequential movements with different complexities. It
seems that the BG are important in emergent-timing, but their control over event-based timing
and therefore temporal organization of sequential movements is negligible. In this case gaining
temporal control over rhythmic movements for PD by recruiting the intact cortical and subcortical areas does not appear to be an impossible task.
4. MOTOR COMPLICATIONS AND PARKINSON’S DISEASE
People with PD can possess several motor and non-motor symptoms classified as
Parkinsonism or non-Parkinsonism syndromes, respectively. Parkinsonism syndrome includes
tremor, bradykinesia, postural instability and rigidity, while non-Parkinsonism syndrome
involves depression, cognitive disorders, sleep disorders or autonomic dysfunction. According to
UK Parkinson’s Disease Society Brain Bank a patient is diagnosed with PD if they show signs of
bradykinesia and one other symptom within the Parkinsonism syndrome category [105].
Because other diseases, such as multisystem atrophy or vascular pseudo-parkinsonism also share
Parkinsonism signs [105, 106], there are exclusion and supportive criteria that help with the
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diagnosis of PD (For details see Appendix A). Due to the overlap and lack of a standard
measure, errors do occur and PD is not always accurately differentiated at the initial stages of the
disease [106]. Note, that PD patients do not always present with non-Parkinsonism symptoms.
Therefore, the focus of this chapter is to elaborate on Parkinsonism syndrome and other motor
complications that exist in the Parkinson’s population, to review how these complications affect
control of upper and lower extremities and to introduce a theoretical link to such control.
Motor complications usually appear on one side of the body and gradually become
symmetric through progression of PD [1]. For completeness each major basic motor
complication associated with PD is defined and in Appendix B. These include those categorized
as Parkinsonism syndrome as well as other common motor complication. Motor complications,
as they apply to the upper and lower extremities, are presented in the corresponding sections that
follow.
4.1. Motor Complications and Control of Upper Extremities
Upper extremity movements are an integral part of activities of daily living. It is of no
surprise that complications in performing such tasks can limit an individual at a functional level.
Functional abilities of upper extremity control in those with PD become worse with the severity
of the disease [107]. Simple tasks such as grasping a cup to drink may require more time and
effort for people from this population [108, 109]. The focus of this section is to review the motor
complications for people with PD identified for unilateral reaching and grasping tasks and tasks
involving bimanual coordination. These actions will provide insight to upper extremity
movements performed concurrently in those with PD.
4.1.1. Reaching and Grasping
Aiming, reaching and grasping tasks, the most common tasks used to evaluate control of
the upper extremities in PD [110-113], offer a good action for evaluating upper extremity
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control. As common tasks they are well-practiced relatively easy movements for various
populations to perform. Moreover, they represent goal-directed sequential movements, which
demand coordination of transportation and grasp phases [114] to not only provide insight to
movement coordination, but also movement precision similar to that of a single aiming
movement [115].
Patients with PD perform the reaching aspect of a reach and grasp task different than
people with no known movement disorders. They underestimate target distance [116] and move
towards an object in an irregular and jerky matter [117, 118]. Movement time (MT) of reaching
increases significantly in PD patients [110, 117] usually due to a prolonged initial segment of
movement execution [110, 119, 120], which can increase up to 30% compared to that of healthy
population [117].
Investigations on the two components of the reach and grasp reveal temporal and spatial
deficiencies in those with PD. A temporal link between the maximum grasp aperture and the
hand transport phase in healthy individuals exist [115, 121] such that maximum aperture occurs
at the time of maximum deceleration of the transport phase [115]. Consistency of the relative
distance of peak aperture to the targets across varying target distances [121, 122] and sizes [121]
while reaching toward the target, further reveal ―normal‖ spatial coordination in healthy controls.
During reach and grasp tasks patients with PD generally vary the time and distance of the grip
aperture regulation relative to the reaching action, unlike that of controls [122-125]. PD patients
produce smaller maximum apertures (hypokinesia) [123] and generate grip forces at a slower
rate [126]. They also generate the maximum grip aperture with a significant delay [117, 123],
possibly explaining why they close the aperture close to the target [115, 124].
The delays in movement control could be considered secondary to bradykinesia and
muscle force production (discussed later), as hand velocity is highly correlated to the grip
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aperture closure time, distance as well as rate of muscular force production [124, 127]. As a
strategy to overcome the constant oscillation of a pathological action tremor, individuals with PD
perform the task slower than usual, a sign of secondary bradykinesia [128]. A direct correlation
between tremor in agonist muscles and peak acceleration and velocity profiles during arm
extension [129] further support the role of tremor in slowing movements.
In tasks where accuracy is not an issue PD coordination and synergy between the
acceleration and deceleration transport phases are closer to that of the normal population. The
movement organization becomes more irregular as task performance becomes more complex
[130, 131], like tasks demanding precise contact to small targets [130], fast accurate reaching
[122] or simultaneous prehension of two limbs [131]. Deficits such as these indicate a central
shortcoming in regards to coordination [122, 132]. Because many movement difficulties
disappear during externally guided reaching tasks, some suggest this phenomenon could
represent dysfunction of the BG in triggering internally generated movement [133, 134].
However, given the example above, it seems that task or type of internally generated movement
must also be considered. It is unclear what makes the task ―too complex‖ for a Parkinson’s
patient. However, central control involving additional demands of attention, sensorimotor
integration or a combination of the two seem to be viable possibilities.
PD patients also produce grasp forces that do not match object properties, again reflecting
some degree of abnormality [126, 135]. The link to abnormal force production appears to be
associated with object unfamiliarity. Force regulation appears to be normal for PD patients when
manipulating familiar objects [136] or using self-regulated speeds [137, 138]. Abnormal force
production occurred in cases involving objects lighter and smaller than expected [126] or having
to move faster than normal [137, 138]. In the latter cases the demands of temporal and/or spatial
accuracy elevate, possibly explaining why during tasks that involve manipulation of fine objects
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the regulation becomes impaired [122]. In these cases evidence supports that force production
problems result from the patient’s inability to generate regular and sufficient forces [139] for the
novel sensory inputs, possibly resulting from inadequate sensorimotor integration [126]).
During voluntary movements the pathological tremor can impose on the task and appear
as an abnormality in force regulation [140]. There is evidence that when performing an action in
the presence of tremor, the frequency of muscle bursts become entrained to that of the tremor,
making it difficult to accumulate bursts to create the appropriate force [141]. These constant
force oscillations are usually present during all phases of the movement and can eventually lead
to reduction of the total grip force [142].
PD patients produce insufficient and irregular forces [139, 143] that can affect movement
accuracy [126], which necessitates intact proprioception and sensorimotor integration [144]. PD
patients demonstrate proprioceptive deficits, as they show deficiencies in detecting passive upper
extremity movements [145]. Intact proprioceptive-related evoked potentials in the brain reveal
normal afferent information and provide evidence that suggest impairment in cortical processing
of kinesthesia in PD [146]. Evidence for underestimation of target location in reaching to a visual
target compared to that with a kinesthetic target [147] and for difficulty in matching a visually
cued hand posture to that of a kinesthetic posture in individuals with PD, offer support for the
hypothesis that proprioceptive and sensorimotor integration deficits are to blame for irregular
force production in those with PD [148].
Although some unilateral movement deficits are viewed as secondary to bradykinesia
[127] and tremor [140], most PD deficits appear to result from the inability of BG to integrate
[126]) and coordinate [132] various aspects of the movement. Thus, production of the desired
movement [134] or force [143] and inhibition of unnecessary movement is impaired.
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4.1.2. Bimanual Coordination
Bimanual tasks present good examples for evaluating concurrent upper extremity control
used for movement coordination. The BG through connections to SMA contribute to
coordination of bimanual movements [149], thus providing a good action to study those with
damage to the BG.
In individuals with and without PD the ability to perform anti-phase or asymmetric
bimanual coordination tasks becomes unstable as a function of speed, causing the anti-phase
movements to relapse into the in-phase or symmetric movement at fast performance rates [150].
Not only do PD patients perform worse than controls at higher rates, but they tend to switch to
the in-phase state at lower frequencies [151, 152]. Also, when PD patients are asked to reach for
objects of different sizes with both upper limbs simultaneously, they tend to synchronize their
grip patterns (unlike controls) reflecting the inability to independently adjust each limb to
properties of the objects [153]. Not surprisingly, PD patients also perform the bimanual tasks at
slower speed and amplitudes [151]. Bradykinesia especially occurs during conditions where
processing of several sensory inputs is required (e.g. full vision vs. no vision), which might
reflect an adopted strategy to allocate enough time for processing and integrating all the available
sensory information in order to achieve maximum accuracy [154, 155]. However, sometimes
even allocation of more time does not guarantee precision [155], possibly reflecting bradykinesia
associated with the disease rather than that of a control strategy.
Variability in movement amplitude, movement duration and variability of the relative
phase between the limbs increases in PD patients performing bimanual tasks [155-157]. The
increase in variability for in-phase coupling of the two limbs in PD patients with great
asymmetric symptoms is less frequent than that of anti-phase bimanual tasks [155-157]. During
anti-phase movements such behavior might be secondary to additional sub-movements during
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deceleration, a phenomenon that does not occur in the healthy population and that represents
efforts to avoid switching to the more stable in-phase condition [149]. The patients’ inability to
resist the underlying force towards synchronization more often than controls provides additional
evidence that PD patients have greater difficulty independently controlling each limb during
complex skills [153, 158].
Limb dominance is another factor that can affect bimanual task performance in PD
patients. Similar to healthy individuals, patients reveal greater movement variability and errors in
the non-dominant hand during metronome-paced bimanual tasks, however, the difference
between the two limbs is significantly exaggerated in the patients [131, 152]Unlike controls, PD
patients do not synchronize the non-dominant hand to a shift in frequency ([151]. The reason is
unclear, but by increasing use of the limb that entails more proficiency the patient exaggerates
the movement differences of the limbs [131, 152].
Some scientists explain the added deficiencies in PD patients performing familiar
bimanual skills as manifestations of the compensation of other CNS structures for the
dysfunctional BG [131, 159]. Since the PD population is more accurate in making transitions to
in- or anti-phase bimanual movements and maintaining the correct relative phase performing
these tasks in the presence of external cues, the greater deficits without the cues may be
explained by the basal ganglia’s role in internal guidance of a movement [151, 154], like that
associated with SMA function [160]. Transcranial magnetic stimulation (TMS) of SMA affects
anti-phase coordination tasks in such a way that it forces the anti-phase movement into the stable
in-phase pattern [149]. Combined with the information that monkeys with SMA lesions have
difficulty with independent limb control [161], these findings support that greater movement
deficits in PD are linked to the altered BG connections to the SMA.
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In summary, not only do deficits for PD patients undermine the ability to coordinate
different segments of a movement within a limb in a reach and grasp task [132], they also
undermine these abilities across limbs in a bimanual coordination task [153, 158]. Most evidence
for the cause of such deficits is contributed to dysfunction in the BG-SMA connections, known
to contribute to coordination of bimanual movements [149]. A generalization of these findings
would suggest similar bilateral movement deficits for the lower limbs.
4.2. Motor Complications and Control of Posture
Postural instabilities are one of many motor complications present in patients with PD
[162]. These complications are of special interest as they are resistant to medication and even
some surgical procedures [162] and they increase risk of falling. A fall in an older adult, like
many with PD, normally leads to injury and further motor complications. Insight to posture and
its underlying control factors in this population may lead to therapies that help reduce this
downward spiral.
Abnormalities of postural responses in PD patients manifest in muscle reactions to
sudden perturbations and postural transitions. PD patients show impaired muscular timing and
amplitude for changing and coordinating motor actions [163-165]. Experiments reveal changes
in latencies in the stabilizing and the destabilizing muscle responses to a sudden dorsiflexion for
PD patients [166]. Reduced and impaired [167] stretch reflexes of leg muscles also exist. When
required to make a transition from backward displacement to toe up rotation, the amplitude of
muscle activation does not respond accordingly [165]. These deficits contribute to the abnormal
postural responses in PD [168] through abnormal force production.
PD patients commonly provide inadequate force to meet the sudden changes in external
(i.e. platform movement) and internal (i.e. voluntary movements, heel rises) perturbations [163,
169, 170]. The latter of which explains the abnormal anticipatory postural adjustment (APA) in
133

this population [171]. PD patients present with difficulties in modifying the magnitude of muscle
force [172] and manifest unnecessary muscle activation, affecting the regulation of force
production [162, 169, 172]. The inability to produce sufficient muscle force also explains the
reduced center of pressure (COP) and the increased center of mass (COM) displacements in
response to perturbations in PD [163]. Insufficient muscle activation in the lower limbs leads to a
small COP displacement, inadequate to control the COM, therefore increasing its displacement
[173]. Compensatory efforts to reduce the COM-COP distance (safety or stability margin) in PD
involve a limited body movement, narrow base of support (BOS) and stiff posture [163, 174].
The size of the stability margin is a good indicator of the level of stability for different
directions in PD patients [173]. Unlike the constant stability margin of healthy individuals,
stability margin changes for perturbations in different directions in people with PD [173]. The
smallest margin appears to be for the backward displacement [173], explaining why PD patients
are more susceptible to backward falls [175]. The stooped posture, which is common in PD
patients, might be a functional compensatory strategy used to diminish backward displacement
of the COM for preventing backward falls [176]. The mediolateral displacement is the second
most unstable condition for posture control, but unlike the backward displacement the condition
improves with a wider BOS [173].
In summary, PD patients present with major deficits in stability, linked to muscle activation
[172], thus force production [169]. These deficiencies also stem from insufficient postural
reflexes in response to external forces and internal muscular noise and stiffness [163]. Some link
the abnormality of postural reflexes to modulations in spinal and supra-spinal reflexes as a result
of a defective BG [165, 172, 177].
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4.3. Motor Complications and Control of Lower Extremities
Normal function of the lower extremities is essential for performing certain daily
activities. Loss of balance and difficulty with walking (gait) are two noticeable motor
complications in patients with PD involving the lower limbs. Common contributors to these
deficits for these patients are a forward posture and muscular rigidity [178]. The focus of this
section is to offer insight to the motor complications associated with postural and gait control for
PD patients.
4.3.1. Gait Control
Difficulty with walking is one of the most noticeable motor complications in patients
with Parkinson’s. Higher cadences occur as a compensation to the shorter stride length [179],
resulting in increased step numbers. The typical stooped posture, shuffling of feet, reduction of
arm swing and joint range of motion (ROM) apparent during gait [10, 180] cause PD patients to
walk with flexed knees, hips and ankles and therefore on their toes [10, 58, 181]. Additional
characteristics of PD gait include decreased movement amplitude [182, 183] and gait speed [184,
185], increased freezing of gait and asymmetric stride time (increased stride to stride variability)
[182] and difficulties in gait initiation (akinesia) [186, 187] and termination [188]. Some of these
characteristics are indicative of performance of other populations and do not limit daily function.
Decreases in stride length and gait speed commonly exist in the normal older person (e.g.,
Nagasaki et al., 1996), but do not limit these people’s abilities to grocery shop or perform other
daily tasks. Other characteristics such as freezing of gait and shuffling of feet may limit
functional performance and/or increase fall risk, thus are of most concern within this population.
Since approximately 80% of PD patients on medication show symptoms of freezing and
akinesia [189] and because the risk of experiencing recurrent falls is nine times higher in PD than
that of age-matched controls [175], gait deficits are of a major concern to this population.
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Discussing the motor deficits in various divisions of the gait cycle (gait initiation, progression
and termination) should help explain the major motor complications of PD gait.
4.3.2. Gait Initiation
Gait initiation is a motor task that involves a transition from a stationary double support
position, to a dynamic gait cycle [190]. The initiation of the step is tightly connected to
equilibrium [191], vertical height above the ground (posture) [192] and activation of the major
lower limb muscles [59, 176, 190]. ―Start hesitation,‖ one landmark of Parkinson’s gait [187],
especially occurs after long periods of immobility [186] where PD patients take several short
steps before they can generate a large enough propulsion that can lead to a normal step length
[186].
In PD velocity and amplitude of forward COM displacement reduces significantly for the
preparatory (postural) and stepping phases of gait initiation [192]. Hesitation in starting the
movement is partly attributed to prolongation of the postural phase because attaining a stable
condition for initiating gait demands more effort and time [193]. Slower stepping phases can
result from improper force production in the plantar and dorsi flexors due to a stooped posture
[194], in the antigravity muscles of the leg due to impairment in the sensory detection of body
load [195] and in other homologous muscles due to central mechanisms [193]. In a healthy
individual activation of SMA is observed prior to gait initiation, reflecting its role in planning
different components of gait [194]. Activity of SMA is terminated by signals from the BG,
which is followed by activity in M1 and preparation for planning of the next sub movement
[196, 197]. Therefore, the BG fail to trigger SMA on time, where the activation of M1, the
execution of the current movement and the preparation of the subsequent movement do not occur
[196, 197].
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To summarize, the dysfunction of the BG causes slowness of gait initiation in PD due to
insufficient force production and inabilities in detecting the amount of force produced. Patients
who are unable to accurately detect gravitation forces have difficulty adjusting their posture to
prepare for the initial step [195]. Insufficient force production leads to reduction in COP
displacement and a smaller and slower COM displacement, causing a delay and a smaller and
less effective propulsive force, thus a slower and smaller step [193]. The BG delay in activating
SMA leads to a delay in recruiting the motor units [194] needed to produce greater force.
4.3.3. Gait Progression
Gait patterns within gait progression commonly adhere to a rhythmic and cyclic pattern
in the normal functioning adult. Although this activity is much different than gait initiation,
similar deficits can occur in PD patients. The following sections will correspond to major motor
complications associated with the gait progression including freezing of gait, muscular activity
and gait variability.
4.3.3.1. Freezing of Gait
Freezing of gait (FOG) is a complicated motor symptom in PD with unclear
pathophysiology [198] that represents the lack of movement during repetitive and sequential
tasks [199]. As with start hesitation, freezing is another important subcategory of akinesia [199].
It is characterized by sudden, involuntary, transient and paroxysmal episodes where the
individual becomes incapable of maintaining gait and re-starting it, despite arduous efforts [58,
200, 201]; instead several tiny steps are produced [58, 178]. This complication especially occurs
when patients approach a narrow space like a doorway (25% of patients), need to make a turn
(45% of patients), cross over an obstacle, shift their attention or are under stress [58, 192, 198].
This phenomenon is highly debilitating, increasing the risk of falls and jeopardizing patients’
independence [202].
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The prevalence of FOG is 7% in mild cases and 45% or more in severe cases of PD
(severity determined by the stage of the disease according to Hoehn and Yahr scale, Appendix C)
[198, 203, 204]. Longer disease duration (>5 years) and longer medication treatment (i.e.
levodopa) contribute to prevalence of FOG [198, 204, 205]. Only 16% of patients under no
medication experience this phenomenon [58, 204] which, if present, will be mild and of short
duration [203]. FOG is more prevalent in PD patients who demonstrate signs of dementia,
dyskinesia, speech disorder, dystonia, postural instabilities and longer double support time
during gait [200, 205], however for unknown reasons it is experienced less in those whose
disease involves major signs of tremor [204, 205].
FOG is often accompanied by the hastening phenomenon of festination, where the
cadence increases just prior to the freezing [178, 206]. During this time shifting the weight
between legs takes place more rapidly and appears to be incomplete, as the amplitude of mediallateral transfer of the COP decreases [178] and accompanies a decrease in stride length [206],
signifying decreased force production and loss of control over cadence [206]. The loss of
temporal control is also evident when one considers that stride-to-stride duration variability is
correlated to the severity of FOG [207]. In terms of muscular activity, FOG is viewed as the coactivation and dys-synchronization of leg muscles [178, 208]. Unlike the consistent reciprocal
pattern of activation in flexor and extensor muscles of the thigh and legs in a healthy individual,
the reciprocal activation is interrupted by co-contraction of flexors and extensors in PD patients
just prior to freezing [178]. The co-contraction of muscles describes a dystonia specific to gait
[205]. Prominent EMG signals in the lower leg muscles are premature and prolonged [208],
emphasizing major irregularities in the temporal domain, which influence spatial irregularity.
According to the current literature, freezing stems from spatial and temporal
dysfunctions in PD muscle activation. The greater muscular dys-synchronization highlight the
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temporal deficits such as co-contraction possibly leading to inadequate force production and the
associated reduction in movement amplitude, as that in the shorter stride length. Limited research
in this area makes it difficult to determine causality. However, evidence from other research on
motor complications in PD would place emphasis on the BG-SMA connection deficits.
4.3.3.2. Muscular Activity
In the previous sections changes of muscular activity and their contribution to gait
initiation and pattern complications were presented. To avoid redundancy changes that were not
discussed previously are presented below.
Abnormalities in muscular synergies and loss of functional symmetry of muscle
activation complicate the gait of PD patients when performed at comfortable speeds [184, 209].
Some scientists suggest the general pattern of muscle activation is unsmooth, ―noisy‖ and
variable with a significant disruption in the ―rate of force production‖ [139], while others show
similar timing activation to healthy older adults [210] or report impairments only when excessive
adaptation to external situations is required [211], thus for complex tasks. Some researchers
believe that changes in muscle activity during gait in those with PD include [210][209][209] less
amplitude in distal muscle activity, a delay in reaching the maximum force and over-activity of
proximal muscles [139, 210].
Problems with force production during gait are always present [211] and since the
abnormalities become more significant in patients at later stages of the disease [210], a role of
the BG may be in regulation of force. This would explain how the low amplitude in dorsiflexion
and premature, prolonged and ineffective activity of plantar flexors delay the development of
forward momentum preceding the first step in start hesitation [193]. The reduction in activity of
the plantar flexors [195, 210-212] along with insufficient activity of the hip extensor muscles,
cause a very weak push off [210, 211], reducing the stride length [181, 210]. Moreover,
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significant weakness in dorsiflexors [210] further affect the swing phase resulting in shuffling of
gait [210].
Production of adequate force and accurate timing of force production are essential
contributors for accurate movement control. Deficits in the BG resulting in inadequate timing,
through inadequate and abnormal muscle stimulation, likely contribute to dysfunctional control
of gait initiation and patterns.
4.3.3.3. Gait Variability
Rhythmicity is an important feature reflected in stride-to-stride variability [184].
Arrhythmia describes increase in stride-to-stride variability [213], where rather than a continuous
sequential movement the individual performs a series of disconnected strides [184]. Temporal
and spatial variability are features that remain constant (coefficient of variation for stride length
and stride time are 3-6% and < 3% respectively) [214] as one ages, unless some type of
complication occurs [215, 216]. Therefore, alterations in variability of gait are important in
reflecting a pathological dysfunction [215].
Patients with PD show increase in variability of spatial and temporal components of gait
[182, 184, 217]. Increases in variability of force amplitude of the leg muscles [209], stride length
[182, 217, 218] and gait cycle duration [184, 217, 219] are present at very early stages of the
disease [213], preceding changes in step velocity and length [219]. Variability in stride length
and duration significantly correlate with frequency of falls and episodes of freezing in PD [207,
213, 220, 221] and support the pathological nature of these findings. However, some
investigators reject the connection of stride length variability to disease severity [181], report an
increase only in stride time variability at early stages [219] or do not regard the stride length
variability a distinct feature of PD [222], resulting in more attention towards variability of stride
duration. Stride time and length variability are independent of other factors that can vary across
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PD patients such as velocity [209], average gait cycle duration [184, 213], bradykinesia, rigidity
and tremor [213], making measures of variability good candidates for evaluating motor
complications in PD.
Several investigators have searched for a theory to explain the increased variability in
PD. Because pattern of spatial variability in mice differ according to the region of BG disrupted
by neurotoxins, some researchers blame spatial variability on a specific neural pathway
involving the BG for specifying step length and width [223]. Two causative explanations for
temporal variability in Parkinson’s exist; central malfunction and motor fluctuations. Based on
the two components of variability (central and motor) introduced by Wing & Kristofferson 1973,
temporal variability is related to the central time keeping systems, due to the strong correlation
between the variability of the central command and the IRI variability of finger tapping in PD
[224]. This finding is in line with more recent studies that also show an increase only in the
central component of variability during finger tapping [90] and others who report that temporal
gait variability occurs without detection of any changes in force amplitude [219, 225] or lacks
the correlation with amplitude of muscle force [226]. Comparison of finger tapping to gait is
reasonable as there is evidence for significant correlation between IRI variability of finger
tapping to that of stride duration [213]. Opposing views consider the motor component (muscular
noise representing random variability during the execution) an additional factor to that of the
central for explaining the increase in temporal variability in sequential movements in PD [91,
227]. This opposition is based on the significant correlation found between the motor component
of the variability and the variability of IRI of finger tapping in PD.
No matter what underlies the increase in variability in PD, the presence of increased
variability at early stages of the disease, before consumption of any medication exists. The close
relationship between measures of variability and freezing or falls reflects the significance of
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these measures in predicting motor complications and possibly in establishing an appropriate
evaluation measure for the effectiveness of a treatment.
4.3.4. Gait Termination
Termination involves transition from a dynamic state to a static one leading to a more
stable condition [228]. Gait termination demands control of a person’s COM, whether it is a
transition that is planned or a response to a sudden perturbation [229]. The lower limbs must
increase the decelerating (braking) forces in the swing limb and decrease the accelerating forces
in the stance limb [230, 231] to keep the COM within the BOS at movement end [232].
Complications with gait termination are relevant to the PD patient’s general inability to
control changes of the displacement of COP and COM [163]. To compensate for a failure to
generate sufficient braking forces in a planned gait termination, PD patients reduce gait velocity
earlier in the course of walking, reaching the final step with a slower velocity than that of the
control (84% vs 90%) [188]. Unlike healthy individuals PD patients also produce muscle
activation patterns opposite to that of controls, leading to inadequate force generation and
corresponding to use of the compensatory ―extra step strategy‖ not only during sudden stops
[188], but also when sudden changes in direction are required [233].
Clearly, defective force production associated with stopping difficulties in PD must result
from ineffective muscle contraction. The limited studies on gait termination in this population
make it difficult to offer any conclusions on muscular control. However, one can hypothesize
similarities to our previous discussions regarding muscle activation (i.e. inadequate and
abnormal muscle stimulation due to BG deficits) exist for gait termination.
4.4. Theoretical Links
Different theories and/or models have been proposed to describe the functional
connections of the BG nuclei and to predict the pathologies related to the motor dysfunction of
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these nuclei in PD. In the literature two theories stand out for their ability to explain functional
pathways within the BG nuclei (internal loops) and predict results of motor malfunctions in the
pathways among the nuclei and other neural structures used in motor control (external loops).
The dynamic theory of the BG proposes a model to describe internal loop function and the motor
set theory targets the external loop function.
The dynamic theory describes the BG as a network of non linear dynamic pathways
which work in symmetry to produce a normal behavior [15, 16, 69, 234]. The internal circuits of
the BG are considered self stabilizers of the system whose function is necessary for ―modulating
the excitability‖ of the BG (Obeso et al. 2000). The output is viewed as gains for the direct,
indirect and hyperdirect pathways and the projections of the BG output nuclei, representing
information necessary for feed-forward (projections to cortical areas not involved with input, e.g.
second column, Fig. 2) and feedback (projections to cortical areas of input, e.g. fifth column, Fig.
2) control of each limb (Suir, Albani, & Glattfelder, 1997). Therefore the internal self-stabilizing
circuits regulate the net gain of the system and provide a state in which the desired motor plans
affecting the trajectories, velocities and forces are released. Examples of such stabilizing routes
are the connections of the GPe to the STR, the SNc to the STR and the thalamus to the STN and
STR (Fig. 3), which work together to regulate properties of the functional units of the input
nuclei by affecting their net membrane potential [235] or oscillation frequency [236].
With PD some of the internal circuits become affected and the symmetry among the
external BG pathways is lost. For instance, the dopamine deficiency does not allow for the
normal interaction of all projections received by the STR, affecting the cell membrane potential.
Therefore, repetitive movements during which the minimum cell potential is held constant and
the discrete movements during which the cell potential is temporarily depolarized both become
affected [235]. In other terms harmony between the projections to the STR is lost and changes
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the oscillatory patterns of cells affecting their output [236]. Such changes in properties of the
input nuclei not only cause the overall gains of direct, indirect and hyperdirect pathways to
become abnormally small or large (spatial) (Suir, Albani, & Glattfelder, 1997), but also cause
disequilibrium among the three pathways (temporal) and therefore a shift in the net output
(Obeso et al. 2000). As a result, cortical areas and desired action become inhibited and abnormal
behaviors occur [15, 237]. This theoretical description efficiently introduces a system of internal
BG networks where normal functioning is essential for a normal and context appropriate output,
but ignores its external connections.

Figure 3. A schematic diagram of the inter-neurons and afferent projections to the striatum that regulate
its excitability. Two inter-neurons and two striatum neurons are depicted. Only two dopamine receptors
(D1 and D2) located on a striatum neuron are highlighted. Excitatory connections are represented by filled
arrows with external connections in bold and inhibitory connections are represented by empty arrows.
(Ach—acetylcholine; GABA—gamma amino butyric acid, SNc—substantia nigra pars compacta; STN—
sub-thalamic nucleus; Gpe—globus pallidus pars externa)
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The ―motor set‖ model describes the motor functions of the BG (external connections)
while disregarding specific internal circuits. The term set was introduced sometime before 1911.
The idea of a set has been used in various ways including a response to a stimulus—motor set
[238]. The idea of a motor set, was developed through experiments involving dichotic listening
[239] and reaction times (RT) [240]. Flower and Robertson, 1985 provide us with the most
comprehensive description of a motor set. Motor sets are ―the characteristics of an action plan
which determine the kind of movement or sequence of movements to be executed in order to
fulfill the goal or intention contained in the plan‖ [241]. A motor plan refers to designating one
or more predetermined movement characteristics (motor program) for an action. In more specific
terms motor sets execute the following actions: they 1) impede execution of alternative motor
plans and activate the desired one(s); 2) maintain the activated motor plan(s); and 3) respond to
changes in the environment or goals of action by changing the plan, terminating or replacing it.
Specifically, the motor set has the function of maintenance or regulation of the motor plan which
already harbors the appropriate motor program(s).
The BG via their numerous cortical and sub-cortical connections function as motor sets in
humans. Such an assumption mounts from investigations on RT and choice RT of PD patients,
which report no evidence for delayed formulation of central motor programs [242], only a
significant increase in MT and therefore impairment in implementing the motor program [64].
The ability of PD patients to learn and generate two sequences of button pressing, each tested in
isolation but not in sequence, and to learn and generate an action that required transformation of
two different sequences into a new combination, suggest that the inability is not in integration or
learning of information but rather involves the maintenance of an action plan or its modification
in response to environmental needs [243].
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Various motor symptoms in PD patients relate to a dysfunctional motor set. The patients’
inability to perform more than one movement sequence simultaneously [101, 243], their
difficulty in executing relatively long sequences [219, 226, 244], their failure to maintain the
global goal during a sequence of actions [245-247], their impairment in execution of tasks that
demand aiming to unexpected target locations [111] and their generation of movements and
postures irrelevant to the environment [172, 248] are examples that would not occur with a
normal motor set function. Akinesia, freezing and bradykinesia also relate to a motor set that
cannot release or maintain a motor plan. Therefore, the ability of PD patients to gain normal
movement magnitude [249] and initiation [250] or to decrease abnormal movement
characteristics (i.e. variability) [219, 226] in presence of external cues suggest a compensatory
strategy for accessing the motor plan [248, 249] via bypassing the dysfunctional motor set.
Two theories were presented to help explain the internal and external connections of the
BG. In order to impede alternative motor plans and activate the desired one(s), the normal
hyperdirect and direct pathways are required. The dynamic theory explained how PD can affect
the internal direct, hyperdirect and possibly indirect pathway connections to alter the BG output
and produce erratic movement results. The motor set theory suggests that the external
connections to the BG are involved in selecting, maintaining or terminating the appropriate plans
for desired movement. Whether it is possible for the internal pathways to respond to changes in
the environment by allowing for an alternative motor plan to replace the original (motor set
theory) in PD is still unclear. However, since no model currently explains all aspects of the
complex BG and a disease with unclear pathophysiology, this combination develops a
framework for the possibility of effective treatment.
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5. TREATMENT OF PARKINSON’S DISEASE
Various treatment strategies are used to manage motor complications associated with PD.
Medications and surgical interventions relieve some symptoms with fewer side effects in the
latter. Insufficient medicinal and surgical interventions in alleviating all motor symptoms in PD
emphasize the need for careful review of successful rehabilitation strategies in this population.
Physical therapy approaches, which are considered useful non-pharmacological treatments to
improve motor complications in Parkinson’s patients [183] vary so greatly, that at present, it is
impossible to suggest a universal protocol for this population. Review of the treatment
approaches will offer insight to current treatment strategies for PD and identify gaps and
limitation in evidence-based studies. Thus, the focus of this chapter is to briefly describe the
current medications and surgical treatments used for this population, but to offer more detailed
review of the therapeutic treatments to guide future study design in this area.
5.1. Medication
Pharmacological interventions are based on pathophysiology of PD. Administration of
medication aims to alleviate motor and cognitive symptoms of PD [251]. Although medication is
successful in relieving motor symptoms such as bradykinesia, tremor and rigidity in early stages,
its long term application leads to secondary complications which debilitate PD patients, causing
cognitive problems such as hallucinations [10, 252] and motor dysfunction such as dyskinesia
[58, 252, 253]. Motor complications such as akinesia, freezing, postural instabilities [252] and
changes in stride duration variability [254] are not alleviated by most medications targeting the
dopamine system, are linked to unclear causes and require a different form of treatment.
Several drugs are available for targeting the dopamine related symptoms of PD. At the initial
stages drugs that cause less side effects and motor fluctuations may be prescribed (MAO-B
inhibitors or Amantadine). With progression of the disease stronger medication (i.e. L-dopa or
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dopamine agonists) are administered as an adjunct to earlier medication or in isolation [251].
Unfortunately, each medication comes with several limitations. For example, dopamine agonists
cannot control PD symptoms for more than 3 to 5 years, obligating addition of a stronger
medication. The stronger medication of L-dopa causes major secondary symptoms such as
dyskinesia calling for changes in dose and frequency of the medication and/or regulation of the
adjunct drugs. Table 1 summarizes the common drugs administered for relieving motor
symptoms of PD. Readers are referred elsewhere [253, 255]for further information regarding
medication for PD. As just reviewed, medications are somewhat effective in alleviating PD
symptoms at initial stages of the disease. They lose their efficiency and cause secondary motor
and cognitive complications, not to mention they only affect some PD symptoms. Such
limitations call for other treatment options such as surgery and therapy.
5.2. Surgical Intervention
Surgical interventions that do not prevent the neuro-degeneration process of PD, are used
for symptomatic treatments. More importantly, this method does not lead to the debilitating side
effects present with medication [256]. Surgical interventions for PD may involve severing
certain parts of the basal ganglia as with pallidotomy, thalamotomy and subthalamotomy [257]
or less abrasive methods such as deep brain stimulation (DBS) [257-260]. The latter is preferred
because similar benefits with fewer side effects are achieved. Advantages of DBS over neural
removal are numerous and include decreased demand for re-operation, lower morbidity rates,
reversibility, larger improvements in motor and non-motor symptoms [259, 260] and decreased
dose demand for medication [261, 262]. DBS can target different nuclei within the BG and its
connections. Targeting the thalamus eliminates signs of tremor [263] without affecting other
motor symptoms [264]. Stimulation of GPi reduces signs of drug induced dyskinesia and major
PD motor symptoms such as bradykinesia, akinesia and rigidity [265], but the effectiveness
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declines after the first year of the surgery [266]. The most common procedure is stimulation of
the STN, where benefits involve general improvement in motor function (58%) and reductions in
Table 1. Summary of major drugs prescribed for alleviating motor complication in PD. The
characteristics of each drug and its cardinal advantages and disadvantages are included. Adopted
from [255]b
Drug
L-dopa

Dopamine
agonists
bromocriptines,
cabergoline, dihydroergocryptine,
lisuride, pergolide,
pribedil, pramipexole, ropinirole
MAO-B
inhibitors:
Sekegukube
(deprenyl),
rasagiline
Amantadine

Characteristics
Precursor of dopamine
Usually administered in
conjunction with
catechol-Omethyltransferase
(COMT) inhibitors
(entacapone, tolacapone)
to prolong half life of Ldopa. It is metabolized to
dopamine & 3-o-methyl
dopa.
Stimulate dopamine
receptors

Advantages
-relieves major motor
symptoms
-increases life
expectancy
-improves quality of
life
-most effective for
symptomatic
treatment of PD
-the most effective &
gold standard drug
-reduced incidence of
motor fluctuations &
complications
compared to L-dopa
-antioxidant effect
-provide neuron
protection

Disadvantages
-causes motor fluctuations
-causes dyskinesia
-does not affect nondopaminergic symptoms
(freezing, dysautonomia,
dysarthria)
-non-motor side effects;
nauseas, hallucination,
sleepiness, autonomic
problems

-nausea, vomiting,
bradycardia, postural
hypotension, dizziness
-high risks of daytime
sleepiness, hallucination,
psychosis, insomnia
-dyskinesia with L-dopa
-less motor improvement
Increases half life of
-reduces symptom
-insomnia
dopamine in the brain by severity
-with L-dopa increases
inhibiting oxidative
-delays start of Lnausea, dyskinesia,
deamination of
dopa
confusion, hallucination,
dopamine
-reduces motor
autonomic side effects
fluctuations
(orthostatic hypotension)
Exact mechanism
-delays start of L-efficacy reduces after
unknown.
dopa
months of continuous use
Enhances release of
-reduces akinesia,
-side effects include
dopamine from
tremor, rigidity
livedo reticularis, ankle
dopamine terminals.
-reduces cardinal
edema, dryness of the
Increases affinity of
symptoms some
mouth, blurred vision,
dopamine receptors
-compared to L-dopa difficulty focusing,
mild side effects with confusion, depression,
appropriate dosage
nightmares, hallucination
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tremor (82%), akinesia (57%,) rigidity (52%,) postural instability (49%) and drug
induced dyskinesia (83%) [262]. The exact mechanism of DBS is not known. There is evidence
for inhibitory and excitatory effects of stimulation on neuronal activity of the targeted nuclei
[267]. Investigators suggest that DBS works by regulating the neural oscillation of the targeted
nuclei [268]. Stimulation appears to terminate the dysfunctional activity of neurons and shifts the
temporal pattern of their discharge to a more optimal and synchronized frequency [269]. This
pattern of activity replaces the random deleterious pattern of BG network with a regular pattern
of neural bursts causing a stabilized and symmetric activity across different regions within BG
[267].
Benefits of DBS, although promising, are most effective when used in conjunction with
patients’ regular medication [253]. Unfortunately, not all PD patients can undergo such surgery.
The suitable surgery candidate is responsive to medication, less than 75 years of age with
relatively normal cognitive status and disease onset greater than 5 years [270-272]. Therefore,
research continues for discovering more effective medical and surgical techniques, including less
invasive techniques such as rehabilitation.
5.3. Rehabilitation
The goal of rehabilitation in PD is to overcome the associated motor symptoms for
improved functioning. It is assumed that the ability to generate the correct movement is not lost
in PD [243], rather that major motor complications rise from the loss of internal ability to
activate the appropriate motor plan or suppress the unwanted plans [237, 243]. Incidentally,
different rehabilitation techniques such as physical therapy (PT) should focus on activating the
correct motor plan.
The beneficial effects of rehabilitation are reported in previous investigations ([273, 274],
some almost three decades old [275]), yet the numerous techniques have no unified therapeutic
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approach. The focus of the next sections is to review the major therapeutic techniques and the
motor learning studies in the literature as they apply to rehab in PD patients to offer insight to
successful learning strategies and outcomes that lay the framework for future and/or other
interventions.
5.3.1. Physical Therapy
Some scientists report benefits of combining training techniques. Training PD patients
with Proprioceptive Neuromuscular Facilitation (PNF), water resistance exercises and
coordination exercises of upper and lower extremities [276] for twenty weeks (60 sessions),
revealed improvements in the Unified Parkinson’s Disease Rating Scale (UPDRS) scores,
walking time and the Self Assessment Parkinson’s Disease Disability Scale (SAPDDS) scores.
Franklyn & Stern also report a ―modest‖ improvement in PD patients who attended a four week
physical therapy program 2 times per week based on PNF and Bobath and Peto methods which
aim at improving balance, posture and gait complications. Similar to Pellachia et al., they believe
that the results are successful in improving patients’ quality of life and further report long term
beneficial effects even five weeks after cessation of the PT program. Others state advantages of
long term PT programs involving passive and active mobilization exercises and walking for four
months [277], six weeks (12 sessions) of training with a combination of cardiovascular activities,
stretching, strengthening, gait with auditory stimulation, balance training and relaxation
exercises [274], or 16 session of stretching, strengthening and balance training over 8 weeks
[278]. PT techniques involving repetitive exercises targeting ROM, endurance, balance, walking
and motor dexterity for four weeks are also reported to be beneficial [279].These studies state
that such techniques improve functional status of the quality of life regarding physical mobility
based on mobility portion of Sickness Impact Profile (SIP-68) [274, 277]. Improvements in the
activities of daily living section of the UPDRS [274, 279], the motor section of the UPDRS [278,
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279] and total UPDRS score [274, 278] also exist in this population. Improvements in balance
after a ten week program (30 Sessions) composed of strength and balance training where PD
patients undergo several conditions challenging the somato-sensory and/or visual systems while
predisposed to unstable positions are also reported [280, 281].
More common exercise training regimes may also result in effective rehabilitation for
PD. Twelve weeks of karate training, revealed improved coordination of fine movements, gait,
tremor and grip strength [282]. Improved aerobic capacity in terms of VO2 max scores and better
movement initiation were identified after sixteen weeks of cycling and/or walking [283]. A
combination of various training exercises such as flexibility training and resistance exercises in
water led to improvements in UPDRS scores and improved range of joint motion, strength and
flexibility after 14 weeks of training [284]. High intensity resistance exercise lasting for 12
weeks resulted in increased walking endurance and greater muscular force production and
mobility during ascending and descending stair stepping [285, 286]. Focused exercises that target
spinal flexibility improve functional reach performance in just ten weeks [287] and eight weeks
of exercises concentrating on lower extremity resistance training reveal increases in strength, gait
velocity and stride length [286]. The benefits PD patients take from these training types are
successful in targeting a specific physical limitation, thus strength, flexibility and endurance
training provide similar results to that of the normal population [286].
Another recent intriguing rehab technique involves the practice of motor imagery [288].
This technique shows promising results when used in combination with PT techniques including
sitting without support while using upper extremities, standing up, walking, stopping and
changing direction. The motor imagery task required PD patients to imagine themselves
performing the same tasks as trained. The benefits were more significant for patients who
underwent the PT techniques in combination with motor imagery than performing the physical
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therapy alone. Most improvements involved performance in sequential movements; walking,
standing up, lying down and standing up again and turning in bed, but improvements were also
found in the UPDRS motor score and cognitive tasks including clock drawing and stroop tests
[288]. The fact that PD patients can practice motor imagery at their convenience makes this
method attractive to some patients.
The therapeutic strategies applied in the literature are numerous and results in several
improved outcomes in PD patients. The improved functioning resulting from these techniques is
of great importance and cannot be denied, however, the combination of techniques does not
isolate exercise effectiveness and in some cases lacks a scientific explanation for their
effectiveness (i.e. cannot explain how they bypass the dysfunctional BG), making it unclear
whether all the exercises are beneficial. Several guidelines have been introduced to overcome
some variability in techniques applied in rehabilitation settings (Table 2). Readers are referred
elsewhere [289-291]for further information regarding rehabilitation strategies for PD.
Table 2. Guidelines for physical therapists in developing rehabilitation strategies.
1 Be knowledgeable of the disease, individual characteristics of the patient, medications and
peak effect time (on/off periods), cognitive impairments and presence of other pathologies
2 Normal movements are not lost, though it is important to find a way to activate them
3 In order to avoid complexity within a sequence break the movement into components
4 Allow for attention to take control and compensate for the loss of normal automaticity of a
movement and take advantage of the cortically controlled movement
5 Use external cues, this will allow the patients to start the movement with normal velocity and
amplitude
6 Avoid simultaneous tasks especially at initial stages of therapy
Adapted from Iansek 1999; Morris, 2000
5.3.2. Motor Learning
Learning is an imperative component for a successful rehabilitation. Motor learning
abilities appear to differ according to learning conditions and tasks, making the specific aspects
of motor learning in PD not easy to determine. The following paragraphs provide some insight to
these aspects.
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PD patients are able to learn motor skills with different levels of difficulty and benefit
from practice [292]. Patients can improve their performance in pursuit rotor tasks in one day
[292, 293] and sequential reaching movements such as pointing to a sequence of targets in two
days [292]. Authors suggest that the improved RT (pre-motor and motor components) and MT
with practice reflect the ability of this population to improve central (pre-motor time) and
peripheral (motor time) components of the movement [292].
Some researchers suggest that PD patients are not able to learn tasks that involve
simultaneous learning of different components of a skill (i.e. spatial and temporal components)
[72, 294]. They further suggest that PD patients are only able to learn [295] and retain [296]
simple to moderate sequences, as those that involve less than seven sequences of upper extremity
movements [295]. These concerns for learning abilities in PD are supported by investigators who
recognize the BG as the major structures responsible for motor learning in humans [297].
Interestingly, experimental findings suggest that PD patients can learn more complex
tasks. Bimanual drawing of triangles is a perfect example. The improvements in cycle duration
variability, speed accuracy, synchrony between the limbs and consistency of the size of the three
sides of the triangle occur in greater extent in PD subjects compared to age-matched controls
after two days of practice [298]. Patients also showed improvements in buttoning a vest, and
once re-learned after only ten trials of practice, performed the task concurrently while tapping
the foot [299]. In other experiments PD patients learned a complex Tai Kwan Do movement
involving twelve postural sequences and coordination of upper and lower extremities within
three weeks and retained this performance ability for three weeks after termination of practice
[300]. Moreover, after only one day of practice these patients improved balance skills [301] and
postural stability [302] in various aspects such as increasing the speed and the level of end point
exertion while shifting their center of gravity (COG) and further improved speed of reaction to
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perturbation and the length of the compensatory step a week (former) or months (latter) after
termination of practice.
Success in learning of more complex skills is possibly attributed to the methodology
used. PD patients who were given more time than healthy individuals, were allowed to correct
their own errors in learning a Tai Kwan Do movement [300]. Those who were provided with
constant augmented visual feedback of their COG to improve their balance in one study [301]
and given positive reinforcement after production of the appropriate postural response in the
another [302] may have contributed to their improvements. For the studies on improved balance
[300, 302] and Tai Kwan Do [300, 302] the practice schedule started with blocked practice and
ended with a random practice order. Since blocked practice provides greater opportunity for
early success and random practice results in better retention and transfer skill performance [303,
304], this schedule likely aiding with learning and retention of movement.
As indicated by positron emission tomography (PET) scan [295] and functional magnetic
resonance imaging (FMRI) [305] studies, motor improvements reflect the PD patients’ ability to
overcome their deficiency by recruiting greater areas within the cortical and sub-cortical regions.
Unlike the PET scan experiment that reported compensation for simple to moderate tasks, the
FMRI study revealed the ability of PD patients to reach automaticity for a sequence of twelve
different movements (indicated by performing the skill accurately in presence of a secondary
task) by recruiting additional areas such as the cerebellum, pre-motor, pre-frontal and parietal
cortices. It appears that with sufficient time and appropriate training strategies learning is limited
to mild or moderate skills in PD.
Clearly, PD patients can learn tasks of various difficulties under the appropriate
conditions. Providing the additional time, training and or feedback are likely the keys to success
of learning more complex tasks in this population. However, whether the PD patients can
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maintain the skills for the long term and generalize the learned motor skills to their daily routine
is less clear. Studies in these areas should offer insight to rehab in this population.
5.3.3. External Stimulation
―Kinesia paradoxical‖ refers to the ability of PD patients to produce normal movements
under certain conditions [306]. The use of external stimulation is one condition that can enable
patients to perform the correct motor task. A strategy to enable motor plan activation in PD
involves recruiting neurons from other areas of the brain and bypassing the BG [183, 288]. This
was observed in a study on regional cerebral flow measures, where authors report less activity in
SMA in PD patients during self-determined tasks but similar activity of the motor cortex of PD
patients to that of controls during an externally driven tasks [307], revealing direct access to
other areas of the motor cortex and bypass of BG-SMA pathway under external stimulation
[308]. These findings highlight the importance of external stimulation in generating normal
movements in PD.
Visual feedback is a type of external stimulation used successfully in assisting PD
patients in a single session. Providing patients with visual cues (i.e. providing dots on the paper
as cues) can aid in controlling hypokinesia (small hand writing) and therefore enlarging the
amplitude and size of their strokes [309]. In reaching tasks PD patients behave similar to controls
in providing appropriate force and velocity possibly because of the visual feedback provided by
the moving target of interest [133]. Aiming tasks with visual feedback of the movement can
improve the accuracy of speed and duration of the movement [310]. Stride length and velocity
increase with visual feedback of ―appropriate‖ step placement [249, 311, 312]. Balance control
with visual feedback of the COP can decrease postural instabilities [313].
PD patients also benefit from practice of visually enhanced gait (walking on the marked
floor) [314, 315] and balance (moving the trunk to colored targets) [315]. After four weeks of
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practice they improved functionality by increasing independence in activities of daily living
measured by performance in walking, dressing, eating and hygiene based on Northwestern
University Disability Scale [315] and increased step length and gait speed [314]. These
improvements were retained three months (former) and one month (latter) after termination of
practice.
Other types of external stimuli were also investigated. An example is an insole vibration
device that improved the gait complications of PD patients [316]. Stimulating the feet with
vibrating insoles as they contact the ground increased the stride length, speed and cadence and
decreased the stride duration variability [316]. The effect of somato-sensory cues in form of
vibration for improving stride length was noted elsewhere [317] and appears to be a novel
effective strategy. Cutaneous triggers in forms of electrical stimulation of the feet used as a go
signal were advantageous in increasing the produced force and anticipatory postural adjustments
during gait initiation [170]. During gait presence of cutaneous cues decreased COP displacement,
velocity and the abnormally prolonged double support time were evident [318]. Unfortunately,
these studies are performed in a single session and long term effects of these stimuli still require
further study.
Clearly, the use of external stimuli can improve some of the motor complications in PD.
The most valuable stimuli, effectiveness of external stimuli and strategies for their incorporation
into patients’ daily routines require further investigation. The next chapter will concentrate on a
detailed review of the use of auditory stimulation and how it applies to the PD population.
5.4. Summary
Studies on the use of medications, surgery and rehabilitation can result in improved
motor performance for those with PD. It seems that understanding the purpose and limitation of
each strategy is imperative to effectively treat PD. Moreover, with greater improvements
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identified for the use of combined strategies compared to that of a single strategy (i.e. benefits of
PT in improving certain motor symptoms were greatest when used in conjunction with patients
medication [276, 289], it is probable that the most successful treatments will involve multiple
techniques.
6. AUDITORY STIMULATION, MOTOR CONTROL AND PARKINSON’S
DISEASE
Auditory stimulation (AS) is only one type of external stimuli used to manage motor
complications associated with PD by replacing the lost internal trigger for movement
modulation. Outcomes with visual and tactile cues discussed in the previous chapter gave insight
to the successful use of these stimuli, primarily in short sessions with relatively long term effects.
Clearly, the review of literature on outcomes of using auditory cues for motor control in this
population is warranted, as are the limitations in this research. However, these findings are not as
meaningful without motivation for using this technique. Therefore, the first focus of this section
is to show why auditory stimulation may have benefits over other sensory modalities.
6.1. Why Use Auditory Stimulation?
Auditory and visual cues are the most common modalities used as external stimuli for
treatment of PD symptoms. Researchers consider many outcomes associated with their use
successful, explaining why these cues are commonly used and why the following discussion
concentrates on outcome studies using these modalities.
Based on measures of variability of the IRI of finger tapping to external stimuli and the
ability to coordinate each tap to the stimulus, normal subjects produce less stable and less
accurate synchronized and syncopated movements in response to visual stimuli compared to
auditory while pacing the finger tapping [319, 320], and continuing it upon removal of the
stimuli [319, 320]. In these experiments the subject is asked to synchronize (pace movements
with each stimulus presentation) or syncopate (pace movements between each stimulus
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presentation) the motor response to a rhythmic external stimulation, and is required to continue
the pattern after removal of the stimulus. The outcomes suggest that auditory cues are easier for
the healthy subject to follow no matter the task complexity; syncopation, which requires more
cognitive effort than synchronization, is considered to be more complex [321].
Investigators also report an ―auditory dominance in temporal processing‖ [322]
compared to visual and tactile counterparts. In a bimodal condition, where rhythmic auditory and
visual stimuli are both present, the temporal pattern of inter response duration of finger tapping is
similar to that of auditory alone [322]. Individuals have a higher tendency to match the pattern of
their finger tapping to auditory distracters during a visual synchronization task than to visual
distracters during an auditory synchronization task [320]. Use of auditory stimulation in
combination with visual cues during gait have no benefits in improving gait velocity and stride
length over using the auditory stimulation alone [323]. In addition, perceiving duration of visual
intervals are more variable than those of auditory [321, 324] and RT is longest for vision,
followed by that of touch, then by audition [325]. Together, these results support the auditory
dominance hypothesis.
CNS recordings, which provide evidence for modality dependent mechanisms,
compliment the previous findings [319, 321]. The continuous activity of visual specific brain
areas after removal of the visual stimulation [321] is unlike that for auditory stimulation, where
the auditory specific brain areas become inactive during this time [319, 321]. Interpretation by
these researchers include that auditory information directly transfers into an accurate and stable
motor output, dismissing the need for continuous activation after stimulus removal [321] and/or
that visual information is ―too demanding‖ for directly generating a motor response [319].
Evidence regarding encoding of temporal characteristics of rhythmic visual stimulation to the
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auditory cortex accounts for the prolonged brain activity of the visual modality [326] and likely
accounts for the auditory dominance previously reported.
The evidence for sub-cortical processing of auditory stimuli [327, 328] adds to the
potential benefits of its use. Results that auditory stimulation can increase the excitability of
spinal motor neurons via the reticulo-spinal pathway in response to an unexpected loud noise
[329] and that listening to a low threshold single tone can facilitate the H-reflex [330] exist. The
latter findings manifest the enhanced motor response with auditory stimulation [330] without use
of the startle reflex, suggesting support for the auditory signal rather than just an autonomic
response.
In summary, advantages of auditory stimulation are numerous. Auditory stimulation
offers superior temporal organization of movement and perception thus appears to be the most
appropriate external stimulation modality for motor control.
6.2. Outcomes of Auditory Stimulation
Playing music or generating beats with a metronome or computer enable researchers to
study the effects of auditory stimulation on movement control. Most scientists that study effects
of auditory stimulation use rhythmic beats of a metronome instead of that from music to
eliminate the emotional and motivational effect of music (e.g. Pacchetti, Mancini, Aglieri,
Fundaro, Martignoni, & Nappi, 2000). Moreover, dance students synchronize their steps better
with the rhythm of a metronome compared to music [331], suggesting another advantage for
metronome use for movement control.
Several studies use finger tapping to an external rhythm as a common task for
investigating sequential movement disorders in PD. However, the aims of these studies involve
the role of the BG in control of sequential movements rather than its effects on movement
control [90-93]. Therefore, the focus of this section is to review investigations on the study of
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short term effects and practice effects of auditory stimulation for enhancing the motor
performance in PD and not the roles of the BG.
6.2.1. Short Term Effects
Investigations on the short term benefits of auditory stimulation evaluate the movement
during externally driven tasks or during and immediately after removal of the auditory stimuli.
Although beneficial effects of AS on different gait parameters are commonly proposed, scientists
do not always agree on the training method(s) and the nature of the benefits. Such discrepancies
partially rise from the inconsistent methodology across studies. Table 3 offers a brief synopsis of
short term training effects of AS on movement control (single session studies), highlighting the
methodological differences, while the following text summarizes the major findings and lists the
corresponding conclusions.
A fixed AS frequency set to that of a preferred cadence appears to be beneficial for
improving control of cadence during the externally driven gait [332, 333]. A 100 beats per
minute (bmp) metronome frequency caused changes in PD muscular activity patterns when
walking 8.5 meters, revealing increased EMG slope, decreased time to reach maximum force as
well as reduced variability of selected EMG time patterns in the lower leg muscles to levels
similar to age-matched controls [334] . Patients were also able to walk 40 meters in a shorter
duration, with fewer steps and less freezing episodes to a metronome set at 96 bpm compared to
a self-selected walk [335]. These findings suggest that the temporal control offered by fixed AS
frequencies faster than preferred walking speed alter temporal organization of muscle activity
and the ensuing force production and minimize certain undesirable symptoms of PD.
Relative frequencies of AS also reveal mixed findings for short term alterations in people
with PD. Decreased double support time [333] and increased step length (Freedland et al., 2002;
McIntosh, Brown, Rice, & Thaut, 1997), gait velocity [336] and cadence [332]; [336] are
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reported in this population for metronome frequencies set above baselines set at either
comfortable or maximum cadence. In contrast there are reports of no change in step length [332,
337, 338, 340] and double support time [332] and speed [338] for rhythmic auditory frequencies
15% higher than the preferred cadence or less. The double support time was reported to improve
when compared to comfortable self-paced gait [333] but showed no changes when compared to
gait synchronized with metronome set at preferred gait cadence[332]. Gait speed showed no
changes in one experiment where subjects practiced to five different frequencies set above that of
the preferred cadence[338]. Recanzone, 2003 suggests that spatial changes are not expected with
auditory stimulation, as this type of modality is more beneficial in terms of temporal
organization of movement. However, opposing outcomes regarding the double support time, step
length and speed may result from methodological differences.
Interestingly, significant effects when walking to AS frequencies above preferred and
maximum cadence did transfer to free walking conditions. Cadence, step length [336]; Freedland
et al. 2002), step velocity [336] and cycle time (Freedland et al. 2002) are reported for walking
without stimuli after the application of frequencies at preferred cadence and 10% above. At a
more functional level benefits of auditory stimulation also appear to be promising [339]. For
example, training PD patients to walk to an auditory rhythm set at the preferred speed while
carrying a tray of cups from the kitchen helps increase gait velocity without influencing cadence
[339].
A frequency set at -7.5% of preferred cadence bears no effect on gait velocity, stride
length, cadence and double support time [332, 340], while that of a -10% does not affect MT or
gait velocity [110]. Yet a metronome set at -10% of the preferred cadence increases the stride
length and double support time, while decreasing the gait velocity [332]. A frequency of -15%
only decreases gait velocity and cadence without affecting the stride length [340], but imposing a
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rhythm as low as -20% appears not to affect gait velocity, stride length and cadence beyond that
of the -15% [332]. In addition, the -20% frequency increases the step to step variability of the
step length and duration and is considered detrimental [222].
A single auditory signal is shown to alter muscular activity affecting the initiation of a
task in PD subjects. A single cue can enhance the initiation of the movement by facilitating the
suppression of the plantar flexor muscles before the PD individual takes the first step to walk
[341]. MT and variability decrease and peak velocity increase during a task where patients reach
for a pen and begin to write, if the task is triggered by an initial auditory signal compared to a
self-selected start [250]. A single audiovisual signal can increase the peak hip flexion and knee
extension torque as the individual with PD starts to rise from a chair, reducing the time to
complete the sit to stand task when compared to a self-regulatory condition [342]. Although not
performed in isolation, auditory stimulation alone is likely to have a significant effect in the
findings of this experiment similar to previous findings [341]. Whether the single auditory
stimulus is superior to a visual cue is still unclear, as an increased COP velocity for the single AS
condition was associated with a smaller step length than the condition in response to a single
visual stimulus [318].
There is also evidence that short term practice with AS contributes to the neural plasticity
[343].TMS of M1 evoked thumb flexion changes in movement amplitude and direction after
practice of thumb extension movements under rhythmic AS with a 1 Hz metronome beat for 15
minutes. Post practice, TMS that evoked thumb flexion initially, resulted in more regular
(symmetrical) extension movements. These findings were significantly stronger when subjects
practiced thumb extension with auditory cue compared to self-paced practice.
Some of the abovementioned improvements such as increase in efficiency of reaching
for a pen, peak reaching velocity [250] and suppression of plantar flexors of the step initiation
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[341] occur only for PD patients. These observations not only reveal the ability of PD patients to
improve but also suggest that unlike the healthy individuals, PD patients possess some
movement deficits which open the space for improvements [250].
Review of the short term effects of auditory stimulation are appealing for some aspects of
movement control. The use of different methodologies, resulting in varying results, offers some
insight to successful protocols. For example, it is probable that the changes that occur during gait
practice with AS generalize to normal walking, at least for the short term. However, when the
use of similar methodology result in varying results, one must wonder if other factors such as
motivation or fatigue during the session are to blame. Results from longer term practice may
offer greater insight to the role of AS on movement control.
6.2.2. Practice Effects
The effects of short term training are only successful as a rehabilitation technique if they
bear long term benefits. Therefore, the initial focus of this section was to not only determine any
additional benefits observed with long term use of auditory stimulation, but also to determine
whether the benefits of its use will remain for the long term after termination of practice and
upon removal of the external stimulation. However, since no studies involving movement
benefits for the long term after the use of AS were identified, the focus of this section is limited
to long term use. A brief synopsis of relatively long term training effects of AS on movement
control are presented (Table 4), while the following text summarizes the major findings and lists
the corresponding conclusions.
Initial studies for relatively long term use of AS in PD patients reveal benefits at the
muscular and functional levels. Three weeks of walking to AS of beats imbedded in music at a
preferred cadence for 25 minutes per day resulted a significant reduction in variability of the
pattern of the activity of lower leg muscles, increase in the symmetry of bilateral leg muscles and
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increase in gait velocity and stride length [209]. Over a similar training time for 30 minutes per
day using a similar rhythmic auditory stimulation but with frequency ranging from preferred
cadence to 10% and 20% faster resulted in increased gait velocity, stride length, symmetry of
bilateral leg muscles and a more rapid termination muscle pattern; like that of controls [344].
Training in the latter study was altered such that performances were on flat and inclined surfaces
with possible ―stop and go‖ cues or while stair stepping. Together, these findings suggest that the
effects of auditory stimulation are important in regulating the motor unit recruitment patterns
[209] that result in certain functional alterations.
Movement alterations in PD subjects were also found for practice sessions lasting 60 min
for five days a week for four weeks. Training required PD patients to walk to the rhythmic AS of
a metronome with frequencies ranging from 30 to 150 bpm while performing manual tasks that
became more complex along the course of a four week practice [345]. Gait velocity, step length
and cadence increased for preferred walking pace with and without upper limb movement and at
maximum speed for 7.62 meters. The variability of the step duration decreased to baseline
control level for preferred pace walking with no upper limb movement. Since the variability
measures for PD patients were originally similar to that of controls for the maximum speed, no
change was expected in this case. However, because walking with upper limb movements offers
a higher level of complexity and greater deficits in patients, they had more room for
improvement, thus could benefit from a longer practice.
There is no evidence that one week of AS training at the preferred walking speed can
reduce the number or duration of freezing episodes in PD subjects [346]. In fact, authors found
an increase in their gait duration on a 60 foot track with 2 U-turns and one doorway. Whether
alterations in their methodology would result in reduction in the freezing episode number or
duration remains to be tested.
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Experiments regarding the effect of auditory stimulation on cortical and sub-cortical
regions after practice are few in number, especially when considering PD patients. One recent
study has addressed this issue. After four weeks of performing manual tasks and walking to
auditory cues ranging from 30 to 150 bpm, PD patients reduced the amount of variability of IRI
for gait and finger tapping [347]. Although there were no significant changes in other parameters
such as movement velocity, stride length and gait or tapping cadence, a significant increase in
activation of parietal and temporal lobes as well as right cerebellum hemisphere and dentate
nucleus after therapy were identified during finger tapping. According to investigators AS
therapy resulted in activation of a pathway used for temporal control of movement [347].
Whether these findings are long lasting and can circumvent the damaged BG over the long term
remain to be tested, however the initial results are promising.
6.3. Limitations of Previous Research
The aforementioned studies showed various effects of short and long term practice with
AS on different aspects of movement in those with Parkinson’s. Although several alterations
were considered beneficial for improving the function in this population, acknowledging the
limitations of previous studies will not only highlight the areas that need more research but also
guide future investigation improvements.
The first apparent limitation is on the number of studies involving AS effects on
movement outcomes in PD. For example, brain imaging studies are numerous when it comes to
evaluating brain areas activated during auditory stimulation application [319, 321] or during
assessment of general learning abilities [305, 348] in the normal and PD population . However,
only a few of the published studies were identified using PD subjects. Moreover, the number of
studies identifying long term outcomes for this population is limited. Since the longest reported
alterations were recorded only one day after termination of practice [336, 344, 345, 347] it is
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very difficult to determine and/or predict the benefits of auditory stimulation as a rehabilitation
regiment. Rehabilitation methods should focus on the individuals’ ability to apply what they
learn beyond the doors of clinics or research labs.
Understanding the optimal training or practice methodology is not clear because of the
presence of different or combined methodologies used and conflicting results. Varied [332, 338,
339, 344, 345, 347] and constant [335] frequencies of AS have resulted in movement alterations
in PD, leaving one to wonder which is better. The most difficult training methodology to follow
are those studies lacking the clear description of the training condition [344 345, 346], especially
when it changes across time and conditions. Although few studies have incorporated different
levels of complexities within their auditory stimulation intervention [209, 345] and such changes
may be beneficial for the subjects, none used an objective measure to present the new level of
complexity. The researchers that set a baseline cadence for practice comparisons have used a
maximal [323, 336] or preferred [337, 339, 344, 346] cadence, thus producing varied outcomes
due to comparison difference. Auditory stimulation has not been used exclusively in all
experiments; it has been used in combination with visual cues for gait [323] or gait initiation
[342]. Using multiple stimuli and embedding metronome-like beats in music [336, 349] could
offer different results than pure metronome training.
Further limitations are noted with precise inspection of the methodologies. Without a
control group [333] it is difficult to determine if PD patients improve to the level of their peers
without neurological deficits. It becomes very difficult to make conclusions in some cases
because authors do not report the effects of AS on some of the recorded depended variables
[333] or lack information regarding the patient population such as duration of the disease [340]
or whether patients were tested on or off their medication [333].
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Auditory stimulation superiority previously reported for temporal organization of
movement and perception is not necessarily true for spatial measures. It has been suggested that
vision is of more importance for spatial organization [350]. The fact that AS use does alter
spatial measures such as step/stride length [337, 344] is an added benefit, however the extent of
such improvement may be incomplete.
The limitations listed above are not inclusive, nor do they deny the movement alterations
that have occurred with AS practice in Parkinson’s patients. Rather, they are a reminder that
there is still much to learn about the use of AS for movement improvements in this population.
Greater insights to the particular use of AS in PD subjects are offered below in the ―Future
Directions‖ section.
7. SUMMARY
As a disease of unknown etiology, the pathology of Parkinson’s disease is difficult to
understand. The major motor symptoms of tremor, bradykinesia, postural instability and rigidity,
used for diagnosis, result from a defective BG with well-mapped connections, however the exact
motor role(s) and functional organization of the BG remain a mystery. Although controversies
exist in regards to the exact role of the BG and cerebellum in temporal movement control, it is
obvious that PD patients are less capable of releasing and inhibiting the appropriate movement at
the appropriate time for proper control.
Motor complications resulting from damage to the BG in PD lead to control deficits in
this population. Complications of posture and gait that ensue from these deficits are of great
importance as they affect independent functioning of the individual, making the person prone to
falls and the associated consequences. Although new surgical interventions are promising and
lack debilitating side effects present with medication, the outcomes are limited and not all
patients qualify for its use.
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Because PD patients show preserved motor learning abilities, rehabilitation can play an
important role in keeping the individuals active and in overcoming some of their motor
complications. Of the various rehabilitation techniques external stimuli are of great interest as
they may replace the malfunctioned BG, the lost internal trigger for movement modulation. As
the dominating stimulus for temporal processing, auditory stimulation can significantly assist
individuals with PD to regain temporal control over their actions with the hope of improving
their motor performance.
There is ample evidence that treatment for motor complications associated with PD is
multidimensional. For example, Parkinson’s patients on medication commonly receive greater
benefits from rehabilitation and surgical techniques than when not medicated. Understanding the
literature in regards to successful treatment outcomes is imperative to offering insight to more
effective rehabilitation techniques. Summary of the major gaps in the rehabilitation literature and
major limitations of previous studies is presented next to offer insight to future directions of
treatment for this population.
8. FUTURE DIRECTIONS
8.1. Need for Future Investigations
Reaching, grasping and walking, motor abilities simply and sub-consciously performed
by people with no neurological problems, become strenuous activities for patients with PD. No
current treatments exist to help these people overcome all their motor deficits. In fact, some
treatments cause detrimental secondary side effects.
A century has passed since PD was discovered based on its significant motor symptoms,
however no consensus on effective rehabilitation techniques for PD symptoms exists. It is
possible that early scientists failed to recognize the plastic nature of the central nervous system
and the roles rehabilitation can play, as training use for therapeutic regimes using specialists is
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relatively new (PT inception, world war I [351]) and the use of evidence-based research in this
field is lacking [352, 353]. Clearly, there is need for additional research on rehabilitation of
motor symptoms in people with PD.
8.2. Rehabilitation in Future Investigations
Auditory stimulation has been used to successfully alter temporal control in PD patients.
(See the Why use auditory stimulation? section in chapter six for the rationale of using auditory
stimulation for rehabilitation for people with PD). Even though researchers report the positive
effects of auditory stimulation on movement control, there is still much to be learned about its
short and long term effects and how it should be used in rehabilitation efforts. It is clear that with
the different stimulus frequencies, durations and methods used previously (see Tables 3 and 4),
there is a need for more research on the application of rhythmic auditory stimulation for
movement control.
As a preliminary to studying the effect of auditory stimulation on movement of
individuals with PD, some initial questions posed to fill gaps regarding stimulus frequency were
included in a pilot study. Does training with different frequencies of auditory stimulation affect
the temporal outcomes of gait? Does the order of application of different frequencies of auditory
stimulation affect the temporal outcomes of gait? Does training in one specific sequence help
individuals apply the results to a different sequence? Although order of frequency application did
not affect the temporal outcomes of gait in normal young subjects, training in different sequences
did. Although similar training outcomes are probable for people with PD, the training effects for
using multiple frequencies remain to be tested.
Three major limitations of most, if not all previous experiments on AS, used in PD
include: the effects of treatment over a longer time period, its long term effects and the
determination of whether it generalizes to daily activity. Although one time training sessions are
170

easy to arrange and provide insight to AS effectiveness, they provide little time for changes in
neural plasticity. Furthermore, in previous AS studies re-evaluation of PD patients’ control long
term after practice do not exist, while testing control with stimulus removal in a different context
is limited. Thus, how long the benefits last and how well they serve this population in the context
of everyday life is unclear. To improve the use of auditory stimulation in a rehab setting, several
questions still need to be answered. Accordingly, the following aims and hypotheses are
proposed.
8.3. Developed Aims and Hypotheses
Aim1: To investigate the effect of using multiple frequencies and tones of auditory
stimuli within a single trial for PD patients. As mentioned previously, the BG are important in
selecting, releasing and switching a motor plan which allows for sub-cortical or more automated
performance of a sequence of actions. To bypass the BG one should take advantage of
performing the tasks at a cortical level. Using one frequency within each session or trial allows
one to predict the following beat, habituates the patient and does not challenge the CNS in
withholding the competing plans required for daily living. Assigning different tones to different
actions will demand constant monitoring of the presented beats to modulate the movement, likely
encouraging facilitation of compensatory pathways. It is hypothesized that using different tones
or frequencies within a trial will result in improved movement control for PD patients.
Aim 2: To investigate how PD patients benefit from longer practice duration that is
organized with feedback. There is evidence that PD patients struggle to execute certain
movements, especially activities that are more complex in nature and require several sequential
movements. However, significant learning and retention of complex sequential movements has
occurred in this population often when practice time was extended and feedback was provided.
Taking advantage of longer practice schedules and other successful motor learning principals
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such as providing feedback and beginning with a simple blocked practice design and moving
towards more random design with improvement should foster a good learning environment. It is
hypothesized that using different tones or frequencies within trials in an unpredictable random
manner after some blocked practice will initially be more difficult for PD patients to perform, but
ultimately result in improved movement control abilities.
Aim3. To investigate the ability of PD patients to generalize what they practice to similar
conditions but in different contexts. Many studies test patients after training in a very similar
environment of practice. Thus, improvements with training are evident in this environment.
However, whether these results transfer to different tasks or environments remains unanswered.
It is hypothesized that using different tones or frequencies within trials in an unpredictable
random manner will result in improved movement control abilities in similar tasks of different
contexts.
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A-APPENDIX A. UK Parkinson’s Disease Society Brain Bank diagnosis criteria
Step1. Diagnosis of Parkinsonian syndrome
Bradykinesia with at least one of the following:
Muscular rigidity
4-6 Hz resting tremor
Postural instability not caused by primary visual, vestibular, cerebellar, or
Proprioceptive dysfunction
Step2. Exclusion criteria for Parkinson’s disease
History of repeated strokes with stepwise progression of Parkinsonian features
History of repeated head injury
History of definite encephalitis
Oculogyric crises
Neuroleptic treatment at onset of symptoms
More than one affected relative
Sustained remission
Strictly unilateral features after 3 years
Supranuclear gaze palsy
Cerebellar signs
Early severe autonomic involvement
Early Severe dementia with disturbances of memory, language and praxis
Babinski sign
Presence of cerebral tumor or communicating hydrocephalus on computed tomography
Negative response to large doses of levodopa if (if malabsorption excluded)
1-methyl-4phenyl-1,2,3,6-tetrahydropyridine exposure
Step3. Supportive prospective positive criteria for Parkinson’s disease
(Three or more required for diagnosis of definite Parkinson’s disease)
Unilateral onset
Rest tremor present
Progressive disorder
Persistent asymmetry affecting the side of onset
Excellent response (70-100%) to levodopa
Severe levodopa-induced chorea
Levodopa response for 5 years or more
Clinical course of 10 years or more
Source: Meara, J., Bhowmick, B. K., & Hobson, P. (1999). Accuracy of diagnosis in
patients with presumed Parkinson's disease. Age Ageing, 28(2), 99-102.
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A-APPENDIX B. Modified Hoehn and Yahr Scale for identifying stage of Parkinson’s
disease
Stage 0—No signs of disease.
Stage 1—Unilateral disease.
Stage 1.5—Unilateral plus axial involvement.
Stage 2—Bilateral disease, without impairment of balance.
Stage 2.5—Mild bilateral disease with recovery on pull test.
Stage 3—Mild to moderate bilateral disease; some postural instability; physically independent.
Stage 4—Severe disability; still able to walk or stand unassisted.
Stage 5—Wheelchair-bound or bedridden unless aided.
Source: Gancher, S. T. (2006). Parkinson's Disease. In R. M. Herndon (Ed.), Handbook of
Neurological Rating Scales (2 ed., pp. 153). New York: Demos Medical Publishing.
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A-APPENDIX C. Descriptions of Major PD Motor Complications
Rigidity: a state of muscular stiffness; the abnormal increase in muscular resistance opposing the
passive movement of the limb. Lead-pipe rigidity is consistent through the whole movement and
cog-wheel rigidity is intermittent. It increases with stress and effort in performing an action and
may contribute to reduction of deep tendon reflexes and lead to postural deformities [58, 59].
Dystonia: abnormal co-contraction of antagonist muscles of upper/lower extremities. Dystonia
involves abnormal muscle tone and appears secondary to medication. If not controlled, dystonia
can lead to limb deformities and abnormal posture. Dystonia can characterize juvenile PD or
advanced PD and the change in muscular tone can hardly be distinguished from that of rigidity
[354, 355].
Hypokinesia*: reduction of movement size. It is usually the major and initial symptom of PD as
its incident is even more common than rigidity and tremor. [356].
Bradykinesia*: Slowness of the voluntary movement [356].
Akinesia*: difficulty in initiation of the movement. [357].
*Unfortunately, hypokinesia, bradykinesia and akinesia are motor symptoms that are sometimes
used interchangeably; however each term represents a different complication [356]. Akinesia,
hypokinesia and bradykinesia interfere with activities of daily living such as buttoning a shirt,
turning over in bed or starting a simple movement. These symptoms worsen with fatigue and
severity of the disease but can be prevailed with cognitive effort, external stimulation or
emergency at least for short periods of time, a phenomenon referred to as ‘kinesia paradoxical’
[357].
Dyskinesia: Involuntary choreic movements which usually occurs secondary to medication (i.e.
levodopa) (prevalence of 40-90%), and it can appear in upper and lower extremities as well as
trunk and head [58, 358].
Tremor: Rhythmic oscillation of at least one functional body region [359]. This symptom is
more prominent in upper extremities [1]. It usually starts intermittently in one finger. Tremor
spreads to other fingers, the wrist and elbows with disease progression and possibly the head,
face feet and other regions of the lower extremities in late stage [189]. Resting tremor is tremor
at rest. Action tremor could be observed as postural, kinetic and isometric tremors. PD tremors
can be categorized into 3 types: Type I (classical parkinsonian tremor)--action (kinetic and
postural) and resting tremors with similar frequencies; Type II--similar to type I except that the
frequency of action tremor is higher than that of the resting tremor; Type III--postural action
tremor observed in isolation, i.e. not accompanied by resting tremor (see (Deuschl, Volkmann, &
Raethjen, 2007).
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A-APPENDIX D
Table 3: This table summerizes the major findings of the short term effects of auditory
stimulation on movement characteristics in Parkinson’s disease.
Rehab
Subjects, No Improvements
Major changes
Source
Age, PD
duration
Walking inside
23 PD, H&Y: March: Gait
Tactile: Gait duration,  Enzensberg
and outside on a 3-4, Patients duration, Number Number of freezing
er
4m x10m
experienced of freezing
et al. 1997
episodes (Inside: Step
walkway with 3
freezing
episodes, (Type II: number; Outside: Step
Uturns to march
Step number)
number)
music (type I &
March: Step number
II), a metronome
(type I)
or tactile
Metronome:  Gait
stimulation
duration, Step number, 
Number of freezing
episodes
Walking 30m a
21 PDon, 71 PDon: Symmetry PDon, PDoff: Cadence, McIntosh
click tone
yrs, 7.5 yrs, (time ratio between Velocity, Stride length et al. 1997
embedded in
H&Y: 2-4
two successive
Control: Cadence,
music at
steps)
10 PDoff24
Velocity
maximum cadence (24h), 73 yrs, PDoff24,48:
10% above
Symmetry
7.5 yrs,
Cont: Stride
H&Y: 2-3
length,
1 PDoff48
(48h), 73 yrs, Symmetry
8.5 yrs,
H&Y: 3
10 Cont, 71
yrs
Aiming Task:
8 PDoff, 62 Retention PD &
Immediate effect PD & Platz et al.
moving a stylus to yrs, 7.6 yrs, Cont: MT,
Cont: Max acceleration, 1998
a target at the
H&Y : 2
Deceleration
MT, Deceleration
distance of
8 Cont, 60.8 duration, Corrective duration, Corrective
200mm as
yrs
phase duration
phase duration
accurate and fast
Retention PD & Cont:
as possible with
Maximum acceleration
rhythmic beats set
at 10% below the
fastest reaching
speed [2]
Walking 6m with 7 PDon, 44- PD: Step length,
Zijlstra et
PD: Step frequency
6 metronome
74 yrs,
Speed
al. 1998
frequencies
H&Y: 1-3
(comfortable
5 Cont, 55cadence to 125
60 yrs
198

bpm)
Walking 10m with
metronome set at
20% below
preferred cadence

Reaching for a pen
(R), bringinging
the pen to the
paper (B), and
writing down a
phrase with a
single auditory
stimulation
present

Walking 1.5m
with a metronome
set at preferred
cadence and 10%
above
Sit to stand from a
chair with arm
folded in front of
the body as fast as
possible after:
Simultaneous
presentation of a
flash light and a
verbal cue (1
trial).

Walking 20m with
a metronome set at
comfortable
cadence (baseline)
and 15% above on
right and left sides

11 PDon,
Cont: Variability
60.8 yrs, 20 of step duration
months
11 PDoff,
63.1 yrs, 16
months
22 Cont, 61.8
yrs

PD (ON & OFF):
Variability of step
length, Variability of
step duration, Step
length
Cont: Variability of step
length,
 Step length
16 PDon,
PD: Number of
PD: Efficiency (R)
64.6 yrs, 6.6 movement units [3]  Peak velocity, Number
yrs, H&Y:
(R), Efficiency [4] of movement units (B),
2.65
(B), Inter-trial
MT,
16 Cont, 65.6 variability (B)
Inter-trial varaiblity
yrs
Cont: MT, Peak
(Ronly)
velocity, Number Cont: Efficiency (R)
of movement units,
Inter-trial
variability,
Efficiency (B)
16 PD, 74 yrs PD: Size of base of PD: Step length,
support
Cadence,
FAP score (from
GaitRite) [5],
Double support duration,
 Gait cycle duration
15 PDon,
PD: Peak hip
PD: Peak hip flexion,
65.5 yrs, 5.5 extension torque,
knee extention torque,
yrs, H&Y:
Time to peak hip
Peak COM velocity,
2.6
flextion torque
Time to peak hip
Patients
Cont: Peak hip
extension, knee extension
experienced flexion, hip
& ankle torque, MT
freezing
extension & ankle Cont: Peak knee &
15 Cont, 69.5 torque; Time to
ankle torque
yrs
peak hip flexion,
hip extension, knee
extension, ankle
torque, Peak COM
velocity, MT
7 PDon
Baseline, Right
Baseline, Right side (ON
(PDoff), 75.2 side (OFF) [6]:
& OFF): Velocity,
yrs, H&Y:1- Stride length
Cadence; Left side
3,
+15%, Right side (OFF): Stride length,
Patients
(ON & OFF):
Velocity,
experienced Stride length
Cadence; Left side (ON):
freezing
Velocity, Stride length
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Ebersbach
et al. 1999

Ma et al.
2001

Freedland
et al. 2002

Mak et al.
2002

McCoy et
al. 2002

+15% , Right side(ON):
Velocity,
 Cadence, Left side (ON
& OFF): Velocity,
Stride length, Cadence
Walking 9m with 11 PDon, 54 Higher
Higher frequencies:
Howe et al.
a metronome set at yrs, H&Y: 1- frequencies: Stride Cadence, Speed
2003
small (7.5%) and 2
length
Lower frequencies:
large (15%)
Lower
large: Cadence, Gait
frequencies above
frequencies: small: speed
(high) and below
Gait speed,
(low) preferred
Cadence, small &
cadence.
large: Stride
length
PD: TA & GM: Time to
peak amplitude, Time
between activation,
Activation duration,
Variability of Time
between activation, Time
to peak amplitude,
Activation duration
Walked 5m as fast 7 PDon, 69 PD RE, RA & SA: PD RE, RA: Lateral &
as possible after a yrs, 6.7 yrs
RT, Single support Posterior COP [7]
single metronome H&Y: 2-3
time, Sacral
displacement, COP
signal (SA), the
Experienced velocity
velocity, Double support
metronome at 96 freezing &
time, Sacral
bmp (RA), feeling akinesia
displacement, Step
electrical stimulus 7 Cont, agelength
at 96 bpm (RE)
matched
Walking 7.62 m
24 PDoff,
Visual cue: Speed Visual cue:  Stride
with Visual cues, 68.9 yrs, 6.9 Metonome cue:
length, Cadence
metronome 25% yrs, H&Y:
Stride length
Metonome cue: Speed,
above maximum 2.75
Both: Cadence,
Cadence
cadence, both
Experienced Stride length
Both: Speed
instabilities
& freezing
Stand up, walk to 18 PDon,
PD [1]: Step
PD: Velocity
the kitchen, grab a 64.6 yrs, 10 length, Cadence
Cont: Cadence
tray with two cups yrs, H&Y:
Cont: Velocity,
& walk, set tray
1.5-4,
Step length
down & sit down Experienced
with auditory tone freezing
and flash light at 10 Cont, age
preferred cadence matched
Walking 8.5 m,
turned 180
degrees, returned
to the starting
position with
metoronome set at
100 bmp

6 PDon, 58 Cont: no change
yrs, H&Y: 34
5 Cont, agematched
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Fernandez
del Olmo &
Cudeiro,
2003

Dibble et
al. 2004

Suteerawat
tananaon et
al. 2004

Rochester
et al. , 2005

Thumb extension 7 PDon1,
with metronome, 1 68.1 yrs,
Hz [8]
H&Y: 2-3
Experienced
freezing
5 PDon2, 61
yrs, H&Y: 23
Did not
experience
freezing
9 Cont, 64.3
yrs

PDon1 & PDon2:
Amplitude of TMS
induced movement,
regularity of thumb
movement trace, TMS
induced movement
changed toward extension
(5 PDon1, 4 PDon2)
Cont : Amplitude of
TMS induced movement,
Direction of TMS induced
movement changed
toward extension [9] (5
people)
Moved two steps 9 PDon, 66.1 PD (trailing leg): PD (trailing leg): TA
forward hearing a yrs, H&Y: 2- SOL amplitude
amplitude
single auditory
4
Cont (trailing leg): Mean H-reflex amplitude
warning cue then 7 Cont, 64.6 SOL amplitude,
of SOL
seeing a single
yrs
Mean H-reflex
Cont (trailing leg): TA
flash light (go cue)
amplitude of SOL amplitude
Walking 80 m
with metronome at
preferred cadence
and 10% or 20%
above and below

10 PDon,
60.6 yrs, 6.2
yrs, H&Y:
2.7,
Experienced
freezing
10 PDon,
68.4yrs, 11.8
yrs H&Y 2.8
Did not
experience
freezing
10 Cont, 63.6
yrs

Chuma et
al. 2006

Hiraoka et
al. 2006

PD & Cont
PD & Cont preferred
Willems et
preferred speed: speed: Step frequency
al. 2006
Gait speed, Stride PD & Cont higher
length, Double
frequencies: Step
support time
frequency, Gait speed
Synchronization
(non-freezers), Step
error [10]
frequency,
PD & Cont higher Stride length (freezers)
frequencies:
PD lower frequencies:
Double support
Stride length (nontime,
freezers), Double
Synchronization
support time,
error
Synchronization error,
Cont lower
frequencies: Stride Gait speed, Step
frequency
length, Double
Cont lower frequencies:
support time,
Speed
Synchronization
 Step frequency
error
Gastrocnemius (GM); Hoehn and Yahr scale (H&Y); healthy control subjects (Cont);
Parkinson’s Disease (PD); on medication (PDon); off medication (PDoff); Soleus muscle (SOL);
Tibialis Anterior (TA); Transcranial Magnetic Stimulation (TMS); Range Of Motion (ROM);
Center Of Pressure (COP); Center Of Mass (COM); Movement Time (MT); Reaction time (RT)
1- Data were recorded after both trials were completed
2- After every five practice trial the frequency was adjusted to 90% of mean movement time of
those five training trials.
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3- Movement unit includes 1 acceleration and 1 deceleration phase
4- Efficiency reflects peak velociy/average velocity
5- FAP score: funcational ambulation performance calculated by GaitRite system based on
spatial and temporal gait parameters
6- The dominant side and the affected side were not identified
7- The amount of COP displacement were smaller for PD in all directions compared to controls
8- TMS evoked thumb flexion was used for testing the effect of practice
9- All changes were significanlty higher for those who practiced with metronome, compared to
those who practiced thumb extension with no cues.
10- synchronization error is defined as the absolute time difference between metronome beat and
foot contact
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A-APPENDIX E
Table 4. This table summerizes the major finidings of the practice effect of auditory stimulation
on movement characteristics for Parkinson’s disease.
Rehab
Subjects,
Duration No Improvements Major changes
Source
Age, PD
duration
Walking an 8m
19 PDon,
3 weeks PD: EMG pattern PD:  Gait
Miller et al.
walkway with
71yrs, 7.2 yrs, 25
variability (VL),
1996
speed, Stride
metronome beats H&Y: 2-3
minutes a Temporal
length,  EMG
embeded in
18 Cont,
day
variability (GM,
pattern symmetry
rhythmically
68yrs
TA & VL), EMG (TA),  EMG
accented music
pattern symmetry pattern variability
(GM, VL),
(GM & TA)
Temporal
symmetry (GM,
TA &VL)
1-Walking on a
Experimental 3 weeks (EX, T, NT) Flat (EX) Flat
Thaut et al.
6m flat surface
(EX): 15
7
walkway:
walkway:
1996
and a 3m inclined PDon, 69 yrs, days/week Temporal
Velocity,
surface with
7.2 yrs, H&Y: 30
variability (TA,
Cadence
metronome beats 2.3
minutes GM, VL),
Timing (VL),
embedded in
Training,
Activation
Stride length
music:
similar to EX
symmetry (TA,
(EX, T) inclined
a) set at a
but no cues
GM, VL), Timing walkway:
comfortable (T): 11 PDon,
[2] (TA, GM)
Velocity
cadence
74 yrs, 5.4
(EX) Flat
(T) Flat
b) set at 5-10% yrs, H&Y: 2.5
walkway: Onset walkway:
above
duration (GM, TA, Velocity,
Non-training
comfortable (NT): 11
VL), Termination
Stride length
cadence
PDon, 71 yrs,
duration (GM)
(NT) Flat &
c) set at 10-15% 8.5 yrs, H&Y:
(T, NT) Flat
Inclined
above the
2.6
walkway:
walkway:
comfortable
Cadence, Timing
Velocity
cadence [1]
(VL)
2-Stair stepping to
(NT) Flat
a-c
walkway: Stride
3-Stop and go to
length
a-c
Walking with a
12 PDon,
1 week
Freeze duration,
Gait duration, Cubo et al.
metronome at
65.8 yrs, 12.4
Number of freezes,
2004
preferred cadence. yrs, H&Y: 2-4
Average duration
Testing: walked freezers
of all freezes
60ft with 1
doorway & 2
turns.
Walking 30m
15 PDon,
4weeks
PD:
del Olmo et
with a metronome 61.7 yrs, 7.26 5
Velocity, Step al. 2005
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set at 30 to 150
yrs, H&Y: 2 days/week
length,
bpm with and
15 Cont, 63 60
Cadence, 
without upper
yrs
minutes
Variability of
limb movements
step duration
Walking 30m
9 PDon, 61
5 times a PD (movement): PD, (PET scan): del Olmo et
and/or performing yrs, 5.7 yrs,
week,
Cadence, Gait
al. 2006
Metabolism—
uni- or bi-lateral H&Y: 1-2
4weeks
speed,
temporo-parietal
arm movements 5 Cont, 63
60
Stride length
conjunction,
movements with yrs
minutes
cerebellum,
and without the
dentate
use of a
PD (movement):
metronome set at
Step duration
30-150 bpm.
variability,
Testing:
Finger tapping
movement and
variability
PET scan
Gastrocnemius (GM); Hoehn and Yahr scale (H&Y); healthy control subjects (Cont);
Parkinson’s Disease (PD); on medication (PDon); off medication (PDoff); Positron Emission
Tomography (PET); Soleus muscle (SOL); Tibialis Anterior (TA); Vastus Lateralis (VL)
1- After each week of training the frequency of the metronome beats increased by 5%
2- Timing of a muscle represents the temporal focus of EMG activity where higher values reflect
―EMG activity focused in a small percentage of the gait cycle‖
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APPENDIX B--- APPLIED FUNCTIONAL MEASURES

UPDRS II (ADLs) & III (Motor) & Composite (13-15, 29-30)

II. Activities of daily living
5. Speech
0—Normal.
1—Mildly affected. No difficulty being understood.
2—Moderately affected. Sometimes asked to repeat statements.
3—Severely affected. Frequently asked to repeat statements.
4—Unintelligible most of the time.
6. Salivation
0—Normal.
1—Slight but definite excess of saliva in mouth; may have nighttime drooling.
2—Moderately excessive saliva; may have minimal drooling.
Unified Parkinson’s Disease Rating Scale
3—Marked excess of saliva with some drooling.
4—Marked drooling; requires constant tissue or handkerchief.
7. Swallowing
0—Normal.
1—Rare choking.
2—Occasional choking.
3—Requires soft food.
4—Requires nasogastric tube or gastrotomy feeding.
8. Handwriting
0—Normal.
1—Slightly slow or small.
2—Moderately slow or small; all words are legible.
3—Severely affected; not all words are legible.
4—The majority of words are not legible.
9. Cutting food and handling utensils
0—Normal.
1—Somewhat slow and clumsy, but no help needed.
2—Can cut most foods, although clumsy and slow; some help needed.
3—Food must be cut by someone, but can still feed slowly.
4—Needs to be fed.
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10. Dressing
0—Normal.
1—Somewhat slow, but no help needed.
2—Occasional assistance with buttoning, getting arms in sleeves.
3—Considerable help required, but can do some things alone.
4—Helpless.
11. Hygiene
0—Normal.
1—Somewhat slow, but no help needed.
2—Needs help to shower or bathe, or very slow in hygienic care.
3—Requires assistance for washing, brushing teeth, combing hair, going to bathroom.
4—Foley catheter or other mechanical aids.
12. Turning in bed and adjusting bed clothes
0—Normal.
1—Somewhat slow and clumsy, but no help needed.
2—Can turn alone or adjust sheets, but with great difficulty.
3—Can initiate, but not turn or adjust sheets alone.
4—Helpless.
13. Falling (unrelated to freezing)
0—None.
1—Rare falling.
2—Occasionally falls, less than once per day.
3—Falls an average of once daily.
4—Falls more than once daily.
14. Freezing when walking
0—None.
1—Rare freezing when walking; may have start-hesitation.
2—Occasional freezing when walking.
3—Frequent freezing. Occasionally falls from freezing.
4—Frequent falls from freezing.
15. Walking
0—Normal.
1—Mild difficulty. May not swing arms or may tend to drag leg.
2—Moderate difficulty, but requires little or no assistance.
3—Severe disturbance of walking, requiring assistance.
4—Cannot walk at all, even with assistance.
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16. Tremor
0—Absent.
1—Slight and infrequently present.
2—Moderate; bothersome to patient.
3—Severe; interferes with many activities.
4—Marked; interferes with most activities.
17. Sensory complaints related to parkinsonism
0—None.
1—Occasionally has numbness, tingling, or mild aching.
2—Frequently has numbness, tingling, or aching; not distressing.
3—Frequent painful sensations.
4—Excruciating pain.
III. Motor examination
18. Speech
0—Normal.
1—Slight loss of expression, diction, and/or volume.
2—Monotone, slurred but understandable; moderately impaired.
3—Marked impairment, difficult to understand.
4—Unintelligible.
19. Facial expression
0—Normal.
1—Minimal hypomimia, could be normal ―poker face.‖
2—Slight but definitely abnormal diminution of facial expression.
3—Moderate hypomimia; lips parted some of the time.
4—Masked or fixed facies with severe or complete loss of facial expression; lips parted 0.25 in. or more.
20. Tremor at rest
0—Absent.
1—Slight and infrequently present.
2—Mild in amplitude and persistent or moderate in amplitude, but only intermittently present.
3—Moderate in amplitude and present most of the time.
4—Marked in amplitude and present most of the time.
21. Action or postural tremor of hands
0—Absent.
1—Slight; present with action.
2—Moderate in amplitude, present with action.
3—Moderate in amplitude with posture holding as well as action.
4—Marked in amplitude; interferes with feeding.
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22. Rigidity (judged on passive movement of major joints with patient relaxed in sitting position;
cogwheeling to be ignored)
0—Absent.
1—Slight or detectable only when activated by mirror or other movements.
2—Mild to moderate.
3—Marked, but full range of motion easily achieved.
4—Severe, range of motion achieved with difficulty.
23. Finger taps (patient taps thumb with index finger in rapid succession, with widest amplitude possible,
each hand separately)
0—Normal.
1—Mild slowing and/or reduction in amplitude.
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.
4—Can barely perform the task.
24. Hand movements (patient opens and closes hand in rapid succession with widest amplitude possible,
each hand separately)
0—Normal.
1—Mild slowing and/or reduction in amplitude.
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.
4—Can barely perform the task.
25. Rapid alternating movements of hands (pronation-supination movements of hands, vertically or
horizontally, with as large an amplitude as possible, both hands simultaneously)
0—Normal.
1—Mild slowing and/or reduction in amplitude.
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.
4—Can barely perform the task.
26. Foot agility (patient taps heel on ground in rapid succession, picking up entire foot; amplitude should
be approximately 3 in.)
0—Normal.
1—Mild slowing and/or reduction in amplitude.
2—Moderately impaired. Definite and early fatiguing. May have occasional arrests in movement.
3—Severely impaired. Frequent hesitation in initiating movements or arrests in ongoing movement.
4—Can barely perform the task.
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27. Arising from chair (patient attempts to arise from a straight-back wood or metal chair with arms
folded across chest)
0—Normal.
1—Slow; or may need more than one attempt.
2—Pushes self up from arms of seat.
3—Tends to fall back and may have to try more than one time, but can get up without help.
4—Unable to arise without help.
28. Posture
0—Normal erect.
1—Not quite erect, slightly stooped posture; could be normal for older person.
2—Moderately stooped posture, definitely abnormal; can be slightly leaning to one side.
3—Severely stooped posture with kyphosis; can be moderately leaning to one side.
4—Marked flexion with extreme abnormality of posture.
29. Gait
0—Normal.
1—Walks slowly, may shuffle with short steps, but no festination or propulsion.
2—Walks with difficulty but requires little or no assistance; may have some festination, short steps, or
propulsion.
3—Severe disturbance of gait, requiring assistance.
4—Cannot walk at all, even with assistance.
30. Postural stability (response to sudden posterior displacement produced by pull on shoulders while
patient erect with eyes open and feet slightly apart; patient is prepared)
0—Normal.
1—Retropulsion but recovers unaided.
2—Absence of postural response; would fall if not caught by examiner.
3—Very unstable, tends to lose balance spontaneously.
4—Unable to stand without assistance.
31. Body bradykinesia and hypokinesia (combining slowness, hesitancy, decreased arm swing, small
amplitude, and poverty of movement in general)
0—None.
1—Minimal slowness, giving movement a deliberate character; could be normal for some persons.
Possibly
reduced amplitude.
2—Mild degree of slowness and poverty of movement which is definitely abnormal. Alternatively, some
reduced amplitude.
3—Moderate slowness, poverty or small amplitude of movement.
4—Marked slowness, poverty or small amplitude of movement.
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Timed-Up-and-Go Test
The timed "Up & Go" test measures, in seconds, the time taken by an individual
to stand up from a standard arm chair (approximate seat height of 46 cm, arm
height 65 cm), walk a distance of 3 meters (approximately 10 feet), turn, walk
back to the chair, and sit down again.
The subject wears his/her regular footwear. If participant’s usually use assistive
devices such as canes or walkers, they should use them during the test, but this
should be indicated on the data collection form. No physical assistance is given.
Setting Up the test area
Determine a path free from obstruction
Place a chair with arms at one end of the path.
Mark off a 3 m (10 ft.) distance using tape or a cone or other clear
marking.
Start the test
Speak clearly and slowly.
Inform participant of sequence and outcome: ―When I say go, you will stand up from the chair, walk to
the mark(cone) on the floor, turn around, walk back to the chair
and sit down.‖ ―I will be timing you using the stopwatch.‖
Ask participants to repeat the instructions to make sure they
understand.
Participant starts with their back against the chair, their arms resting on
the arm rests, and their walking aid at hand
Using a cue like ―Ready, set, go‖ might be useful.
Either a wrist-watch with a second hand or a stop-watch can be used to
time the performance
Adopted from: Thrane, G., Joakimsen, R. M., & Thornquist, E. (2007). The association between timed up
and go test and history of falls: the Tromso study. BMC Geriatr, 7, 1.
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Dynamic Gait Index

1. Gait level surface _____
Instructions: Walk at your normal speed from here to the next mark (20’)
Grading: Mark the lowest category that applies.
(3)
Normal: Walks 20’, no assistive devices, good sped, no evidence for imbalance, normal gait
pattern
(2)
Mild Impairment: Walks 20’, uses assistive devices, slower speed, mild gait deviations.
(1)
Moderate Impairment: Walks 20’, slow speed, abnormal gait pattern, evidence for imbalance.
(0)
Severe Impairment: Cannot walk 20’ without assistance, severe gait deviations or imbalance.
2. Change in gait speed _____
Instructions: Begin walking at your normal pace (for 5’), when I tell you ―go,‖ walk as fast as you can
(for 5’). When I tell you ―slow,‖ walk as slowly as you can (for 5’).
Grading: Mark the lowest category that applies.
(3)
Normal: Able to smoothly change walking speed without loss of balance or gait deviation. Shows
a significant difference in walking speeds between normal, fast and slow speeds.
(2)
Mild Impairment: Is able to change speed but demonstrates mild gait deviations, or not gait
deviations but unable to achieve a significant change in velocity, or uses an assistive device.
(1)
Moderate Impairment: Makes only minor adjustments to walking speed, or accomplishes a
change in speed with significant gait deviations, or changes speed but has significant gait
deviations, or changes speed but loses balance but is able to recover and continue walking.
(0)
Severe Impairment: Cannot change speeds, or loses balance and has to reach for wall or be
caught.
3. Gait with horizontal head turns _____
Instructions: Begin walking at your normal pace. When I tell you to ―look right,‖ keep walking straight,
but turn your head to the right. Keep looking to the right until I tell you, ―look left,‖ then keep walking
straight and turn your head to the left. Keep your head to the left until I tell you ―look straight,― then keep
walking straight, but return your head to the center.
Grading: Mark the lowest category that applies.
(3)
Normal: Performs head turns smoothly with no change in gait.
(2)
Mild Impairment: Performs head turns smoothly with slight change in gait velocity, i.e., minor
disruption to smooth gait path or uses walking aid.
(1)
Moderate Impairment: Performs head turns with moderate change in gait velocity, slows down,
staggers but recovers, can continue to walk.
(0)
Severe Impairment: Performs task with severe disruption of gait, i.e., staggers
outside 15‖ path, loses balance, stops, reaches for wall.
4. Gait with vertical head turns _____
Instructions: Begin walking at your normal pace. When I tell you to ―look up,‖ keep walking straight, but
tip your head up. Keep looking up until I tell you, ―look down,‖ then keep walking straight and tip your
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head down. Keep your head down until I tell you ―look straight,― then keep walking straight, but return
your head to the center.
Grading: Mark the lowest category that applies.
(3)
Normal: Performs head turns smoothly with no change in gait.
(2)
Mild Impairment: Performs head turns smoothly with slight change in gait velocity, i.e., minor
disruption to smooth gait path or uses walking aid.
(1)
Moderate Impairment: Performs head turns with moderate change in gait velocity, slows down,
staggers but recovers, can continue to walk.
(0)
Severe Impairment: Performs task with severe disruption of gait, i.e., staggers
outside 15‖ path, loses balance, stops, reaches for wall.
5. Gait and pivot turn _____
Instructions: Begin walking at your normal pace. When I tell you, ―turn and stop,‖ turn as quickly as you
can to face the opposite direction and stop.
Grading: Mark the lowest category that applies.
(3)
Normal: Pivot turns safely within 3 seconds and stops quickly with no loss of balance.
(2)
Mild Impairment: Pivot turns safely in > 3 seconds and stops with no loss of balance.
(1)
Moderate Impairment: Turns slowly, requires verbal cueing, requires several small steps to catch
balance following turn and stop.
(0)
Severe Impairment: Cannot turn safely, requires assistance to turn and stop.
6. Step over obstacle ____
Instructions: Begin walking at your normal speed. When you come to the shoebox, step over it, not
around it, and keep walking.
Grading: Mark the lowest category that applies.
(3)
Normal: Is able to step over the box without changing gait speed, no evidence of imbalance.
(2)
Mild Impairment: Is able to step over box, but must slow down and adjust steps to clear box
safely.
(1)
Moderate Impairment: Is able to step over box but must stop, then step over. May require verbal
cueing.
(0)
Severe Impairment: Cannot perform without assistance.
7. Step around obstacles _____
Instructions: Begin walking at normal speed. When you come to the first cone (about 6’ away), walk
around the right side of it. When you come to the second cone (6’ past first cone), walk around it to the
left.
Grading: Mark the lowest category that applies.
(3)
Normal: Is able to walk around cones safely without changing gait speed; no evidence of
imbalance.
(2)
Mild Impairment: Is able to step around both cones, but must slow down and adjust steps to clear
cones.
(1)
Moderate Impairment: Is able to clear cones but must significantly slow, speed to accomplish
task, or requires verbal cueing.
(0)
Severe Impairment: Unable to clear cones, walks into one or both cones, or requires physical
assistance.
8. Steps _____
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Instructions: Walk up these stairs as you would at home, i.e., using the railing if necessary. At the top,
turn around and walk down.
Grading: Mark the lowest category that applies.
(3)
Normal: Alternating feet, no rail.
(2)
Mild Impairment: Alternating feet, must use rail.
(1)
Moderate Impairment: Two feet to a stair, must use rail.
(0)
Severe Impairment: Cannot do safely.
Adopted from: Shumway-Cook A, Woollacott M. Motor Control Theory and Applications, Williams and
Wilkins Baltimore, 1995: 323-324
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Tinetti Mobility Test
Tinetti Assessment Tool: Balance
Initial Instructions: Subject is seated in a hard, armless chair. The following maneuvers are tested.
1. Sitting balance: Leans or slides in chair =0
Steady, safe =1
2. Arises: Unable without help =0
Able, uses arms to help =1
Able without using arms =2
3. Attempts to arise: Unable without help =0
Able, requires> 1 attempt =1
Able to arise, 1 attempt =2
4. Immediate standing balance (first five seconds):
Unsteady (swaggers, moves feet, trunk sway =0
Steady but uses walker or other support =1
Steady without walker or other support =2
5. Standing balance Unsteady =0
Steady but wide stance (medial heels >4 in.
apart) and uses cane or other support =1
Narrow stance without support =2
6. Nudged (subject at maximum position with feet as close
together as possible, examiner pushes lightly on
subject’s sternum with palm of hand 3 times):
Begins to fall =0
Staggers, grabs, catches self =1
Steady =2
7. Eyes Closed (at maximum position No. 6)
Unsteady =0
Steady =1
8. Turning 360 degrees Discontinuous Steps =0
Continuous =1
Unsteady (grabs, staggers) =0
Steady =1
9. Sitting down Unsafe (misjudges distance, falls into chair) =0
Uses arms or not a smooth motion =1
Safe, smooth motion =2
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Tinetti Assessment Tool: Gait
Initial instructions: Subject stands with examiner, walks down hallway or across room, first at ―usual‖
pace, then back at ―rapid, but safe‖ pace (using usual walking aids).
10. Initiation of gait (immediately after told to ―go‖)
Any hesitancy or multiple attempts to start =0
No hesitancy =1
11. Step length and height
a. Right swing foot: does not pass left stance foot with step =0
passes left stance foot =1
right foot does not clear floor completely with step =0
right foot completely clears floor =1
b. Left swing foot: does not pass right stance foot with step =0
passes right stance foot =1
left foot does not clear floor completely with step =0
left foot completely clears floor =1
12. Step Symmetry
Right and left step length not equal (estimate) =0
Right and left step appear equal =1
13. Step Continuity
Stopping or discontinuity between steps =0
Steps appear continuous =1
14. Path (estimated in relation to floor tiles, 12-inch diameter;
observe excursion of 1 foot over about 10 ft. of
the course.)
Marked deviation =0
Mild/moderate deviator or uses walking aid =1
Straight without walking aid =2
15. Trunk Marked sway or uses walking aid =0
No sway but flexion of knees or back or spreads
arms out while walking =1
No sway, no flexion, no use of arms, and not use
of walking aid =2
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16. Walking Time Heels apart =0
Heels almost touching while walking =1

Adopted from: Tinetti ME. Performance-oriented assessment of mobility problems in elderly
patients. J Am Geriatr Soc.
1986;34:119-126.
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Freezing of Gait Questionnaire
Freezing of Gait Questionnaire (FOGQ)
1. During your worst state—do you walk:
0 Normally
1 Almost normally—somewhat slow
2 Slow but fully independent
3 Need assistance or walking aid
4 Unable to walk
2. Are your gait difficulties affecting your daily activities and independence?
0 Not at all
1 Mildly
2 Moderately
3 Severely
4 Unable to walk
3. Do you feel that your feet get glued to the floor while walking, making a turn or when trying to initiate
walking (freezing)?
0 Never
1 Very rarely—about once a month
2 Rarely—about once a week
3 Often—about once a day
4 Always—whenever walking
4. How long is your longest freezing episode?
0 Never happened
11–2s
2 3 – 10 s
3 11 – 30 s
4 Unable to walk for more than 30 s
5. How long is your typical start hesitation episode (freezing when initiating the first step)?
0 None
1 Takes longer than 1 s to start walking
2 Takes longer than 3 s to start walking
3 Takes longer than 10 s to start walking
4 Takes loner than 30 s to start walking
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6. How long is you typical turning hesitation (freezing when turning)?
0 None
1 Resume turning in 1 – 2 s
2 Resume turning in 3 – 10 s
3 Resume turning in 11 – 30 s
4 Unable to resume turning for more than 30 s
Adopted from: Giladi, N., Shabtai, H., Simon, E. S., Biran, S., Tal, J., & Korczyn, A. D. (2000).
Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat
Disord, 6(3), 165-170.
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APPENDIX C--- AVERAGE STEP NUMBER AND AVERAGE RAS BEATS
Average step number from participants in the C (Cue) group and the average number of rhythmic
auditory stimulation (RAS) beats for different speeds are presented below.

Participant

Slow
steps

Slow
RAS-beat

Normal
steps

Normal
RAS-beat

Fast
RAS-beat

Fast
RAS-beat

C1

11.31

13

15.52

16

16.32

18

C2

9.02

11

13.36

13

13.436

15

C3

6.11

8

9.35

10

12.51

13

C4

5.33

6

7.28

8

10.35

10

C5

6.15

7

8.38

9

12.01

12

C6

6.07

8

10.31

11

11.42

12

C7

4.37

5

6.13

7

8.13

9

C8

8.34

10

11.12

12

13.71

14
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